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Summary
The 5-HT3 serotonin receptor belongs to the cys-loop ligand-gated ion channel
(LGIC) family. It is located in the central and peripheral nervous system and is
implicated in certain pathologic situations. The 5-HT3 receptor is investigated here,
as a typical example of these LGIC’s, to elucidate its structure and dynamics in
living cells.
Distribution, receptor-ligand interaction and low-resolution structural infor-
mation of the 5-HT3 receptor were determined using a new method for protein
labelling (chapter 2). This generic method does not require the fusion of bulky flu-
orophores or other moieties to the target molecule. Instead, small nickel-chelating
nitrilotriacetate probes are used that bind specifically and reversibly to polyhistidine
loops on the target proteins.
The lateral mobility of the 5-HT3 in different functional states was investigated
by single-molecule microscopy using the newly developed repetitive protein labelling
method (chapter 3). A significant reduction of the lateral mobility of the desensitized
receptor was observed indicating the role of serotonin in modulating the diffusion of
the receptor, which might be important in the development of the synapse.
Conformational transitions of the 5-HT3 receptor were investigated by tether-
ing a fluorophore to a single cysteine side chain introduced at the 20’ position in the
TM2 region (chapter 4). During serotonin application, fluorescence decreased by
∼18% indicating a change of the fluorophore environment. Eighteen single cysteine
receptors were characterized for functionality and cysteine accessibility.
Finally, electrical current through single activated 5-HT3 mutant receptors was
measured (chapter 5). Five different conductance levels were determined and noise
analysis of current fluctuations in the open states of the activated receptor revealed
a 1/f α dependence with α < 1. According to a proposed model, the oscillating
domain responsible of the current fluctuations contains charged amino acids.
These results contribute to a more comprehensive model of the dynamics both
of the 5-HT3 receptor and 5-HT3 receptor within cells.
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Version abre´ge´e
Le re´cepteur de la se´rotonine 5-HT3 appartient a` la famille des canaux ioniques
active´s par un ligand de type cys-boucle. Il est localise´ dans le syste`me nerveux
central et pe´riphe´rique, et est implique´ dans diffe´rentes pathologies. Le re´cepteur
5-HT3 est utilise´ ici comme exemple typique de ces canaux ioniques active´s par un
ligand pour e´lucider sa structure et sa dynamique dans des cellules vivantes.
La distribution, l’interaction ligand-re´cepteur ainsi que des informations struc-
turelles a` faible re´solution ont e´te´ de´termine´es en utilisant une nouvelle me´thode de
marquage de prote´ines (chapitre 2). Cette me´thode ge´ne´rique ne requiert pas la
fusion de fluorophores volumineux a` la molecule d’inte´reˆt. De petites sondes de ni-
trilotriacetate che´latant du nickel suffisent a` lier de manie`re spe´cifique et re´versible
les boucles de polyhistidines de la mole´cule d’inte´reˆt .
La mobilite´ late´rale du 5-HT3 dans diffe´rents e´tats fonctionnels a e´te´ e´tudie´e
par microscopie de mole´cule unique en utilsant la nouvelle me´thode de marquage
re´pe´titif de prote´ines (chapitre 3). Une diminution significative de la mobilite´ late´rale
du re´cepteur de´sensibilise´ a e´te´ observe´e indiquant le roˆle de la se´rotonine comme
modulateur de la diffusion du re´cepteur, ce qui doit eˆtre important dans le de´veloppe-
ment des synapses.
Les transitions conformationnelles du re´cepteur 5-HT3 ont e´te´ e´tudie´es en at-
tachant un fluorophore a` la chaˆıne late´rale d’une cyste´ine unique introduite a` la po-
sition 20’ du second segment transmembranaire (chapitre 4). Pendant l’application
de se´rotonine, la fluorescence a diminue´ de 18% indiquant un changement de l’envi-
ronnement du fluorophore. Dix-huit re´cepteurs contenant une seule cyste´ine ont e´te´
caracte´rise´s pour leur fonctionnalite´ et l’accessibilite´ de la cyste´ine.
Finallement, le courant e´lectrique traversant un seul mutant du re´cepteur 5-
HT3 a e´te´ mesure´ (chapitre 5). Cinq niveaux diffe´rents de conductance ont e´te´
de´termine´s et l’analyse de bruit des fluctuations de courant dans les e´tats ouverts
du re´cepteur active´ a indique´ une de´pendance du bruit de 1/f α avec α < 1. Selon
xi
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un mode`le propose´, le domaine d’oscillation responsable des fluctuations de courant
contient des acides amine´s charge´s.
Ces re´sultats contribuent a` un mode`le plus complet de la dynamique du re´-
cepteur lui-meˆme ainsi que la dynamique du re´cepteur dans les cellules.
Chapter 1
General introduction
Investigating and understanding the function, structure, interactions and dynamics
of proteins that regulate biochemical networks of cells and organisms are of great
importance because they are central to life. They deliver a fundamental view at
the molecular level on how a cell works and the correlation between disfunction of
biomolecules and disease. Therefore, these studies are of interest for medicine as
well as pharmaceutical industry, allowing the design of new selective and specific
drugs and new therapeutic methods.
Ligand-gated ion channels (LGIC) are excellent drug targets. They are re-
sponsible for electrical signaling in muscles, nerves and synapses and are therefore
associated with a wide range of important pathologies. The investigation of the
serotonin type 3A receptor, a representative member of the LGIC family, is go-
ing to contribute to the understanding of the molecular structural dynamics of this
marvellous machinery, which is the scope of this thesis.
This introduction presents general information on the domain of ion channels
and ligand-gated ion channels with emphasis of the serotonin type 3 receptor.
1.1 The concept of transmembrane signalling
The ability of cells to receive and respond to signals origenating in the plasma mem-
brane is fundamental to life. Bacterial cells receive constant input from membrane
receptors to sample the surrounding medium for pH, osmotic strength, availability
of food, oxygen and light. These signals elicit appropriate responses, such as motion
towards food or away from toxic substances (chemotaxis). In multicellular organ-
isms, cells that have different functions exchange a wide variety of signals. Plant cells
respond to growth hormones and to variation in sunlight. Animal cells exchange in-
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formation about their correct placement in a developing embryo, the concentration
of ions and glucose in extracellular fluids and interdependent metabolic activities
taking place in different tissues. The signal in animals may be autocrine (acting on
the same cell that produces them), paracrine (acting on a near neighbor), or en-
docrine (carried through the bloodstream from the signal producing cell to a distant
target cell). In all three cases, the signal is detected by a specific receptor and is
converted to a cellular response.
Although the number of biological signals is large (antigens, growth factors,
hormones, light, mechanical touch, neurotransmitters, odorants, pheromones, tas-
tants, . . . ), as is the variety of biological responses to these signals, organisms use
just a few evolutionary conserved mechanisms to detect extracellular signals and
transduce them into intracellular changes.
Signal transduction is remarkably specific and exquisitely sensitive. Three fac-
tors account for the extraordinary sensitivity of signal transducers: the high affinity
and specificity of receptors for signal molecules, the cooperativity in the ligand-
receptor interaction and the amplification of the signal. The high affinity of signal
transducers is achieved by precise molecular complementarity between the signal
and receptor molecules, mediated by the same kinds of weak (noncovalent) forces
that occur in enzyme-substrate and antigen-antibody interactions. In multicellular
organisms, specificity is further promoted because the receptors for a given signal,
or the intracellular targets of a given signal pathway, are present only in certain cell
types.
In other words, and in a very broad sense, a receptor can be regarded as a mole-
cular switch which controls the delivery of a message. Being a protein, a receptor
is not a rigid structure, but exists in a variety of more or less stable conformational
states that are in thermodynamic equilibrium [1,2].
The investigated serotonin type 3A receptor (5-HT3A), a member of the ligand-
gated ion channel (LGIC) family, is a channel gated (i.e. opened) by the binding
of the neurotransmitter serotonin. The signal generated through receptor activa-
tion is a depolarization of the cellular membrane caused by cation flux down their
electrochemical gradient triggering a cascade of intracellular events.
1.2 Serotonin: discovery, structure and function
Serotonin or 5-hydroxytryptamine (5-HT), a biogenic monoamine, is widely distrib-
uted both in animal and plant kingdoms. In mammals, high concentrations of 5-HT
are found in the enterochromaffin cells of gastrointestinal mucosa, in the central ner-
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vous system and in blood platelets. 5-HT was first detected in the gastrointestinal
tract and blood serum.
The premise for the discovery of serotonin is a very old observation, going
back to 1868 [3,4]. When physiologists tried to perfused isolated organs with serum
or defibrinated blood, they invariably encountered a disturbing vasoconstriction.
This was studied later in more detail by a number of investigators who gave the
responsible compound various names, such as serum vasoconstriction, adrenaline-like
substance of blood, Spa¨tgift, etc [5]. The origin of this vasoconstrictor principle from
platelets was recognized very early. It is in 1948 that Rapport and Page resumed the
problem with more advanced methodology [6]. Starting from the serum obtained
from two tons of beef blood [7], they succeeded in isolating a creatinine serum
vasoconstrictor complex, having a pharmacological component. The constitutional
formula 5-hydroxytryptamine was suggested for the vasoconstrictor principle, which
was given the name serotonin. This name indicates that its source is serum and its
activity is one causing constriction and blood pressure increase [8].
Independently, Erspamer had discovered in 1940 a factor called enteramine, in
gut mucosa that was later shown to be identical to serotonin. In 1951 synthesis by
Hamlin and Fischer confirmed the chemical structure of serotonin [9]. It had become
clear that 5-HT is not only present in the serum and that its action is certainly not
limited to constriction of the smooth muscles [10].
Physiological functions of 5-HT include regulation of blood pressure, cardiac
function, gastric and enteric motility, nociception and sleep. Although only 1-2% of
the total body content of 5-HT is present in the brain, the action of 5-HT as chemical
messenger (neurotransmitter) between neurons in the central nervous system has
received much attention. Malfunction of the 5-HT system has been implicated to
play a role in the aetiology of several neuronal disorder like depression, schizophrenia,
aggression, anxiety, stress, withdrawal effect from addiction, eating disorders and
migraine [11–16].
The biosynthesis of serotonin starts from the essential amino acid L-tryptophan
following a simple pathway (figure 1.1). Its synthesis is similar to that found for
catecholamines, a family of compounds including dopamine, norepinephrine, and
epinephrine derived from the amino acid tyrosine. Serotonin is formed by the 5-
hydroxylation of tryptophan to form 5-hydroxytryptophan followed by the rapid
decarboxylation of 5-hydroxytryptophan to give 5-hydroxytryptamine (5-HT) also
called serotonin. The first and rate-limiting reaction in this sequence is catalyzed
by tryptophan-5-hydroxylase, an enzyme which belongs to the family of amino acid
hydroxylases [17]. The 5-hydroxylase utilizes two substrates, L-tryptophan and
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molecular oxygen, as well as a reduced pterin cofactor (L-erythro-5,6,7,8-tetrahydro-
biopterin), which serves as an electron donor [18]. The second step in the reac-
tion pathway requires the aromatic L-alpha amino acid decarboxylase; a soluble
pyridoxal-5’-phosphate (PLP) dependent enzyme, with a wide substrate specificity.
5-hydroxytryptophan, which occurs in trace amount, is one of its preferred sub-
strates and is rapidly decarboxylated to 5-HT in serotonergic neurons. As with
other transmitters, serotonin is sequestered in storage vesicles where it is held
prior to release [19]. Serotonin that is not sequestered is rapidly metabolized to
5-hydroxyindoleacetic acid through the actions of monoamine oxidase, which oxida-
tively deaminates the amine to 5-hydroxyindoleacetaldehyde, and aldehyde dehydro-
genase which oxidizes the aldehyde to the corresponding acid (for review see [20]).
N
NH2
OH
O
N
NH2
OH
O
HO
N
HO NH2
L-tryptophan
Serotonin, 5-HT
5-hydroxytryptophan
H H
H2OO2
Tetrahydrobiopterin Dihydrobiopterin
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CO2
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Aromatic L-alpha amino 
  acid decarboxylase
Figure 1.1: Serotonin biosynthesis. Two steps are required to convert L-
tryptophan into serotonin. These steps are catalyzed by specific enzymes, the
tryptophan-5-hydroxylase and the aromatic L-alpha amino acid decarboxylase.
1.3 Receptor classification
The current classification of receptors, proposed by the International Union of
Pharmacology Committee for Receptor Nomenclature and Drug Classification (NC-
IUPHAR), gives to pharmacologists a common language that avoid ambiguity and
inconsistent terminology, as well as a systematic scheme of classification, which is
in itself an important generic research approach in biological science.
Criteria for receptor characterization are based on a combination of infor-
mation derived from the receptor’s amino acid sequence, pharmacology and signal
transduction mechanisms [21–24]. Of these essential criteria, amino acid sequences
of proteins provide a basis for classification into superfamilies. Many receptor pro-
teins with similarities between their primary sequence, differ pharmacologically but
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are functionally similar, as they share a single molecular signal transduction mecha-
nism. This common structure-common function concept is not unique to receptors,
but arises from the observation that families of proteins are probably derived from
a common ancestral gene [25].
Out of this classification from the IUPHAR are four main receptor structure
classes: ion channels and ligand-gated ion channels (LGIC’s), G protein-coupled
receptors (GPCR’s) (seven-transmembrane domain), enzyme-associated receptors
with subunits having one membrane-inserted domain, transcription factor receptors.
Each of theses classes includes superfamilies of receptors. For instance, the serotonin
type 3 receptor belongs to the cys-loop superfamily, which is a member of the ligand-
gated ion channel group. Therefore, the 5-HT3 receptor shares similar features
with the other members of the superfamily. For more information regarding the
classification procedures, receptors numbering and codes, visit the IUPHAR web
page (http://www.iuphar.org).
1.4 Receptors activated by serotonin
Gaddum and Picarelli [26] in 1957 were the first to suggest the existence of more than
one type of 5-HT receptor. They demonstrated that functional responses of guinea
pig ileum (a region in the bowel) could be partially blocked by morphine (M), whilst
the remainder of the response was inhibited by dibenzyline (D). They proposed
therefore a subdivision of these novel receptors naming them M and D respectively.
Actually, neither morphine nor dibenziline is a specific 5-HT antagonist. Morphine
blocks nerve-mediated excitatory responses to 5-HT because it inhibits the release
of acetylcholine, which is a final common excitatory neurotransmitter to enteric
smooth muscle [27, 28]. Dibenzyline is an alkylating agent that inactivates non-
specifically a number of receptors on smooth muscle cells. Despite the fact that the
drugs used to distinguish receptor subtypes were physiological antagonists, they did
establish that there are separate neuronal and muscle 5-HT receptors in the bowel.
More recent research has not only led to the development of specific antagonists
that actually act on 5-HT receptors, but to the realization that there is not only one
neuronal and one muscular receptor subtype for 5-HT but many of them [15]. In
1986, Bradley et al. [29] established a classification scheme for the subtypes of 5-HT
receptors known until then. He based his rational on binding studies of selective
pharmacological agents. In the years following this classification, the application
of molecular biological technology had a major impact in the 5-HT field, allowing
the discovery of many additional 5-HT receptors. Up to now, seven types have
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been reported, 5-HT1−7 comprising 14 structurally and pharmacologically distinct
mammalian 5-HT receptors. The Gaddum’s D and M forms of serotonin receptors
are now, according to this nomenclature, related to the 5-HT2 and 5-HT3 receptors
respectively.
Intense scrutiny has now revealed much about the functional properties of
different 5-HT receptors subtypes. At the molecular level, it has been established,
largely using recombinant receptor models and hydropathy profiles, that the 5-HT
receptors are seven transmembrane spanning, G-protein coupled receptors (GPCR)
5-HT1, 5-HT2, 5-HT4, 5-HT5, 5-HT6 and 5-HT7, with the exception of the 5-HT3
receptor, which is a ligand-gated ion channel. These families can be then divided into
subclasses denoted by letters (table 1.1). In the brain, the function of many 5-HT
receptors can now be unequivocally associated with specific physiological responses,
ranging from modulation of neuronal activity and transmitter release to behavioral
changes (for review [30–32]).
Among these receptors, the 5-HT3 receptor takes a special place. It is phyloge-
netically much older than the other serotonin receptors, all of which have developed
from a single primordial 5-HT receptor and belong to the G-protein coupled receptor
family.
Table 1.1: Classification of the 5-HT receptors.
Subtypes Major signalling pathway
5-HT1 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT1F cAMP
5-HT2 5-HT2A, 5-HT2B, 5-HT2C IP3
5-HT3 5-HT3A, 5-HT3B, 5-HT3C, 5-HT3D, 5-HT3E Ion channel
5-HT4 - cAMP
5-HT5 5-HT5A, 5-HT5B cAMP?
5-HT6 - cAMP
5-HT7 - cAMP
1.5 Ligand-gated ion channels
1.5.1 Fast signal transduction at the synapse
Excitation of sensory cells, neurons and myocytes depends on ion channels, sig-
nal transducers that provide a regulated path for the movement of inorganic ions as
Na+, K+, Ca2+ and Cl− across the plasma membrane in response to various stimuli.
Signaling in the nervous system is accomplished by networks of neurons, specialized
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cells that carry an electrical impulse (action potential) from one end of the cell (the
cell body) through an elongated cytoplasmic extension (the axon). An electrical
impulse, or action potential, propagating along an excited neuron triggers release
of neurotransmitters molecules at the synapse of the presynaptic cell (figure 1.2).
The neurotransmitters then act transiently and specifically on receptors expressed
on the surface of the receiving postsynaptic cell [11]. Upon binding of the neuro-
transmitters to ion channels, a brief flux of ions across the post synaptic membrane
is generated, changing the postsynaptic membrane potential. The amplitude, dura-
tion and direction of this ion flux, as well as the nature of the ions traversing the
postsynaptic membrane, determines whether this response will in turn either acti-
vate voltage sensitive membrane conductance and thus initiate action potentials, or
instead reduce the cell’s electrical activity. Inhibitory (hyperpolarization of the cell
membrane) and excitatory (depolarization of the cell membrane) synaptic neuro-
transmission is mediated by ligand-gated anion (γ-amino-butyric acid type A and
C, and glycine receptors) and by cation channels (nicotinic acetylcholine, serotonin
type 3, purinergic type 2x and ionotropic glutamate receptors), respectively.
1.5.2 Structure and classification of plasma membrane ligand-gated
ion channels
The superfamily of LGIC present in the plasma membrane consists of a group of
receptors such as the nicotinic acetylcholine receptor (nACh), the serotonin type
3 receptor (5-HT3), the ionotropic type A and C γ-aminobutyric acid receptors
(GABAA, GABAC), the glycine receptor, the purinergic receptor (P2x), the ionotropic
glutamate receptor and the zinc activated channel (ZAC), which share functional
features. On the basis of the distribution of hydrophilic and hydrophobic amino
acids residues in the protein sequences (hydropathy profiles), proteolysis and bind-
ing experiments, three different categories of ligand-gated ion channels have been
proposed (figure 1.3). The transmembrane subunits are supposed to be arranged in
a ring forming the ion channel in the center.
The P2x ionotropic receptor family are cation selective, ligand-gated ion chan-
nel that open in response to the binding of extracellular ATP. P2x receptors do
not exhibit significant sequence homology with any of the other ligand-gated ion
channels and are therefore considered to represent a separate class of ligand-gated
ion channels [33]. The absence of a cleaved N-terminal signal sequence places the
N-terminus facing the cytoplasmic site of the membrane. Protein topology predicts
only two membrane spanning segments, TM1 and TM2 connected by an extracellu-
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Figure 1.2: Schematic view of a synapse. The plasma membrane of presy-
naptic neuron is initially polarized (inside negative) through the action of Na+K+
ATPase, which pumps 3 Na+ out for every 2 K+ pumped into the neuron. A stim-
ulus to this neuron causes an action potential (1) to move along the axon (arrow)
by the consecutive opening of Na+- and K+-channels. When the wave of depolar-
ization reaches the axon tip, voltage-gated Ca2+ channels open (2), allowing Ca2+
entry into the presynaptic neuron. The resulting increase of [Ca2+] triggers exo-
cytic release of neurotransmitters in the synaptic cleft (3). The neurotransmitters
bind to a receptor on the postsynaptic neuron, causing its ligand-gated ion channel
to open (4). Extracellular Na+ and Ca2+ enter through this channel, depolarizing
the postsynaptic cell (6). The electrical signal has thus passed the cell body of the
postsynaptic neuron and will move along its axon to a third neuron by this same
sequence of events. Neurotransmitters in the synaptic cleft are removed through
two pathways, uptake of the neurotransmitters by endocytosis in the presynaptic
neuron (5) or degradation by specific enzymes.
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Figure 1.3: Protein topology and models of ligand-gated ion channel
families. Based on the distribution of hydrophilic and hydrophobic residues in
the protein sequences and on biochemical experiments, three families of ligand-
gated ion channel receptors can be distinguished according to predicted structure.
TM stands for transmembrane region and BS for binding site.
lar loop; the mature P2x receptor is homotrimeric [34,35].
Glutamate receptors (GluR) form a separate class and are grouped into three
broad subtypes [36]; the kainic acid, the α-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid (AMPA) and the N-methyl-D-aspartic acid (NMDA), based on amino
acid sequence and agonist pharmacology. A typical GluR subunit consists of an
amino-terminal domain, a ligand binding domain composed of the juxtaposition of
two extracellular domains [37], three transmembrane domains with a re-entrant pore
loop and a carboxy terminal domain. The re-entrant pore is located between the
first and the second transmembrane domain. This so-called P-loop sequence lines
the channel and determines many of its electrophysiological properties. The receptor
is a tetramer assembled as dimers of dimers [38–41].
For the nACh, glycine, GABAA, GABAC, ZAC and the 5-HT3 receptors,
it is suggested that all members of this superfamily fold into four transmembrane
domains (TM1-TM4) with the N- and C-termini both located extracellularly [42–45].
In all these members, a region of strong conservation in the extended N-terminal
extracellular domains can be recognized. This region is characterized by a pair of
cysteine residues, whose positions are conserved between different subunits of the
ligand-gated ion channel. These residues may form disulfide bridges essential for the
stabilization of the tertiary structure/subunit assembly. The number of amino-acids
between the two cysteins is also conserved. This region is used as a fingerprint for
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this class of receptor that is thus called the cys-loop family. All these receptors
form homo- or heteropentamers indicating that the members of this ligand-gated
ion channel superfamily share a conserved quaternary structure. In all cys-loop
members, the pore formed by the co-assembly of five subunits is lined by residues
from five TM2 domains, and is located along the pseudo axis of symmetry of the
receptor complex.
The alignment of TM2 domains and flanking region of the cys-loop LGIC
family reveals conservation of the residues between and within the two ion selectivity
classes (anion and cation channels). The leucine residue in the 9’ position is the only
fully conserved residue (only in the 5-HT3B holds a valine residue) and is considered
as a signature for this class of receptors [46].
Coassembly of subunits beyond the boundaries of ligand-gated ion channel
families have been shown to form functional receptor. For instance, heteromeric
5-HT3/α4 nACh has similar pharmacological profiles to the homomeric 5-HT3A re-
ceptor, but distinct sensitivities to antagonists [47]. Moreover, as ligand-gated ion
channels are close relatives in the gene superfamily, it was also possible to gener-
ate chimeras. The first reported one is a chimeric nicotinic-serotonergic receptor, a
homopentamer containing at the N-terminal part the nicotinic α7-subunit and the
complementary C-terminal domain of the 5-HT3A subunit that is gated by nico-
tinic ligands [48]. Other similar homopentameric chimeras were constructed like
GABAA/glycine receptor [49], AChBP/5-HT3A receptor [50] and AChBP/glycine
receptor [51]; acetylcholine binding protein (AChBP) is a homopentamer homolo-
gous to the extracellular domain of nACh receptors, the structure of which has been
determined at atomic resolution [52]. These chimeras were mainly designed to un-
derstand the mechanism of allosteric coupling between the ligand-binding domain
and the ion channel of cys-loop ligand-gated ion channels.
1.5.3 Functional states of the ligand-gated ion channels
From a general point of view, ligand-gated ion channels open within a fraction
of seconds after binding of agonist-type ligands and close thereafter into a state
where channel opening is blocked while the ligand is still bound. After removing
the ligands, the receptor can be activated as before. Such behavior is described
in general by three distinctive functional states , the resting state or basal state
(closed) (B), the open state (A) and the desensitized state (closed) (D) as illustred
in figure 1.4. The basal state is the most stable state in the absence of agonist
and the desensitized state is the most stable state in the presence of the agonist.
1.6. The 5-HT3 receptor 11
The open state is metastable in that its concentration rises transiently and reaches
a very low value at equilibrium. The role of desensitization is uncertain but there
are indications that its kinetics can determine the size, timecourse and frequency
of transmitted signals [53]. Ligand-gated ion channels are allosteric; the oligomeric
channel contains multiple agonist-binding sites, non-competitive-antagonist sites,
and gates that interact at a distance through changes of the quaternary structure of
the receptor. They also open, albeit rarely, and desensitize in the absence of agonist.
Their behavior can therefore be described by the Monod-Wyman-Changeux (MWC)
model of allosteric interaction [54].
AB
D
Figure 1.4: Simple three states allosteric model. The simplest allosteric
model describing the functional states of the ligand-gated ion channels. It con-
sists of a basal state B, an open state A and a desensitized state D. Transition
probabilities between these states are modulated by ligand binding.
1.6 The 5-HT3 receptor
1.6.1 Physiology and pathophysiology of the 5-HT3 receptor
The serotonin type 3 receptor is a ligand-gated cation channel located in the cen-
tral and peripheral nervous system. It has also been found in a variety of other
cells like mononuclear cells, lymphocytes and intestinal enterochromaffine cells. In
the periphery, 5-HT3 receptors have been detected on pre- and postganglionic auto-
nomic neurons and on neurons of the sensory and enteric nervous system (myenteric
and submucosal plexus). A high density of 5-HT3 receptors has been found in the
following central nervous system locations (mostly on GABAergic neurons): area
postrema, nucleus tractus solitarii, nucleus accumbens, nucleus caudatus, nucleus
dorsalis nervi vagi, amygdala, hippocampus, entorhinal cortex, frontal cortex, cin-
gulate cortex and dorsal horn ganglia [55,56].
5-HT3 receptors are found in the brain predominantly in presynaptic regions
associated with axons and nerve terminals (70-80%) except in hippocampus, where
they are mostly postsynaptic receptors located on somatodendritic regions [57]. The
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predominant localization on nerve endings is consistent with a physiological role of
5-HT3 receptors in the control of neurotransmitter release [58]. On the molecular
level, activation of presynaptic 5-HT3 receptors followed by rapid depolarization of
the peripheral or central neuron causes a rapid rise in cytosolic Ca2+ concentration
by inducing calcium influx and mobilization of intracellular calcium stores as well
as modulating the release of various neurotransmitters and neuropeptides such as
dopamine, cholecystokinin, acetylcholine, γ-aminobutyric acid (GABA), substance
P or serotonin itself [59]. They have been demonstrated to be involved in sensory
transmission, regulation of autonomic functions, integration of the vomiting reflex,
pain processing and control of anxiety.
While the physiologic functions of the 5-HT3 receptor are discrete and dif-
ficult to detect, the receptor plays a key role in certain pathologic situations re-
lated to increased serotonin release. 5-HT3 receptor antagonists revealed a remark-
able range of activities [60]. They do not modify any aspect of normal animal
behavior or induce pronounced changes of physiological functions in healthy sub-
jects except for intestinal transit. Clinical efficacy was shown for various forms of
emesis like chemotherapy-induced, radiotherapy-induced, and postoperative emesis,
diarrhoea-predominant irritable bowel syndrome, skin burn wounds, anxiety, chronic
fatigue syndrome, alcohol abuse and in pain syndromes such as fibromyalgia and
migraine [61–63]. 5-HT3 antagonists are also suggested to be effective for the treat-
ment of other rheumatotic diseases such as rheumatoid arthritis, tendinopathies,
periarthropathies and myofascial pain as well as for chronic heart pain and bu-
limia [64–66]. A better understanding of the role played by the 5-HT3A receptor is
likely to result from new molecular tools, such as gene knock-out mice, especially in-
ducible mice in which a specific genetic alteration can be restricted both temporally
and anatomically [67–69].
1.6.2 5-HT3 receptor subtypes and 5-HT3A/3B properties
5-HT3 receptors, like other members of the cys-loop family (nACh, GABAA and
glycine receptors), exist as homo- and hetero-pentamers in the membrane. Up to
now, five different human 5-hydroxytryptamine type 3 receptor-like genes have been
cloned; 5-HT3A, 5-HT3B, 5-HT3C, 5-HT3D and 5-HT3E (table 1.1). No functional
data are available for 5-HT receptor genes C, D and E except that 5-HT3D expression
is restricted to kidney, colon and liver and 5-HT3E expression to colon and intestine,
whereas all other genes are widely expressed in many tissues including brain [70,71].
Concerning the human 5-HT3C, its sequence has been patented and hardly any detail
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is published [72]. Much is known about the 5-HT3A and 5-HT3B. By contrast to the
5-HT3A subunit, the 5-HT3B subunit appears to be much more complex, because
its TM2 segment lacks any structural homology to that of other ligand-gated ion
channels.
In contrast to the 5-HT3A subunit, 5-HT3B subunit does not form func-
tional homopentameric channel because of its retention in the endoplasmic reticu-
lum (ER) [73]. This retention has been attributed to an ER retention signal located
within the first cytoplasmic loop between TM1 and TM2 [74]. The presence of the
5-HT3B subunit modulates the biophysical properties of the channel, presumably
by forming hetero-pentamers with the 5-HT3A subunit [75–77]. Electrophysiological
and pharmacological studies showed that native receptors are distinct from the ho-
mopentameric receptor expressed in heterologous systems [42,78,79] suggesting the
presence of another subunit before the discovery of the 5-HT3B. Combinations of
5-HT3A and 5-HT3B subunits produce receptors with several distinctive properties.
Heteromeric receptors are less potently activated by 5-HT than are homomeric re-
ceptors (table 1.2); homomeric receptors have a higher permeability to Ca2+ relative
to monovalent cations than do heteromeric receptors; and heteromeric receptors have
a significantly greater single channel conductance than do homomeric receptors [75].
In addition to these known 5-HT3 subunits, two splice variants further in-
crease functional diversity of these receptors. These two 5-HT3A subunits differ in
the presence of six amino acids in the large intracellular loop and have different
expression profiles during development [80, 81]. However, thus far, physiologically
relevant functional differences between the splice variants have not been shown. It
is possible that additional undiscovered 5-HT3 receptor subunits exist.
A new type of ionotropic 5-HT receptor has been reported in the nematode
Caenorhabditis elegans. It is a 5-HT-gated chloride channel encoded by the gene
mod -1 for modulation of locomotion defective. The predicted MOD-1 protein is
related to the members of the cys-loop family of ligand-gated ion channels, in par-
ticular to GABA and glycine-gated chloride channels but functions as a 5-HT recep-
tor [82]. Other anion-selective cys-loop ligand-gated ion channels have been found
in C. elegans [83].
1.6.3 Pharmacology of the 5-HT3 receptor
The efficiency of serotonin for the agonist recognition site of the 5-HT3 receptor is rel-
atively low (table 1.2). 5-HT might not be the only endogenous ligand as dopamine
(DA) is a low-affinity agonist of 5-HT3 receptors [84]. Of the various 5-HT3 recep-
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tor agonists known, 2-methyl-5-HT, phenylbiguanide and m-chlorophenylbiguanide
(mCPBG) are the more commonly used. However, highly selective 5-HT3 receptor
agonists have not been found. Non-selective effects, observed at agonist concentra-
tions similar to those required for 5-HT3 receptor activation, include reversal of DA
transport (for serotonin, phenylbiguanide, mCPBG and cocaine) [85,86] and partial
agonism or antagonism of α2 adrenoreceptors (mCPBG for instance) [87,88].
Numerous highly potent antagonists of 5-HT3 receptors have been developed.
Several common 5-HT3 receptor antagonists are listed in table 1.2. In general, these
compounds are highly selective for 5-HT3 receptors and non-selective effects appear
to occur only at concentrations 100-fold or more in excess of those required to antag-
onize the 5-HT3 receptor. The non-selective effects of 5-HT3 receptor antagonists
are of variable nature and include antagonism of receptors other than 5-HT3 re-
ceptors [89,90], agonism of 5-HT4 receptors [91], and local anaesthetic-like block of
ligand- and voltage-gated ion channels [92].
A notable property of 5-HT3A receptors is the potentiation of agonist effects
by alcohols and anaesthetic agents [93] which might complicate the comparison of
in vitro data with data obtained in vivo from anaesthetized animals. For extensive
details on 5-HT receptor pharmacology, see [24].
Table 1.2: Comparison of the pharmacological properties of the ho-
mooligomeric 5-HT3A, the heterooligomeric 5-HT3A/3B and the 5-HT3
in N1E-115 neuroblastoma cells.
5-HT3A 5-HT3A/3B 5-HT3 N1E-115
Agonists 1pEC50
2pEC50
3pEC50
5-HT 5.63 5.22 5.38
2-methyl-5-HT 4.83 5.31 4.76
1-phenylbiguanide 4.52 ND
m-chlorophenylbiguanide 6.06 5.68 5.85
Antagonists pIC50 pIC50 pIC50
ondansetron 8.92 9.60
granisetron 9.85 9.90
D-tubocurarine 8.85 9.09
cocaine 5.63 5.14
pEC50 = -log10EC50(M); pIC50 = -log10IC50(M); ND for not determined.
1Data from [75], [94] and [95].
2Data from [75]
3Data from [96] and [97].
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1.6.4 Molecular structure of the 5-HT3 receptor
Much of the work on the structure of the cys-loop ligand-gated ion channel family
has been performed on nicotinic acetylcholine (nACh) receptors for historical and
practical reasons. The nACh receptor is present in high amounts in the electric
organs of Torpedo electric ray, suitable for electron microscopy [98], and is therefore
a never failing and easy source for experimental investigation. Moreover, toxins
that specifically inhibit the gating of the nACh channel are present in high amounts
in nature in the venom of the snakes Bungarus multicincus (α-bungarotoxin) and
cobra and of marine snails Conus genus (α-conotoxin) [99, 100]. All these factors
contributed to the popularity of this receptor in the scientific community since they
facilitate biochemical and biophysical investigations. Moreover, the structure of a
protein homologous to the extracellular domain of the receptor, named the acetyl-
choline binding protein (AChBP), has been resolved at the atomic level recently [52].
This structure leads to a good idea how the whole extracellular part might look and
has significantly advanced the understanding of the ligand binding domain [101].
Therefore, the nACh receptor is the prototype of the cys-loop receptor family in
terms of biochemistry, electrophysiology and structure.
The amino-acid sequence of the 5-HT3A receptor subunit displays strong se-
quence similarity with the Torpedo nACh receptor α-subunit (27% identity), as well
as the β1-subunit of the bovine GABAA receptor (22% identity) [102]. The most
closely related ligand-gated ion channel is the neuronal nACh receptor α7-subunit,
an homo-pentameric receptor, that shares 30% identity [103]. The AChBP shares
23% and 19% amino-acid identity with the extracellular domain of α7 nACh recep-
tor and 5-HT3A receptor, respectively. These high amino-acid homologies between
members of the cys-loop LGIC family allow reliable structural extrapolation from
resolved structures of a member to an other.
5-HT3 receptors are formed by the assembly of five subunits, each with a large
N-terminal domain and four putative transmembrane domains (figure 1.3). Five
different subunits are known (5-HT3A to 5-HT3E) that can co-assemble to make
functional hetero-pentamers (only known for subunits A and B). However, nothing
is known about the stoichiometry of these different subunits with the exception of the
hetero-pentamer 5-HT3A/3B, where the stoichiometry has rencently been revealed to
be 2A:3B showing the arrangement B-B-A-B-A around the receptor rosette [104].
5-HT3A forms functional homo-pentamers the properties of which are modified by
the presence of the 5-HT3B subunit [75–77].
The 5-HT3A sequence consists of 487 amino acids (length of the unprocessed
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precursor) resulting in a 54 kDa molecular weight for the mature protein [42, 105].
Each subunit contains seven cysteins (two forming the disulfide bridge of the cys-
loop) and thirteen tryptophans. Initial studies showed that the molecular target
size of the 5-HT3 receptor expressed in NCB-20 cells is approximately 250 kDa, sug-
gesting that the functional receptor is a multimeric structure [106]. This suggestion
was confirmed by low resolution electron microscopy studies showing that the 5-HT3
receptor, purified from NG108-15 mouse neuroblastoma x rat glioma cells, is com-
posed of five subunits arranged symmetrically around a central cavity of 2 to 3 nm
in diameter; the 5-HT3 receptor can be modelled as a cylinder 11 nm in length and
8 nm in diameter with a closed end and a central cavity 3 nm in diameter [107]. No
atomic resolution structure has been obtained yet for the 5-HT3 receptor due to the
difficulties inherent in crystallization of ion channels. Information is limited to the
extrapolation of the known homologous structure like AChBP [52] and the recently
proposed structure of the nAChR of Unwin and coworkers [108,109] is deduced from
increasingly higher resolution computer-enhanced cryo-electron microscopy images
(figure 1.5).
1.7 Scope of the thesis
Still today, many questions in the field of ligand-gated ion channels remain to be
resolved: For instance, how ligand binding to the receptor is transduced into an
opening of the ion channel, what are the structural and conformational dynamic
changes of the receptor when activated, how does the receptor behave in a cell
plasma membrane, does it freely diffuse or not, are there different open states of the
channel . . . ? Even if structural data of homologous proteins of the 5-HT3 receptor
increase our structural perception of the LGIC receptor, they are by far not sufficient
to draw a clear picture of these receptors in the different conformational states. The
most advanced published structure of a ligand-gated ion channel is the one presented
by Unwin of the Torpedo nACh receptor [109] at 4 A˚ resolution which is not sufficient
to distinguish individual amino-acid positions (figure 1.5).
The mentioned questions are addressed throughout the next chapters and some
of them are answered, or partially answered. To address these issues, two main tools
have been used. (i) Electrophysiology, because it records the flow of ions across the
pore in living cells down to single channel sensitivity and is therefore a tool of choice
to investigate LGIC. (ii) Fluorescence as an optical technique because it allows
investigations under biological conditions. The measurement itself is nondestructive
and noninvasive. Moreover, fluorescence techniques are very sensitive down to the
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Figure 1.5: Refined structure of the Torpedo nACh receptor at 4 A˚
resolution [109]. Ribbon diagram of the whole receptor, as viewed from the
synapse cleft (a) and after 90◦ rotation, i.e. parallel with the membrane plane
(b). Only the ligand-binding domain is highlighted in (a) and only the front row
subunits are highlighted in (b). The greek letters denote the different subunits
of the Torpedo nACh receptor. αTrp149 residues, interacting with ligand in the
binding pocket, is highlighted in yellow. The receptor has a five-fold symmetry
with a central pore formed by the assembly of five subunits where residues of the
TM2 domains line the channel (a). The receptor is made of three main parts,
the extracellular domain containing the binding site, the transmembrane domain
composed of α-helices forming the channel, and the intracellular part (see figure 1.3
for comparison).
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single fluorophore detection and allow the visualization of multiple phenomena like
protein-protein interactions, diffusion, rotations, environmental changes,. . . , and is
therefore well suited for in vivo investigation of the 5-HT3 receptor.
First, a new and generic fluorescence labelling method is developed and ap-
plied to the 5-HT3A receptor yielding molecular structural information in live cells.
This technique offers several advantages compared to other labelling procedures:
Small size of the tag and probe, reversible labelling and fast kinetic measurements
(chapter 2). Here, this labelling method is used for imaging single receptor mole-
cules in live cells, which allows to measure the diffusion of single receptors in the
plasma membrane (chapter 3). Regarding the structural dynamics of this protein,
fluorescent reporters are site-specifically incorporated into the channel region us-
ing the so-called substituted-cysteine accessibility method, which allows to detect
conformational changes of the receptor (chapter 4). Finally, electrophysiology ex-
periments on the single channel level reveal subconductive states of a high conducted
mutant receptor (chapter 5).
Chapter 2
Reversible site-specific labelling
of membrane proteins in living
cells: Structure of the 5-HT3A
receptor
Abstract — Chemical and biological labelling is fundamental for the elucidation
of the function of proteins within biochemical cellular networks using bioanalytical
techniques. In particular, fluorescent probes allow fast, real-time imaging of mole-
cules and molecular assemblies. A new generic method to label in vivo proteins
selectively, rapidly (seconds) and reversibly, with small molecular probes that can
have a wide variety of properties is presented in this chapter. These probes com-
prise a chromophore and a metal-ion-chelating nitrilotriacetate (NTA) moiety, which
binds reversibly and specifically to engineered oligohistidine sequences in proteins
of interest. The feasibility of the approach is demonstrated, in vitro and in vivo, by
binding NTA-chromophore conjugates to a purified fluorescent protein and to a rep-
resentative ligand-gated ion channel and G protein-coupled receptor, each containing
a polyhistidine sequence. The ionotropic 5-HT3A serotonin receptor is investigated
by fluorescence measurements to characterize in live cells the probe-receptor inter-
actions, yielding structural information and plasma membrane distribution of the
receptor.
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2.1 Introduction
Elucidating the distribution, dynamics, interactions and chemical environments of
proteins inside living cells is critical for understanding the biomolecular mechanisms
of cellular functions. For instance, labelling proteins with fluorescent probes allows
detection of molecular interactions, mobility and conformational changes of proteins
in live cells [110–112]. For this to be feasible, the probes should be well addressed and
not perturbing in order to investigate the more sophisticated function of proteins in
their natural environment. Several methods have been developed to site-specifically
introduce probes into proteins in live cells.
The most prominent method of protein labelling is to genetically encode green
fluorescent protein (GFP) as a fusion to the protein of interest [113]. GFP has been
fused to a variety of protein targets with little or none interference in native protein
functionally. Unfortunately, fluorescent proteins are inherently limited by their spec-
tral characteristics and dimensions (∼27 kDA) even with all the different variants
developed [114]. The need for chemically diverse protein labels has led researchers
to develop various ways to label proteins with small molecule probes having a wide
range of properties. Whereas the strength of the reporters like GFP lies on the
perfect specificity of genetic fusion, the chemoselective reaction of a small-molecule
probe with a single functional group on a single protein in a native environment
poses an enormous problem; it has to exclude thousand of other competing proteins
as well as DNA, RNA, carbohydrates and small molecules.
For labelling proteins with small molecule probes in vitro, the unique reactiv-
ity of cysteine has been exploited and less commonly the N-terminus of proteins.
These strategies can not be used for cellular labelling, because nearly all endogenous
proteins bear cysteine sidechains and a free N-terminus. Thus, strategies for achiev-
ing specificity have relied upon unique combinations of amino-acids (i.e. peptide or
protein sequences fused to the protein under investigation) that recruit the small
molecule probe of interest. For some methods the information contained in the tar-
geting sequence alone is sufficient to confer specificity. In other cases, an enzyme
mediates the conjugation of the probe to the target sequence.
The most straightforward method for targeting a small molecule to a protein
is to use a binding interaction sequence that is genetically fused to the protein
of interest. Cell surface exposed epitopes fused to proteins target various hapten
antibodies with high affinity and specificity. Fluorescent labelling is done using
either fluorescently labelled primary or secondary antibodies directed against the
Fc domain of the primary one [115]. Intracellular epitopes can only be accessed
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by cell permeabilization. More recent approaches have employed the dihydrofolate
reductase (DHFR), a monomeric 18 kDa protein, as a fusion protein that binds with
subnanomolar affinity to its inhibitor methotrexate and its fluorescent derivatives in
DHFR-deficient CHO cells [116]. Similarly, the FK506 immune-suppressant binding
protein (FKBP), that binds with high affinity fluorescein FK analogue (SLF’), was
used in mammalian cell lines [117]. Labelling with these tags is highly specific,
and the method is versatile because it can accommodate probes of many different
properties. However, like GFP, the protein tags are large.
Stabilizing the protein-probe binding event through covalent interaction, was
performed using enzymes with single turn-over. O6-alkylguanine-DNA-alkyltrans-
ferase (hAGT), the human DNA repair protein, fused to the protein of interest
binds various O6-benzylguianine suicide substrates through the alkylation of a cys-
teine residue. A range of fluorescent groups and biotin have thus been intro-
duced [118–120]. A similar strategy named ”Halo TagTM” launched by Promega
used an optimized dehalogenase as fusion protein, which can irreversibly be labelled
by chloro-alkane derivatives carrying fluorescent probes. An elegant variation of
these labelling approaches employed a modified shortened peptide derivative of the
acyl carrier protein (ACP) as fusion protein for cell surface protein labelling. The
post-translational modification of ACP by phosphopantetheine transferase (PPTase)
lead to the transfer of the label added as coenzyme A adduct to a serine residue
of ACP [121]; this method was recently extended to multicolor labelling [122]. All
these three methods have an excellent specificity because the initial binding inter-
actions orient the reactive groups and ensure site-specific interaction. Since nearly
all biophysical probes can be appended without affecting the specificity or rate of
the ligation chemistry, they are all quite versatile. Nevertheless, the size of the tag
remains important.
The fusion of a peptide sequence to the protein of interest presents a much
less invasive option than the fusion of a protein sequence. As with proteins, small
molecules can be targeted to peptide via affinity binding interactions. Fluorogenic
biarsenical (FlAsH) compounds were used to label six amino acids tetracysteine pep-
tide (Cys-Cys-X-X-Cys-Cys, where X were initially undefined amino acids but are
now preferably Pro-Gly). Upon binding to the tetrathiol sequence, the cell perme-
able probe becomes highly fluorescent [123]; the binding is reversed by ethanedithiol
(EDT) in high excess. Even if the FlAsH methodology has already begun to make
significant contributions to cell biology [124–126], several drawbacks limit its util-
ity. Biarsenical compounds retain significant affinity for isolated thiols requiring
complex washouts or presence of thiol compounds (µM-mM). A recently reported
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methodology method for labelling 15 amino acids peptide sequence uses the E. coli
enzyme biotin ligase (BirA), which sequence-specifically ligates a ketone isostere of
biotin to the lysine residue of the acceptor peptide. The introduced ketone is then
selectively labelled with hydrazine derivatives of fluorophores, yielding a hydrazone
adduct [127]. This two steps approach has several short comings; the hydrazone
adduct is unstable and has to be reduced by sodium cyanoborohydride to yield a sta-
ble bond, the coupling of biotin to the acceptor peptide is slow and high amounts of
hydrazine derivatives are required. Surface protein labelling in living cells was there-
fore performed with fluorescently labelled streptavidin and streptavidin-conjugated
quantum dots [128], both whose dimension do not confer any advantages towards
previously mentioned methods.
Another very different approach is the suppressor tRNA technology that site-
specifically incorporates unnatural amino-acids into proteins using the nonsense stop
codon [129–131]. Biophysical probes like benzophenone, aryl azide cross-linkers,
fluorophores have been incorporated at these sites in vitro and in vivo. The major
advantages of unnatural amino acid labelling are the excellent specificity, versatility
and minimal structural perturbation to the protein of interest. However, unnatural
amino acid mutagenesis is not yet broadly applicable in all cell types. Another
serious concern is that the introduction of modified amino-acids into nascent proteins
is mainly limited by the acceptance of the ribosome which places a limit on the
type of probes that can be directly introduced. For reviews on protein labelling,
see [132–134].
Here, polyhistidine sequences are exploited as recognition elements for site-
selective labelling (figure 2.1). These genetically encoded tags can be introduced into
regions of the amino-acid sequence where they do not disturb the protein’s structure
and function such as at the termini or loops, as will be shown; the tags will not be
tolerated within structurally important regions such as helical spanning parts. The
probes contain a metal-ion chelating nitrilotriacetic (NTA) part covalently bound
to a chromophore that can have a wide range of properties. The site-specific inter-
action between the peptide sequence and probe is non-covalent and can therefore
be reversed by competition. Quenchers NTA-probes were first used to overcome the
relatively low affinity (µM) towards the hexahistidine tag and to prove the feasibil-
ity of the method. Several factors involved in the interaction were then investigated
like the length of the polyhistidine recognition peptide, the metal ion and, mono
and divalent NTA-probes. Note that oligohistidine sequences have been widely ap-
plied in combination with NTA for purification [135], in vitro detection [136, 137]
and surface immobilization of recombinant proteins [138]. NTA-chromophore con-
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jugates overcome several limitations of currently used labelling methods and, being
complementary and orthogonal to these methods, they open novel approaches to
the efficient and quantitative investigation of proteins in live biological cells.
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Figure 2.1: Principle of the reversible site-specific labelling with NTA-
probes. (a) A polyhistidine sequence genetically introduced to the protein of
interest is recognized by the probe through the site-specific interaction between the
tag and metal-NTA moiety. Complexing the metal with EDTA reverses the binding
yielding the original tagged protein. (b) Structural interaction between the metal
bound NTA-probe and a polyhistidine sequence. The NTA bound optical probe
can have a vide range of properties since it does not interact with the recognized
peptide sequence.
2.2 Fluorescence resonance energy transfer
Throughout this chapter, fluorescence resonance energy transfer (FRET), which is
the transfer of the excited state energy from the donor (D) to an acceptor (A), will
be used for the characterization of the interaction between NTA-probes and poly-
histidine tagged proteins. The donor molecule typically emit at shorter wavelengths
with overlap with the absorption spectrum of the acceptor. Energy transfer occurs
without the appearance of a photon and is the result of long-range of a dipole-dipole
interactions between the donor and the acceptor. The rate of energy transfer de-
pends upon the extent of spectral overlap of the emission spectrum of the donor
with the absorption spectrum of the acceptor, the quantum yield of the donor, the
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relative orientation of the donor and acceptor transition dipoles and the distance be-
tween the donor and acceptor molecule (figure 2.2). FRET provides signals sensitive
to intra- and intermolecular distances in the 1-10 nm range, which are comparable
to the dimensions of biological marcromolecules or distances involved in biologi-
cal phenomena like molecular binding. Consequently FRET is capable of resolving
molecular interactions and conformations with a spatial resolution far exceeding the
inherent diffraction limit (∼ λ/2). The distance dependance of FRET, and since
fluorescence is non-invasive for in vivo investigations, resulted in its widespread use
in biophysics [139].
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Figure 2.2: Energy transfer principle. A prerequisite for FRET is that the
absorption (−) and emission (−−) spectra of a pair of donor (D) and acceptor (A)
overlaps (hatched area of (a)) and that D and A are in close proximity. Owing to
FRET, the fluorescence of the donor is quenched and fluorescence of the acceptor is
increased (b). The transfer efficiency E can then be calculated using equations 2.8
and 2.7. The transfer efficiency E depends on the distance separating D from A,
described by equation 2.6 and illustrated in (c). FRET is most sensitive to distance
variation when r = R0 (maximal slope).
Mathematical description [140, 141] — The rate of energy transfer from a
donor to an acceptor separated by a fixed distance r is given by equation 2.1 and
2.3 where φD is the quantum yield of the donor in the absence of the acceptor, n
is the refractive index of the medium, NAv is the Avogadro’s number, κ2 is the
orientation factor of the transition dipoles and J is the overlap integral.
kT =
9000 · ln10 · κ2 · φD
128 · pi2 · n4 ·NAv · r6 · τD · J (2.1)
All the experimentally known parameters of equation 2.1 characterizing the D and
A pair interaction are grouped into a term R0 named the Fo¨rster distance (equa-
tion 2.2). kT can then be written in terms of r, R0 and τD as presented by equa-
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tion 2.3. In this relation, the rate of transfer kT is equal to the decay rate of the
donor in the absence of the acceptor τD when D-A distance is equal to R0, then the
transfer efficiency is 50%.
R0 = 9.78 · 102 ×
(
J · κ2 · n−4φD
)1/6 (2.2)
kT =
1
τD
·
(
R0
r
)6
(2.3)
The overlap integral J in equations 2.1 and 2.2 expresses the overlapping
degree between the donor emission and the acceptor absorption. J is determined
by equation 2.4 where FD is the corrected fluorescence intensity of the donor with
the total intensity normalized to unity and εA(λ) is the extinction coefficient of the
acceptor at λ.
J =
∫ ∞
0
FD(λ) · ²A(λ) · λ4dλ (2.4)
The efficiency of energy transfer (E ), which is the ratio of the transfer rate to
the total decay rate of the donor, is expressed as:
E =
kT
τD−1 + kT
(2.5)
Recalling that kT = τD−1(R0/r)6, equation 2.5 is rearranged to yield equation
2.6. This equation shows, as equation 2.3, that the transfer efficiency is 50% when
r = R0 and that it is strongly distance dependent when r is close to R0.
E =
1
1 +
(
r
R0
)6 (2.6)
In practice, the transfer efficiency is typically measured using the relative
fluorescence intensity of the donor in the absence (FD) and presence (FDA) of the
acceptor. The transfer efficiency can also be calculated from fluorescence lifetimes
under these respective conditions (τD and τDA).
E = 1− FDA
FD
(2.7)
E = 1− τDA
τD
(2.8)
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2.3 Materials and methods
2.3.1 Synthesis of NTA-probes
The reactions were performed in the dark at 22◦C. The NTA-probes were purified
by thin layer chromatography (TLC) on silica gel 60 plates 200 x 200 x 0.25 mm3
(Merck, Darmstadt, Germany). The different products of the reactions were easily
distinguishable since they are colored. The excess of NTA-lysine was revealed on
TLC with ninhydrine, which reacts with primary amines yielding a red spot un-
der warming. Extracted products were then aliquoted, lyophilized and stored at
-80◦C. Purity of all the products was verified by TLC using CH3CH2CH2CH2OH/
CH3COOH/H2O 2:1:1 as mobile phase. The solvents used were purchased from
Fluka (Buchs, Switzerland) and were of the highest quality available. NTA-probe
structures are presented in figure 2.3.
Ni-NTA-lysine, Co-NTA-lysine and Cu-NTA-lysine — 381 µmol of N-(5-
amino-1-carboxypentyl) iminodiacetic acid [135] (’NTA-lysine’) were dissolved in a
3.81 ml 0.1 µM NiCl2 (Fluka) water solution; the pH was then adjusted to 8.0 with
NaOH. After 30 min, the water was evaporated yielding blue-green crystals of Ni-
NTA-lysine (MW 318). Co-NTA-lysine (MW 318) and Cu-NTA-lysine (MW 323)
were prepared as for Ni-NTA-lysine with CoCl2 and CuCl2 (Fluka) yielding after
evaporation purple and green crystals, respectively. Crystals were stored at 4◦C.
QSY7-NTA-Ni — The succinimidyl ester of QSY7 (9-[2-[[4-[[(2,5-dioxo-1-pyrroli-
dinyl)oxy]carbonyl]-1-piperidinyl]sulfonyl]phenyl]-3,6 bis(methylphenylamino)- xan-
thylium chloride, Molecular Probes Invitrogen, CA, USA) and 5 equivalents Ni-
NTA-lysine were dissolved in 50 mM NaHCO3 pH 9.0 containing 50% acetonitrile.
The reaction was incubated for 12 hours. The product QSY7-NTA-Ni, was purified
by TLC eluted with CHCl3/CH3OH/H2O 65:24:4 (Rf = 0.27) and extracted with
acetonitrile/H2O 1:1. QSY7-NTA-Ni was distinguishable from QSY7-NTA by TLC
eluted with Acetonitrile/H2O 1:1 (Rf = 0.83 and 0.76 with and without nickel,
respectively).
QSY7-NTA-Co & QSY7-NTA-Cu — QSY7-NTA-Co and QSY7-NTA-Cu were
synthesized as described for QSY7-NTA-Ni with the exception that Ni-NTA-lysine
was replaced by Co-NTA-lysine and Cu-NTA-lysine.
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QSY9-NTA-Ni — QSY9-NTA-Ni was produced by coupling the succinimidyl
ester of QSY9 (9-[2-[[4-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]-1-piperidinyl]sulfo-
nyl]phenyl]-3,6-bis(para-methylphenylamino sulfonic acid)-xanthylium chloride, Mole-
cular Probes Invitrogen, CA, USA) to 5 equivalents Ni-NTA-lysine in 50 mMNaHCO3,
pH 9.0. After 12 hours incubation, the product was purified as for QSY7-NTA-Ni at
the exception that a second TLC run eluted with acetonitrile/H2O 2:1 was required
(Rf = 0.68). The product was then extracted with H2O.
QSY21-NTA-Ni — The succinimidyl ester of QSY21 (Molecular Probes Invitro-
gen, CA, USA) and 5 equivalents Ni-NTA-lysine were dissolved in 50 mM NaHCO3,
pH 9.0, containing 50% acetonitrile and incubated 12 hours. The product was pu-
rified by TLC eluted with CHCl3/CH3OH/H2O 65:24:4 (Rf = 0.19). The product
was extracted with acetonitrile/H2O 1:1.
Cy3-NTA-Ni — Cy3-NTA-Ni was produced by coupling the succinimidyl ester
of Cy3 (Amersham Biosciences, NJ, USA) in DMF to 5 equivalents Ni-NTA-lysine
in 50 mM NaHCO3, pH 9.0 and incubated overnight. The product was purified
by TLC with two subsequent elutions, CHCl3/CH3OH/H2O 64:33:4 (long elution,
Rf = 0.05) and acetonitrile/H2O 2:1 (short elution, Rf = 0.4). The product was
extracted with acetonitrile/H2O 1:1.
Cy3-bis-NTA-Ni — The bis-succinimidyl ester of Cy3 (Toronto Research Chem-
ical, Toronto, Canada) was mixed to 10 equivalents Ni-NTA-lysine as for Cy3-NTA-
Ni. The product was purified by TLC with two subsequent elutions, CHCl3/CH3OH/
H2O 35:65:2 (long elution, Rf = 0.02) and acetonitrile/H2O 2:1 (short elution, Rf
= 0.5). The product was extracted with acetonitrile/H2O 1:1.
Cy5-NTA-Ni — The succinimidyl ester of Cy5 (Amersham Biosciences) was mixed
with 5 equivalents Ni-NTA-lysine in 50 mMNaHCO3, pH 9.0 and incubated overnight.
The product was purified as for Cy3-NTA-Ni with Rf equal to 0.05 and 0.9 for the
first and second elution, respectively. The product was extracted with H2O.
Rho-NTA-Ni — Rhodamine-NTA-Ni was produced by coupling rhodamine B in
form of tetraethylrhodamine isothiocyanate (Fluka) to Ni-NTA-lysine as described
for QSY7-NTA-Ni.
TexasRed-NTA-Ni — The succinimidyl ester of Texas Red-X ”single isomer”
(Molecular Probes Invitrogen) was coupled to 5 equivalents Ni-NTA-lysine in DMSO.
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Figure 2.3: Structures of the synthesized NTA-probes. (a) QSY7-NTA-Ni,
QSY9-NTA-Ni (b), QSY21-NTA-Ni (c), Cy3-NTA-Ni (d), Cy5-NTA-Ni (e), Cy3-
bis-NTA-Ni (f), Rho-NTA-Ni (g) and TexasRed-NTA-Ni (h). For QSY7-NTA-Co
and QSY7-NTA-Cu, the structure is similar to (a), only the complexed transition
metal ions are changed.
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The product was purified by TLC eluted with CHCl3/CH3OH/H2O 64:33:4 (Rf =
0.14). The product was extracted with DMSO.
2.3.2 Molecular and cellular biology
GFP-His6 — This protein was expressed in Escherichia coli DH5α cells, trans-
fected with the p6xHis-GFP IMAC control vector (Clontech, California, USA) en-
coding wild-type GFP from Aequorea victoria with a N-terminal His6 extension
(NCBI accession code U89936). DNA sequence contains two single restriction sites,
EcoR V and EcoR I at the N- and C-terminus, respectively. Bacteria were cultured
at 37◦C in 200 ml of 2YT medium until OD reached 0.7 under ampicillin selection.
Protein expression was induced with 1 mM IPTG at 30◦C for 2 days. Bacteria were
harvested and disrupted by sonication. The protein was purified from the 50’000
x g supernatant using the TALON metal affinity resin (Clontech, California, USA)
with buffer A (50 mM NaH2PO4, 300 mM NaCl, pH 8.0) for equilibration and
buffer B (50 mM NaH2PO4, 300 mM NaCl, 100 mM EDTA, pH 8.0) for elution.
Dialysis against buffer A yielded a solution of 5.0 µM GFP-His6 (ε395nm = 26 ± 3
mM−1cm−1) with a purity of about 50% as evidence by SDS-PAGE.
GFP-His10 — The GFP-His10 was constructed by adding His4 to the N-terminal
of GFP-His6 using the QuickChangeTM site-directed mutagenesis kit (Stratagene,
California, USA) with the conditions required by the provider in the presence of
4% DMSO for the reaction. The used oligonucleotides contain a BamH I restric-
tion site followed by the coding sequence of His4 (p10xHis-wtGFPfor and p10xHis-
wtGFPrev, see appendix A.1). The nucleotide sequence was verified and confirmed
by restriction analysis and sequencing. Expression, purification and dialysis condi-
tions were the same as for GFP-His6, yielded a solution of 3.0 µM GFP-His6 (ε395nm
= 26000 ± 3000 M−1cm−1) with a purity of about 50% as evidence by SDS-PAGE.
5-HT3A receptor sequences — These sequences were based on the short splic-
ing version of the murine 5-HT3R, corresponding to the SwissProt entry p23979
lacking the residues 360-365 (mature sequence numbering). Wild-type 5-HT3R was
transiently expressed in human embryonic kidney (HEK)-293 cells using the plas-
mid pcDNA3.1 (Invitrogen) and transfection using the modified calcium-phosphate
method [142]. Experiments were performed 2 days after transfection. 5-HT3R-
N-His6, containing Ser-His6 between Thr6 and Gln7, was transiently expressed in
HEK-293 cells using pCMVβ (Clontech) upon transfection using Effectene (Qiagen,
Hilden, Germany) with 1.0 µg plasmid per 3.5 cm well. His6 was introduced be-
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tween Ser359 and Ala360 to give 5-HT3R-Loop-His6, which was stably expressed
in HEK-293 cells using pEAK8 expression vector (Edge Biosystems, Maryland,
USA) and puromycin selection. 5-HT3R-C-His6, a 5-HT3A receptor containing a
C-terminal Gly-His6 extension, was stably expressed in HEK-293EBNA cells (HEK-
293 cells constitutively expressing the Epstein Barr Virus Nuclear Antigen-1) using
the pCEP4 expression vector (Invitrogen) and hygromycin B selection. 5-HT3R-C-
His10 was constructed by adding His4 to the 5-HT3R-C-His6 and stably expressed
in HEK-293 cells using pEAK8. Nucleotide sequences of all receptors were verified
by restriction analysis and sequencing. Expressed proteins featured ligand binding
and serotonin-activated current like the wild-type receptor.
GFP-NK1R-His10 — This sequence was composed of the signal sequence of the
mouse 5-HT3 receptor followed by a sequence encoding the enhanced GFP (Clon-
tech) link to the human NK1R having a His10 sequence attached to the C-terminus.
Stably expressing cells were obtained using pCEP4 as an expression vector. Func-
tionality of the construct was demonstrated by ligand binding and Ca2+-flux as-
says. Correct plasma membrane localization of GFP-NK1R-His10 was confirmed
by prominent GFP fluorescence located at the plasma membrane using confocal
microscopy [143].
2.3.3 Experimental methods
Monitoring in vitro labelling of His6-GFP and His10-GFP — Fluorescence
measurements were done on a Spex Fluorolog II (Instrument S.A.) at 1.9 nm excita-
tion and 2.3 nm emission band passes. Samples in 0.5 x 0.5 x 5 cm3 quartz cuvettes
(Hellma GmBH & Co, Mu¨llheim, Germany) were excited at 395 nm; emission was
recorded from 450-570 nm at 22◦C. NTA-probes were titrated into 400 µl 25 nM
GFP-His6 or GFP-His10 in buffer A containing 800 µM C12E9 (Anatrace, Ohio,
USA). Emission spectra were recorded 15 min after each addition. GFP-His tagged
labelling was reversed by the addition of 1 µl EDTA, pH 8.0 to the corresponding
sample.
The kinetics of NTA-probe binding to 2.5 nM GFP-His tagged in buffer A
was monitored at 510 nm upon excitation at 395 nm with 1.9 nm and 3.6 nm for
excitation and emission band passes.
Monitoring in vivo labelling of 5-HT3R — HEK-293 cells, expressing either
histidine-tagged or wild-type 5-HT3Rs, were cultured on 0.18 mm thick glass cover-
slips in 6-well plates in Dulbecco’s modified Eagle medium (DMEM) supplemented
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with 2.2% of fetal calf serum under humidified 5% CO2 atmosphere at 37◦C. The
coverslips were then transferred to a sample holder, and the cells covered 400 µl PBS
containing 15 nM GR-flu (1,2,3,9 tetrahydro-3-[(5-methyl-1H-imidazol-4-yl)methyl]-
9-(3-amino-(N-fluorescein-thiocarbamoyl)-propyl)4H-carbazol-4-one, Glaxo, Switzer-
land). Fluorescence images were recorded using a LSM 510 confocal microscope
(Zeiss, Jena, Germany) equipped with appropriate excitation and emission filters
for fluorescein, rhodamine and Cy5. Subsequently NTA-probes were added to the
concentrations indicated. Receptor binding of NTA-probes was reversed by adding
EDTA, pH 8.0, to give a final concentration of 5 mM. Nonspecific binding of GR-flu
to cells, measured in the presence of 1 µM quipazin, was negligible.
In vivo labelling of GFP-NK1R-His — GFP-NK1R-His10 was labelled with
NTA-probes as described for 5-HT3R.
2.3.4 Data treatment
Fo¨rster distance calculations — The Fo¨rster distance R0 (nm) was calculated
from equation 2.2, where κ2 = 2/3 for the orientation factor assuming isotropic
distribution of the transition dipoles of the donor and acceptor and n = 1.4 for the
refractive index of the membrane. The overlap integral J (M−1·cm3) was calculated
using equation 2.4. The acceptor molar excitation coefficient εA(λ) and the wave-
length λ were in M−1cm−1 and cm respectively. Errors where calculated using the
Gauss propagation method assuming 2% error for ε and emission spectra of GFP.
Affinity of NTA-probes to GFP-His tagged — All measurements were cor-
rected for the contribution of the buffer and for inner filter effects, which is given by
equation 2.9. F cor and F obs are the corrected and observed fluorescence intensities;
ODex and ODem, the optical density at the excitation and emission wavelength.
F corr = F obs · 10((ODex+ODem)/2) (2.9)
Fluorescence intensity of GFP at 510 nm reported versus NTA-probes con-
centration was fitted with the Hill equation (2.10). F and F 0 are GFP fluorescence
intensities with and without NTA-probes, c the concentration of NTA-probes (M),
K d the dissociation constant (M), E the energy transfer efficiency determined by
equation 2.7 and h the Hill coefficient. The distance r separating the GFP emis-
sion dipole and NTA-probes absorbtion dipole was determined from equation 2.6
using the transfer efficiency E value obtained from the fit. Errors for E and K d are
obtained by the fit.
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F = F 0 − E 1
1 +
(
Kd
c
)h (2.10)
Association and dissociation rate constants of NTA-probes to GFP-His
tagged — Fluorescence intensity was corrected for the contribution of the buffer
and for inner filter effects (equation 2.9). The effective rate constant kobs (M·s−1)
was determined by fitting the decrease fluorescent intensity of GFP due to the
addition of different concentrations of NTA-probes using equation 2.11. F t and F 0
are the fluorescence intensities at time t (s) and t = 0 respectively. For the case
of a reaction P + Q ­ PQ, where the concentration of P (protein) stays constant,
kobs is linearly dependant with the concentration of Q (quencher) as described by
equation 2.12 [144]. The association (kon in M−1·s−1) and dissociation (koff in s−1)
rate constants are given by the slope and the intersection with the y axis. c is the
concentration of NTA-probes (M).
F t = F 0 · exp (−kobs · t) (2.11)
kobs = koff + kon · c (2.12)
Kinetic dissociation induced by EDTA was studied using ”Berkeley Madonna”
software, which allows modelling and analyzing dynamic systems by numerical it-
eration. The model reaction presented in figure 2.6 is described by the following
equations where P stands for protein (GFP), Q for quencher (NTA-Ni probes) and
Q∗ for the quencher without the metal (NTA-probes) and PQ for the quencher bound
to the protein. Using the Rosenbrock convergence method, values for the kinetic
constants k1 and k2; kon and koff were obtained from association equation 2.12.
Details are presented in section 2.4.2.
d [Q]
dt
= −kon [P ] [Q] + koff [PQ]− k1 [Q] [EDTA] (2.13)
d [PQ]
dt
= kon [P ] [Q]− koff [PQ]− k2 [PQ] [EDTA] (2.14)
d [P ]
dt
= −kon [P ] [Q] + koff [PQ] + k2 [PQ] [EDTA] (2.15)
d [Q∗]
dt
= k1 [Q] [EDTA] + k2 [PQ] [EDTA] (2.16)
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Affinities of NTA-probes to 5-HT3R in vivo — Affinities of NTA-probes
to the 5-HT3R were determined as for His-tagged GFP. No correction for inner
filter were required since the experiments were performed in a confocal microscope.
Fluorescence intensities were quantified using the LSM 510 software (Zeiss, Jena,
Germany).
Evaluation of in vivo FRET data for the structure of 5-HT3R — Fluores-
cence intensities were quantified from a region of interest using the LSM 510 software
(Zeiss, Jena, Germany). FRET data for the 5-HT3R was evaluated considering the
following (for a detail treatment of FRET see [140]). (i) The 5-HT3 is schematically
depicted as a cylinder with overall dimensions of the highly homologous nicotinic
acetylcholine receptor [107, 108]: 15 nm long, a radius of 4 nm and protruding 7
nm from the extracellular side of the membrane. (ii) The oligohistidine sequences
are located on the surface of the receptor and not buried within the membrane,
as all mutant receptors can be purified by Ni2+-NTA chromatography. (iii) Each
homopentameric receptor carries five equivalent hexahistidine sequences related by
fivefold symmetry around the central axis of the receptor protein; in consequence,
the five bound NTA chromophores are symmetrically distributed on a circle around
the central axis. (iv) Each receptor binds only one GR-flu [145], which is located
at 4.9 ± 0.9 nm above the center of the membrane [146] on the surface of the ex-
tracellular domain of the receptor [147]. (v) The efficiency of FRET is described by
equation 2.17, which is a modified version of equation 2.6.
Esat =
∑
i
(
R0
ri
)6
1 +
∑
i
(
R0
ri
)6 (2.17)
For the pair GR-flu QSY7-NTA-Ni, R0 = 5.83 ± 0.13 nm. The orientation fac-
tor is set to κ2 = 2/3, which is reasonable considering the low fluorescence anisotropy
of the receptor-bound donor indicating high segmental motion of GR-flu. r i is the
distance between the chromophore of GR-flu and of the ith NTA-probe for each of
the the His6 sequences, which are assumed to be independent and equivalent (iden-
tical R0 and K d). Distance reported is the axial height between GR-flu and the
plane comprising the circle of the NTA-chromophores. E sat is three to four times
more sensitive to changes of height than to changes of radius; the radius was set to
4 nm, as variations of 0.5 nm yielded changes of E sat within experimental errors.
Changes in E sat due to rotation of the positions of the NTA-probes around the cen-
tral axis fall within the experimental error. Thus, only axial heights separating the
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NTA-probes and GR-flu can be determined with significance.
2.4 Results and discussion
2.4.1 NTA-probes for in vitro labelling of proteins
Reversible labelling of proteins with NTA-probes was first characterized in vitro for
a green fluorescent protein (wtGFP) containing an N-terminal hexahistidine (GFP-
His6). The probes QSY7-NTA-Ni and QSY9-NTA-Ni (figure 2.3) bind to GFP-His6
within seconds (figure 2.4.a) and act as ideal acceptors for fluorescence resonance
energy transfer (FRET) (figure 2.4.d), quenching the fluorescence of GFP almost
entirely. The kinetics of the labelling reaction is linearly dependant on the con-
centration of the NTA-probes (figure 2.4.c), indicating that only one NTA-probe
binds per GFP-His6. Moreover, the dissociation constants obtained both at equi-
librium and from binding kinetics are in good agreement. The nonunity of the Hill
coefficients (figure 2.4.c) may be due to a slow structural reorganization (structural
ripening) of the oligohistidine-NTA-Ni complex after the initial binding event. The
distance between the fluorophore within GFP and the chromophore of the NTA-
probe is estimated to be 3.3 nm, which is in agreement with the dimension of the
interacting molecules (GFP measures approximately 3 x 4.5 nm, the NTA probes
QSY7-NTA-Ni and QSY9-NTA-Ni about 1.8 x 1.5 nm). Labelling is fully reversed
upon addition of EDTA (figure 2.4.a and b) indicating specific interaction of the
NTA-probes with the polyhistidine sequence of GFP. This is confirmed by the ab-
sence of a decrease of GFP fluorescence upon addition of NTA-probes either without
Ni2+ or in the presence of EDTA or imidazol.
The polyhistidine sequence peptide of GFP was then extended from His6 to
His10. QSY7-NTA-Ni and QSY9-NTA-Ni probes label GFP-His10 within seconds
and binding is fully reversible upon addition of EDTA showing the specificity of the
interaction (figure 2.5.a). The extension of the tag size does not influence neither
the FRET efficiency nor the stoichiometry between the NTA-probes and GFP-His10,
and has few effects on the Hill coefficient; rather it improves the affinity by a fac-
tor of three (table 2.1). Moreoever, the dissociation binding constant obtained at
equilibrium and from binding kinetics are in agreement. A comparison between
the kinetics binding of the probes to GFP-His6 and GFP-His10 (table 2.3) shows
that the extension of the polyhistidine sequence influences only the on rate of the
binding resulting in a higher affinity. This supports the view of a freely diffusing
NTA-probe that has more chance to meet and bind to a longer recognition peptide
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Figure 2.4: Labelling GFP-His6 by QSY7-NTA-Ni and QSY9-NTA-Ni.
(a) Addition of 3.9 µM QSY7-NTA-Ni to 2.5 nM GFP-His6 results in a rapid
decrease of fluorescence intensity (t1/2 ≈ 5 s), which is completely reversed by 1.25
mM EDTA (t1/2 ≈ 60 s). (b) GFP-His6 emission spectra intensity (continuous line,
excitation at 395 nm, 25 nM) subsequently decreases by each addition of QSY7-
NTA-Ni (dotted lines) reaching a saturable state. 1.25 mM EDTA completely
reversed the binding (−− line) (c) Affinity of QSY7-NTA-Ni and QSY9-NTA-
Ni for GFP-His6. Normalized fluorescence intensity at equilibrium of GFP-His6
incubated with the indicated concentration of QSY7-NTA-Ni (◦) and QSY9-NTA-
Ni (¥). Dotted lines are fits using a Hill equation (Eq. 2.10) yielding dissociation
constants Kd = 3.0 ± 0.2 µM and 6.4 ± 0.2 µM, Hill coefficients h = 1.6 ± 0.2
and 2.6 ± 0.2, and FRET efficiencies E = 0.95 ± 0.01 and 0.96 ± 0.01 for QSY7-
NTA-Ni and QSY9-NTA-Ni respectively. The distance between the chromophores
of GFP-His6 and the NTA-probes was calculated to be r = 3.3 ± 0.4 nm (Eq. 2.6,
table 2.1). Insert: the effective rate constants (kobs) of the binding of QSY7-
NTA-Ni (◦) and QSY9-NTA-Ni (¥) to GFP-His6 is linear with the concentration
indicating a one to one stoichiometry. Quantitative evaluation using relation 2.12
yielded rate constants for binding kon of 11.4 ± 4.6 and 7.9 ± 1.9 mM−1s−1, and
for dissociation koff of 0.034 ± 0.034 and 0.061 ± 0.015 s−1 resulting in dissociation
constants Kd = koff/kon of 3.0 ± 3.2 and 7.7 ± 2.6 µM, respectively, for QSY7-
and QSY9-NTA-Ni. (d) Normalized emission spectrum of GFP-His6 (continuous
line, excitation at 395 nm) and absorption spectrum of QSY7-NTA-Ni and QSY9-
NTA-Ni (identical normalized absorption spectrum). R0 = 5.65 ± 0.13 nm for
these pairs (table 2.2).
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than a shorter one.
Designing probes with two NTA-Ni moieties also improves the affinity towards
polyhistidine sequences. For instance a Cy3 fluorescent probe with two NTA-Ni arms
(figure 2.3.f) titrated to GFP-His6 and GFP-His10 improves the affinity thirty fold
(table 2.1) compared to its mono-NTA-Ni analogue (figure 2.3.d). The combination
of an extended His10 polyhistidine peptide sequence with Cy3-bis-NTA-Ni probe
containing two NTA-Ni moieties reaches dissociation constants in the order of 10
nM (table 2.1 and figure 2.5.a); this corresponds to a 100-fold increase in affinity
compared to GFP-His6 with Cy3-NTA-Ni. This led to the idea of synthesizing other
probes containing several NTA-Ni moieties. For this purpose, we tried to couple the
amino group of glutamate, containing two NTA-Ni bound to its carboxylic groups,
to the succinimidyl ester of different probes. Unfortunately, the succinimidyl ester
moiety was not reactive towards the amino group of glutamate. Therefore, probes
containing two NTA-Ni arms are limited to commercially available probes doubly
activated.
The effect of the metal ion upon the binding was also investigated. Ni2+ was
replaced by Co2+ and Cu2+ in QSY7-NTA-Ni. The resulting probes bind to GFP-
His6 within seconds with micromolar dissociation constants (figure 2.5.b) that are
shifted to higher and lower affinity for copper and cobalt, respectively, compared to
the QSY7-NTA-Ni analogue (table 2.1). The increase of affinity in the order Cu2+
> Ni2+ > Co2+ was already observed for IMAC chromatography [148]. Addition of
EDTA or imidazol in high amounts did not completely recover the original fluores-
cence intensity of GFP (table 2.1) resulting in a less specific interaction compared
to Ni2+. In the case of QSY7-NTA-Co, the recovery of only 50% fluorescence after
addition of EDTA may be due to the oxydation of Co(II) to Co(III) resulting in an
irreversible binding of the probe to polyhistidine sequence [148]. This explanation
has not been proved; addition of 2% H2O2 as oxidative agent to the QSY7-NTA-Co
GFP-His6 adduct did not modified the binding (EDTA recovers 50% of the GFP
fluorescence, as it was the case in the absence of H2O2). Therefore, exchange of
the chelated metal ion has a direct effect on both affinity and specificity and does
not confer any advantage compared to nickel since specificity and reversibility of the
binding are of prime importance for the present application. Hence, nickel is used
as the chelated metal ion in NTA-probes.
Other fluorescent probes like Cy5-, TexasRed-, Rho-NTA-Ni and nonfluores-
cent like QSY21-NTA-Ni were characterized upon binding on GFP-His6 and GFP-
His10; dissociation constants and FRET efficiencies are reported in table 2.1. Their
bindings are specific as EDTA completely recovers the fluorescence intensity of GFP.
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Figure 2.5: Improving the affinity binding of NTA-probes. (a) Affinity
of NTA-probes for GFP-His10. Normalized fluorescence intensity at equilibrium
of GFP-His10 incubated with the indicated concentration of QSY7-NTA-Ni (N),
QSY9-NTA-Ni (4) and Cy3-bis-NTA-Ni (+) fitted with a Hill equation (Eq. 2.10)
yielding dissociation constants Kd = 0.62 ± 0.03 µM, 2.4 ± 0.1 µM and 64 ± 5
nM, Hill coefficients h = 2.4 ± 0.3, 1.7 ± 0.1 and 1.0 ± 0.1 for QSY7-NTA-Ni,
QSY9-NTA-Ni and Cy3-bis-NTA-Ni respectively. FRET efficiencies are presented
in table 2.1. Addition of 1.25 mM EDTA totally reversed the binding. Insert: the
effective rate constant (kobs) of the binding of QSY7-NTA-Ni to 2.5 nM of GFP-
His10 (N) is linearly dependant with the concentration of the former yielding kon
= 78.5 ± 30 mM−1s−1 and koff = 0.034 ± 0.035 s−1, resulting in a dissociation
constant Kd = koff/kon of 0.43 ± 0.48 µM. (b) Effect of the metal on the affinity
of NTA-probes with GFP-His6. Normalized fluorescence intensity at equilibrium
of GFP-His6 incubated with the indicated concentration of QSY7-NTA-Co (•),
QSY7-NTA-Ni (¥) and QSY7-NTA-Cu (◦) fitted with a Hill equation (Eq. 2.10)
yielding dissociation constants of Kd = 17 ± 1, 3.0 ± 0.2 and 1.6 ± 0.1 µM, Hill
coefficients h = 3.5 ± 0.4, 1.6 ± 0.2 and 3.2 ± 0.2, respectively. Addition of 1.25
mM EDTA reversed completely the binding for QSY7-NTA-Ni; only 50% and 90%
of the original fluorescence intensity of GFP-His6 was recovered for QSY7-NTA-
Co and QSY7-NTA-Cu respectively. Indeed, the kind of metal ion affects both the
affinity and specificity.
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For all the spectrally different reporters (table 2.2), the distance separating the chro-
mophores of GFP and bound NTA-Ni probes are identical in the errors limits for
probes having comparing linker length; longer linkers between the metal moiety and
the chromophore dipole results in longer distances. This is a supplementary proof
of the specificity of the labelling and therefore shows the potential of the method
for in vitro investigations of proteins containing a polyhistidine sequence.
Table 2.1: In vitro characteristics of the binding between NTA-probes
and polyhistidine sequences His6 and His10 of GFP: dissociation con-
stants, energy transfer efficiencies and distances.
Probes K d (µM) His6 K d (µM) His10
1E 5r (nm)
QSY7-NTA-Ni 3.0 ± 0.2 0.62 ± 0.03 0.95 ± 0.01 3.4 ± 0.4
QSY7-NTA-Cu 1.6 ± 0.1 - 20.98 ± 0.01 23.0 ± 0.6
QSY7-NTA-Co 17 ± 1 - 30.97 ± 0.01 33.2 ± 0.5
QSY9-NTA-Ni 6.4 ± 0.2 2.4 ± 0.1 0.96 ± 0.01 3.3 ± 0.4
QSY21-NTA-Ni 1.3 ± 0.5 0.6 ± 0.3 40.89 ± 0.02 43.2 ± 0.3
Cy3-NTA-Ni 6 ± 1 1.6 ± 0.2 0.89 ± 0.03 4.7 ± 0.5
Cy3-bis-NTA-Ni 0.2 ± 0.1 0.064 ± 0.005 0.92 ± 0.02 4.1 ± 0.5
Cy5-NTA-Ni 7.2 ± 0.7 6.7 ± 1.3 0.75 ± 0.05 3.9 ± 0.4
Rho-NTA-Ni 8 ± 1 - 0.85 ± 0.09 4.4 ± 1.4
TexasRed-NTA-Ni 0.2 ± 0.1 0.83 ± 0.02 0.88 ± 0.03 3.6 ± 0.5
1 FRET efficiencies are the same for GFP-His6 and GFP-His10 when measured.
2,3,4 These value should be corrected for 10%, 50% and ∼14%, respectively, of unspecific binding
respectively as revealed by EDTA.
5 Calculated according to Eq. 2.6 with R0 values from table 2.2. Indicated errors are 95%
confidence.
2.4.2 In vitro competitive dissociation mechanisms of NTA probes
with EDTA
To fully characterize the reversible labelling approach NTA probes, kinetics of the
dissociation of the probes by competition with EDTA is investigated. Different
amounts of QSY7-NTA-Ni are titrated to a solution of GFP-His6, quenching the
fluorescence of the latter though the formation of an adduct between the protein
and the quencher (figure 2.6.a). Addition of a large excess of EDTA reverse the
binding to a complete recovery of GFP fluorescence. However, the time course of
the reversion (figure 2.6) does not correspond to a simple reaction where EDTA
enters in competition by simply ”removing” the nickel chelated to the free NTA-Ni
probe (where k2 = 0 according to figure 2.6.b insert), because its shape cannot be
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Table 2.2: Fo¨rster distances for GFP and the different probes as well as
their spectroscopic properties.
Probes Abs (nm) Em (nm) ε (M−1cm−1) 2R0 (nm)
QSY7 564 1- 87’500 5.65 ± 0.13
QSY9 564 1- 87’500 5.65 ± 0.13
QSY21 660 1- 89’000 4.50 ± 0.11
Cy3 550 570 150’000 6.20 ± 0.15
Cy5 649 670 250’000 4.63 ± 0.11
Rho 543 569 105’000 5.90 ± 0.14
TexasRed 595 615 85’000 5.02 ± 0.12
1 φ was determined to be < 3·10−4 and therefore the probes are assumed nonfluorescent.
2 R0 was determined (Eq. 2.2) using n = 1.40 ± 0.05, φwtGFP = 0.79.
fitted with an exponential function. Therefore, it was suggested that EDTA can
directly have an effect on the PQ adduct resulting in the reaction scheme presented
in figure 2.6.b. This model has no analytical solution and a numerical approach is
required for both approving the corresponding model and determining the different
parameters k1 and k2. This analysis was used to determine the different kinetic
constants for QSY7-NTA-Ni and QSY9-NTA-Ni on both GFP-His6 and GFP-His10
(Table 2.3).
Interestingly, the nature of the probe as well as the length of histidine tagged
sequence do not influence k1 as it was expected by the model; this step of the
reaction involves only the metal-bound to NTA and EDTA. Comparatively, k2 seems
to be influence by the length of the tag. This is not very clear since the errors are
important. An explanation for these high errors on k2 is the following. Since this
factor has been introduced to explain the small ”S” shape of the reversion kinetic
(figure 2.6.b) during the first fifty seconds after the addition of EDTA , few points
are available for the fits resulting in a high error. Nevertheless, the model proposed
for the the interaction of EDTA during the reversion of the binding can be validated.
2.4.3 Structure of the 5-HT3A receptor in living cells revealed with
NTA chromophores
The NTA-probes were subsequently used in live cells to investigate the structure
of the ionotropic serotonin 5-HT3 receptor (5-HT3R) [149] into which hexahistidine
sequences were genetically engineered at any one of the three different positions (fig-
ure 2.7.a). FRET between receptor-bound GR-flu, a high affinity fluorescein labelled
5-HT3R antagonist [150], and NTA-probe was used as indicator of the binding of
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Figure 2.6: Kinetic model of the dissociation reaction induced by EDTA.
(a) Addition of 4.5 µM QSY7-NTA-Ni to 2.5 nM GFP-His10 quenches the fluores-
cence of GFP, reaching a steady state that is reversed by EDTA in large excess
(1 mM). The dotted box represents the region where the normalized fluorescence
intensity is expressed in term of GFP-His6-Ni-NTA-QSY7 concentration (PQ) that
are reported in b. (b) The concentration of the adduct (PQ) between GFP-His6
(P) and QSY7-NTA-Ni (Q) for different concentration of quencher versus time.
Fitting using Eq.2.13, 2.14, 2.15 and 2.16 (as described in section 2.3.4) yielded k1
= 33.4 ± 8.2 M−1s−1 and k2 = 71 ± 180 M−1s−1. Insert: proposed model for the
reversion of the binding by EDTA. P stands for protein, Q for quencher, PQ for
the quencher-bound to the protein, and Q∗ for the quencher without the metal.
No equilibrium is assumed for the reaction involving EDTA due to its high affinity
with divalent metals.
Table 2.3: Kinetics constants.
GFP-His6 GFP-His10
QSY7-NTA-Ni QSY9-NTA-Ni QSY7-NTA-Ni
kon (mM
−1s−1) 11.4 ± 4.6 7.9 ± 1.9 78.5 ± 30
koff (s
−1) 0.034 ± 0.034 0.061 ± 0.015 0.034 ± 0.035
k1 (M
−1s−1) 33.4 ± 8.2 34.8 ± 7.1 45.2 ± 12
k2 (M
−1s−1) 71 ± 180 53 ± 51 270 ± 250
These constants refer to the proposed model (fig. 2.6.b).
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the latter to the receptor, as well as to determine the distance between these com-
pounds. The addition of QSY7-NTA-Ni to cells expressing 5-HT3-C-His6 resulted
in a rapid (within 30 seconds) decrease of fluorescence intensity of receptor-bound
GR-flu, which can be completely recovered within a few minutes upon the addition
of EDTA (figure 2.7.b). The rapid binding of QSY7-NTA-Ni to 5-HT3R allowed con-
secutive additions of the compound to the same cells in order to obtain a complete
binding isotherm; addition of EDTA restored the initial fluorescence of receptor-
bound GR-flu (figure 2.7.c).
Binding of QSY7-NTA-Ni to the three different His-tagged 5-HT3Rs yielded
similar dissociation binding constants ranging from 1-4 µM; however, the fluores-
cence intensity of GR-flu decreased to different extend (figure 2.8.a). As the FRET
efficiency correspond to the observed decrease in normalized fluorescence, these data
indicate that the distance between GR-flu and the NTA-probes decreases in the or-
der 5-HT3R-Loop-His6 > 5-HT3R-N-His6 > 5-HT3R-C-His6. High concentration
up to 6 µM of QSY7-NTA-Ni had no effect on the fluorescence of GR-flu bound
to wild-type of 5-HT3R, which contains no oligohistidine sequence (figure 2.8.a),
showing that it is indeed the NTA-oligohistidine interaction that is the origin of
the observed fluorescence decrease. QSY9-NTA-Ni showed effects similar to those
of QSY7-NTA-Ni on the fluorescence intensity of GR-flu bound to 5-HT3R-C-His6
and 5-HT3R-N-His6, and at concentrations up to 12 µM, did not bind to wild-type
5-HT3R. But in contrast to QSY7-NTA-Ni, it did not affect the fluorescence inten-
sity of GR-flu bound to 5-HT3R-Loop-His6 (figure 2.8.b). These results indicate
that (i) the His6 sequence in the loop is located in the cytosol whereas the N- and
C-terminal His6-sequences are extracellular, confirming the proposed topology of
the 5-HT3R, (ii) FRET is dependant of the binding of QSY9-NTA-Ni to an oligo-
histidine sequence and (iii) the membrane is impermeable to QSY9-NTA-Ni, owing
to its charged SO3− groups (figure 2.3.b). This view is supported by the inability of
QSY9-NTA-Ni to interact with a cytosolic His-tag fused to the C-terminus of NK1R
(see below). Thus, QSY7-NTA-Ni and QSY9-NTA-Ni can be used to determine the
topology of membrane proteins in living cells without the need for fixation and, or,
permeabilization of the cells.
The spatial positions of the polyhistidine sequences within the 5-HT3R were
evaluated from FRET upon QSY7-NTA-Ni binding (figure 2.9). Whereas the av-
erage distances between the donor-acceptor chromophores can be determined with
a precision of about ± 0.3 nm, the binding site of the NTA on a hexahistidine se-
quence in the receptor is located within 1.5 nm from the position of a particular
NTA chromophore; this uncertainty is given by the length of the fully extended
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Figure 2.7: Reversible in vivo labelling of the 5-HT3R.(a) Topology of
a subunit of the homopentameric 5-HT3R showing the extracellular N-terminal
ligand-binding region, the four predicted transmembrane segments, the large in-
tracellular loop and the extracellular C-terminus [147]. Four different protein mu-
tants were produced comprising an oligohistidine sequence either at the N-terminus
(5-HT3R-N-His6), in the second intracellular loop (5-HT3R-Loop-His6) or at the
C-terminus (5-HT−3R-C-His6 or 5-HT−3R-C-His10). The insert shows a cylin-
drical model of the homopentameric 5-HT3R. (b) HEK-293 cells expressing the
5-HT3R-C-His6 were exposed for 15 min to 15 nM GR-flu, resulting in a selective
staining of 5-HT3R in the cellular membrane as observed by fluorescence confo-
cal microscopy (left). Upon addition of QSY7-NTA-Ni at a final concentration
of 5 µM, the fluorescence intensity of GR-flu dropped to 5% of the initial value
(middle). Addition of 5 mM EDTA established the original fluorescence intensity
(right). Scale bar is 50 µm. (c) QSY7-NTA-Ni was added consecutively at the con-
centration indicated to HEK-293 cells containing GR-flu bound to 5-HT3R-C-His6.
On each addition, the fluorescence intensity of receptor-bound GR-flu decreased
to reach a steady level within 1 min and, finally, saturation at 5% of its original
fluorescence intensity. After about 13 min, 5 mM EDTA was added to restore the
original GR-flu fluorescence intensity within 5 min.
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Figure 2.8: Structure of 5-HT3R in live cells investigated by FRET
using NTA-probes. (a) Binding of increase amount of QSY7-NTA-Ni to the
different hexahistidine-containing 5-HT3Rs resulted in a saturable decrease of the
fluorescence intensity of GR-flu. Apparent dissociation constants are Kd = 1.95 ±
0.03 µM, 4.2 ± 0.7 µM and 1.05 ± 0.07 µM and FRET efficiencies at saturation are
E = 0.83± 0.01, 0.52± 0.06 and 1.00± 0.05 for 5-HT3R-N-His6 (•), 5-HT3R-Loop-
His6 (N) and for 5-HT−3R-C-His6 (¤), respectively. Addition of QSY7-NTA-Ni
had no effect on the fluorescence intensity of GR-flu bound to wild-type 5-HT3R
(¦). QSY9-NTA-Ni exhibited apparent dissociation constants Kd = 12.7 ± 0.5 and
7.8 ± 2.4 µM, and FRET efficiencies at saturation E = 0.72 ± 0.06 and 0.78 ±
0.18 for 5-HT3-C-His6 and 5-HT3-N-His6, respectively and had no effect on the
fluorescence of GR-flu bound to wild-type 5-HT3R. In all cases, addition of 5 mM
EDTA resulted in a recovery of 95-100%. (b) Addition of 12 µMQSY9-NTA-Ni did
not affect the fluorescence intensity of GR-flu bound to 5-HT3-Loop-His6. Addition
of 6 µM QSY7-NTA-Ni, however, reduced the fluorescence intensity of GR-flu by
20%. Addition of EDTA to 5 mM restored the original fluorescence intensity.
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spacer separating the NTA chromophore from the His-tag. The margin in the pre-
cision of localization might be reduced to about 0.7 nm by using a NTA-probe with
a shorter spacer and a smaller chromophore. The N-terminal His6 sequence seems
to be located near the apex of the receptor protein, which is in agreement with a
structural model of the 5-HT3R [147]. The oligohistidine tags of 5-HT3R-C-His6
and 5-HT3R-Loop-His6 are located close to the surface or within the interface of
the outer and inner leaflet of the membrane, respectively, because owing to their
polarity, oligohistidine sequences are not expected to be in the hydrophobic mem-
brane core [151]. The observed position of the C-terminal polyhistidine sequence is
in agreement with the hydropathy analysis of the 5-HT3R amino acid sequence [42],
which predicts that only three amino acids at the C-terminus (plus in the case of
5-HT3R-C-His6, the His6 sequence) protrude from the hydrophobic membrane core
to the extracellular side of the membrane. The distance between the NTA-probes
bound to extracellular (5-HT3R-C-His6) and intracellular (5-HT3R-Loop-His6) His6
sequences is > 2.8 ± 0.5 nm (difference between d and c in figure 2.9.f), which is
comparable to the thickness of the hydrophobic membrane core (2.5-3 nm [151,152])
and to the distance of 3-3.5 nm between the two rings of charged amino acids on
either side of the transmembrane domain of the highly homologous nicotinic acetyl-
choline receptor [108]. To my knowledge, this is the first report on localization of
a sequence within the intracellular domain of a ligand-gated ion channel in living
cells.
It has been demonstrated that nonfluorescent NTA probes in combination with
fluorescently labelled protein can deliver important information about the structure
of the protein and its molecular interactions. Molecular interactions between pro-
teins in live cells are often investigated by FRET microscopy using proteins labelled
with, for instance, two spectrally GFP-analogs [112]. In such cases, problems arise
from variations in expression levels of the donor and acceptor proteins, which can be
very different between experiments complicating, in addition to cross-talk, precise
analysis of FRET [112, 139]. However, FRET can be determined accurately by, for
example, acceptor bleaching or fluorescence lifetime imaging [139]. Reversible in vivo
labelling with NTA-probes offers an alternative and simple one-color approach to
measure FRET. One of the interacting proteins is labelled with a fluorescent FRET
donor (e.g., GFP), the partner protein contains an oligohistidine sequence. Then the
latter protein is rapidly labelled with a nonfluorescent NTA-probe as FRET accep-
tor. The interaction between the two proteins is demonstrated unequivocally when
the donor fluorescence intensity decreases upon addition of the acceptor. Speci-
ficity of the labelling can be checked by EDTA addition, which reverses NTA-probe
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Figure 2.9: Model structure of the 5-HT3R from FRET data using NTA-
probes in live cells. The location of the different His-tags within the 5-HT3R
were estimated using the topology information from figure 2.8.b and FRET data
from figure 2.8.a as described in section 2.3.4. R0 = 5.83 ± 0.13 nm for GR-flu
(donor) and QSY7-, QSY9-NTA-Ni (acceptors). In the absence of detailed struc-
tural information, the 5-HT3R is modelled as a 15 nm long cylinder with a 4 nm
radius, protruding 7 nm from the extracellular side of the membrane, correspond-
ing to the dimensions of the highly homologous nAchR [107,108]. The membrane
comprises a hydrophobic core (yellow, 2.5 nm) and two polar interfacial regions
(blue, 2 x 0.75 nm) [152]. GR-flu (•) is bound 4.9 ± 0.9 nm above the center of
the membrane [145] on the surface of the extracellular part of the receptor [147]
(arrow a). For each sort of His-tagged 5-HT3R, the NTA-probes are distributed by
5-fold symmetry on a circle with a radius of 4 nm; their actual angular positions
around the major symmetry axis with respect to the GR-flu could not be deter-
mined as FRET depends only weakly on this axial rotation. In the case of the
5-HT3R-N-His6, NTA-probes are located 4.5 ± 0.2 nm above GR-flu (arrow b),
close to the apex of the receptor. QSY7-NTA-Ni probes bound to 5-HT3R-C-His6
and 5-HT3R-Loop-His6, respectively, are located at 6 3.5 nm below GR-flu in the
extracellular domain (arrow c), and 6.3 ± 0.3 nm below GR-flu in the intracellular
domain (arrow d). The positions of the hexahistidine sequences of a particular
5-HT3R are within about 1.5 nm of the corresponding NTA-probes, owing to the
distance between the chromophore center and the Ni2+ ion (figure 2.3.a and b),
and located with fivefold symmetry within a hemi-torus with torus and tube radii
of 4 and 1.5 nm, respectively, around the receptor, excluding the hydrophobic core
of the membrane owing to the polarity of histidine [151] (crosshatched regions).
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binding.
The fast reversibility of the binding of NTA-probes to oligohistidine sequences
might improve FRET experiments considerably. The fluorescence of the FRET
donor can be easily measured before and after a titration experiment delivering re-
liable reference values indispensable for the quantitative evaluation of FRET. Also,
several FRET acceptors with different R0 values can be applied consecutively to
the same sample, as NTA probe can be removed by EDTA addition and medium
exchange. This subsequently facilitates the optimization of precise distance mea-
surements within proteins and protein complexes.
2.4.4 Fluorescent NTA probes label the 5-HT3 receptor in live cells
Imaging nonfluorescent proteins within a living cell by labelling with NTA fluo-
rophores might be hampered by the relatively low affinity of NTA to hexahistidine
sequences. Because this would result in a considerable fluorescence background
of unbound NTA fluorophores, the hexahistidine sequence was elongated, increas-
ing the affinity of QSY7-NTA-Ni for 5-HT3R-C-His10 sixfold over its affinity for
5-HT3-C-His6 (figure 2.10.a). In turn, labelling the 5-HT3R-C-His10 with tetraethyl
rhodamine-NTA-Ni (Rho-NTA-Ni) in live cells allowed imaging and localization of
the receptor in the cell membrane by confocal microscopy (figure 2.10.b right). The
specificity of labelling with Rho-NTA-Ni was demonstrated with bound GR-flu a
fluorescein labelled antagonist of the 5-HT3R (i) by colocalization of rhodamine and
fluorescein fluorescence (figure 2.10.b left) and (ii) by observation of FRET between
GR-flu and Rho-NTA-Ni (figure 2.10.b middle). This example shows that it is pos-
sible to measure simultaneously the binding of two different markers (Rho-NTA-Ni
and GR-flu) to the receptor. Similarly, other fluorescent NTA-probes were used
(table 2.4).
2.4.5 A G protein-coupled receptor investigated with NTA chro-
mophores in vivo
The novel labelling procedure was also applied to the NK1 tachykinin receptor [153]
(NK1R), a representative of the large G protein-couple receptor family [154]. A
GFP and an oligonucleotide sequence were fused to the extracellular N-terminal
and at the intracellular C terminus, respectively, yielding, GFP-NK1R-His10 (fig-
ure 2.11.a). Binding of QSY7-NTA-Ni diminished the fluorescence of GFP-NK1R-
His10 in a saturable manner, whereas QSY9-NTA-Ni is indeed membrane imperme-
able, as previously shown (figure 2.11.b). Moreover, the affinity of QSY7-NTA-Ni
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Figure 2.10: In vivo labelling of the 5-HT3R-C-His10. (a) Extending the
length of the hexahistidine sequence increases its affinity for NTA-probes. Sequen-
tial addition of QSY7-NTA-Ni to HEK-293 cells expressing the 5-HT3R-C-His6
(¤) and 5-HT3R-C-His10 (M) resulted in a saturable decrease of the fluorescence
intensity of receptor-bound GR-flu, yielding Kd = 1.05 ± 0.07 µM or 166 ± 7
nM, and maximal FRET efficiency Emax = 1.00 ± 0.05 or 0.99 ± 0.02, for the re-
spective receptors. (b) Localization of 5-HT3R-C-His10. HEK-293 cells expressing
5-HT3R-C-His10 were incubated with 20 nM GR-flu for 20 minutes. Subsequently
Rho-NTA-Ni was added to a final concentration of 0.5 µM, decreasing the GR-flu
fluorescence intensity by 25%. Rho-NTA-Ni fluorescence (right: excitation 548 nm,
emission filter LP580 nm) localized with GR-flu fluorescence (left: excitation 458
nm, emission filter BP505-530 nm). Upon excitation of GR-flu, Rho-NTA-Ni fluo-
rescence was also observed because of FRET (middle: excitation 458 nm, emission
filter LP580 nm). Scale bar is 20 µm.
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for the intracellular His-tag in the NK1 receptor is comparable to the one obtained
for oligohistidine-labelled of GFP and 5-HT3 receptor. The distance between the
chromophore of GFP and QSY7-NTA-Ni in the case of GFP-NK1R-His10 is deter-
mined from FRET measurements as 5.7 nm, sufficient to span the membrane the
hydrophobic core of the plasma membrane (2.5-3.0 nm) or the entire membrane (3.5-
4.7 nm) [152]. This shows the potential of the method for studying protein-protein
interactions within cellular signaling.
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Figure 2.11: In vivo labelling of a G protein-coupled receptor. (a) Seven
transmembrane topology of the GFP-NK1R-His10 with the fluorescent protein at
the extracellular N-terminal and the polyhistidine sequence at the intracellular C-
terminal. (b) Addition of increasing concentration of QSY7-NTA-Ni to HEK-293
cells expressing GFP-NK1R-His10 in the plasma membrane results in a saturable
decrease of GFP fluorescence (◦), whereas QSY9-NTA-Ni has almost no effect (¥),
demonstrating the membrane impermeability of the latter probe. Evaluation of
the binding isotherm of QSY7-NTA-Ni yielded a dissociation constant Kd = 2.4 ±
0.2 µM and FRET efficiency at saturation E = 0.41 ± 0.02. A distance of 5.7 nm
between the chromophores of GFP and QSY7-NTA-Ni was obtained using R0 =
5.4 ± 0.3 nm, assuming κ2= 2/3 for enhanced GFP and QSY7-NTA-Ni.
2.5 Conclusion
The present approach overcomes several limitations of existing labelling methods.
It allows fast and reversible, site-specific, and in vivo labelling of proteins by small,
nonperturbing molecular probes (table 2.5). It has been demonstrated that NTA-
probes having a wide range of spectroscopic properties can be used to rapidly label
molecules in a fully reversible manner. This generic method can be applied both
in vivo and in vitro to investigate molecular interactions, to visualize His-tagged
molecules and to elucidate the structure and topology of proteins. This methodology
is nearly a ready for use labelling technique since polyhistidine sequences genetically
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Table 2.4: Kd values (µM) for NTA-probes interacting with polyhisti-
dine tagged receptors in live HEK-293 cells.
Receptors QSY7-NTA-Ni QSY9-NTA-Ni Rho-NTA-Ni
5-HT3R-C-His6 1.05 ± 0.07 12.7 ± 0.5 1.70 ± 0.18
5-HT3R-C-His10 0.166 ± 0.007 2.6 ± 0.6 1.45 ± 1.13
5-HT3R-Loop-His6 4.2 ± 0.7 NB 1.5 ± 0.5
5-HT3R-N-His6 1.95 ± 0.03 7.8 ± 2.4
GFP-NK1R-His10 2.4 ± 0.2 NB
Receptors TexRed-NTA-Ni Cy3-bis-NTA-Ni Cy5-NTA-Ni
5-HT3R-C-His10 0.22 ± 0.05 0.55 ± 0.05 ≥ 2.5
NB for no binding, the cell plasma membrane is impermeable towards the probe.
fused to proteins are used for protein purification. Close to two thousand indexed
proteins contain a His6 recognition sequence peptide (BLAST using the SIB network
sevice) that can be labelled by the present approach. Moreover, NTA probes are
readily and economically produced from commercially available compounds. It will
therefore facilitate the quantitative analysis of biochemical networks that control
and maintain cellular function, which is a major goal of proteomics.
Table 2.5: Comparative table of different methodologies for labelling
proteins with small-molecule probes and their relative attributes.
Methods Tag size Partner size In vivo Reversability Kinetics
GFP 27 kDa - Yes - -
hAGT 20 kDa < 1 kDa Yes No minutes
HaloTag 33 kDa < 1 kDa Yes No min. to hours
DHFR 18 kDa < 1 kDa Yes No min. to hours
ACP 7 kDa < 1 kDa Yes No min. to hours
FKBP 12 kDa < 1 kDa Yes More or less min. to hours
Epitope 5-30 aa 150 kDa No More or less min. to hours
Biotin ligase 15 aa > 1kDa No More or less min. to hours
FlAsH 6-10 aa < 1 kDa Yes More or less min. to hours
NTA 6-10 aa < 1 kDa Yes Yes seconds
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Chapter 3
NTA-fluorophores for
single-molecule microscopy of
living cells: Diffusion of the
5-HT3A receptor
Abstract — Techniques allowing selective detection of a few molecules, or even one
molecule in living cells, offer novel ways to investigate the dynamics of cellular orga-
nization. So far, access to single-molecule properties was achieved by gold particles,
latex beads, fluorescent quantum dots that are all rather big or small covalently-
bound fluorescent labels that irreversibly photobleached. Here, the new fluores-
cence labelling method using NTA-fluorophores specifically and reversibly bound to
engineered oligohistidine sequences, are used to probe the lateral diffusion of the
ionotropic 5-HT3 receptor in living cells. Particle tracking yielded heterogenous and
complex trajectories of the receptor. Distribution of microscopic diffusion constants
and fractions of mobile and immobile receptors revealed a significant decrease of
the lateral mobility of the desensitized receptor after binding of serotonin. The
present approach overcomes several limitations of conventional labelling methods.
Reversibility of the binding allows successive tracking of single membrane proteins
on the same cell under various conditions, yielding information on plasma membrane
distribution, lateral mobility and modulation of these by stimuli.
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3.1 Introduction
The advances in biology over the last half-century can best be summarized as un-
derstanding biology on a chemical basis. The genomes of many species, including
humans, have now been sequenced, as well as high resolution structures of many
macromolecular machineries have been obtained. So what are the new challenges
of the post-genomic era? Well, there are many. But one challenge in particular is
to study how molecular machineries work in real time, especially how they work
individually or together in living cells. In order to reach this goal, technologies have
to be developed which allow the detection of single molecules. Several technologies
opened the door to single molecule detection but only one allows real time imaging of
single molecules in a non-invasive way, suitable for life science; that is single-molecule
imaging (SMI) and single molecule spectroscopy (SMS). Since few years, it is pos-
sible to detect photons emitted by a single fluorescent probe bound to the molecule
of interest at room temperature and to image it over time. Single-molecule spec-
troscopy allows one to realize spectroscopic measurements and to monitor dynamic
processes of a molecule. Single-molecule fluorescence spectroscopy provides a new
and direct approach to investigate the molecular function of biochemical reactions.
In contrast to ensemble measurements like fluorescence recovery after photobleaching
(FRAP) or solution experiments, which yield information only on average molecu-
lar properties, single-molecule experiments provide information on individuals, such
as distribution and time trajectories of properties that would otherwise be hidden.
Whether each individual molecule has slightly different but constant properties or
changes properties over time, cannot be answered correctly by averaging the observ-
able. Therefore, SMS and SMI represent a versatile tool to observe the dynamics,
the motion and folding of proteins or biomolecules in their native environment at
the single-molecule level [155,156].
Different probes have been used so far for the detection of single molecules. For
instance, latex beads (∼500 nm in diameter) [157] and gold nanoparticles (∼40 nm in
diameter) [158] attached to the protein of interest were widely used. Because these
particles are extremely photostable, they allow long and fast measurements, but
their large size is the main drawback; nevertheless, they are still often used. On the
other hand, small fluorophores have been used for SMS on cells like organic dyes (e.g.
Cy5, Alexa 647, Cy3, rhodamine. . . ) covalently bound to the proteins of interest,
fused fluorescent proteins (e.g. GFP, YFP), or coated semiconductor nanoparticles
[128,159]. Quantum dots have the advantage to be extremely photostable compared
to other fluorescent reporters but are unfortunately also rather large (4-8 nm in
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diameter), which might limit certain applications.
Since the development of single-molecule fluorescence spectroscopy at room
temperature, the motion of several different biomolecules has been observed both in
vitro and in vivo. The technique has been applied to directly observe the motions
of linear and rotational molecular motors, enzymatic reactions, structural dynamics
of proteins, DNA-protein interactions, single lipid molecules in a lipid bilayer and
movements of single ion channels in a model membrane in vitro [160–164]. The first
biological events observed at the single-molecule level in vivo were the reaction of
ligand and receptor proteins [165] and the movement of lipid molecules [166] on the
surface of living cells. Since then, ion channels [167], ligand-gated ion channels [159,
168], G protein-coupled receptors [169], cell-adhesion proteins [170], viral proteins
[171], cooperative protein assembly [172] and components of the cytoskeleton [173]
have been visualized as single molecule in live cells. The list of molecules that have
been visualized is growing rapidly.
The interaction of ligand-gated ion channels, like the 5-HT3 receptor, with cy-
toskeletal components and clustering proteins is a major determinant of the topology
of these ionotropic receptors at the cell surface and of their trafficking through syn-
thesis, recycling and degradation pathways. Neurotransmitter receptor movements
into and out of synapses are one of the core mechanisms for rapidly changing the
number of functional receptors during synaptic plasticity. The rapid gain and loss
of receptors from synaptic sites are accounted by both endocytosis and exocytosis,
as well as lateral diffusion of receptors in the plane of the cell membrane [174]. It
has been suggested that endocytosis and exocytosis take place outside the synapse
and that the receptors diffuse inside the synaptic cavity [175, 176]. The events are
independent and are regulated by neuronal activity and interactions with scaffold-
ing proteins [157]. At inhibitory synapses, glycine and GABAA receptor clusters are
stabilized by the scaffolding protein gephyrin, which links to tubuline [159]. Certain
scaffolding proteins have been identified that cluster AMPA and NMDA receptors at
synapses [174]. In the case of the nAChRs, rapsyn is believed to form a cytoskeletal
anchor [177]. Not much is known about the anchoring of the 5-HT3 receptor. It
was reported that both native and exogenous 5-HT3 receptors form clusters associ-
ated with F-actin [178]. These clusters associated to the cytoskeletal network most
probably play a key role in the physiological regulation of the receptor topology and
dynamics, as is the case for other members of the ligand-gated ion channel family.
Here, a new generic method for in vivo membrane protein labelling is pre-
sented, which allows repetitive site-specific labelling with small fluorescent reporters
for single-molecule spectroscopy. As presented in detail in chapter 2, the principle of
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labelling relies on the specific interaction between a polyhistidine sequence as recog-
nition element and a fluorescent NTA-probe. The genetically engineered tag can be
introduced at a particular location where it does not disturb the protein structure
and function in an extracellular accessible region since the probe employed here is
not membrane permeable. The probe contains a metal-ion-chelating nitrilotriacetic
(NTA) part covalently bound to a fluorescent moiety, which can have a wide range of
properties. The site-specific interaction between the polyhistidine sequence and the
small probe is reversible. The mean residence time of the probe on the recognition
peptide sequence is in the order of some tens of seconds, which allows adequate data
acquisition from single fluorescent particles before the probe dissociates. There-
fore, irreversibly photobleached fluorophores can be replaced by fresh ones, which
overcomes the limitation linked with conventional covalent labelling. The labelling
procedure can be virtually indefinitely repeated on the same cell allowing single-
molecule imaging of biological processes under variable conditions with small tags
and small fluorescent probes.
Single-molecule spectroscopy of the 5-HT3 serotonin receptor containing a
polyhistidine tag was performed in live cells to first prove the feasibility of this
labelling method and secondly to get information on the mobility of the receptor in
native plasma membranes. The diffusion of the 5-HT3R was investigated depending
on its activation state revealing significative change in its mobility between the
basal and the desensitized state. The mobility of the 5-HT3R in the basal state
was corroborated by measurements using a specific fluorescent antagonist of the
receptor.
3.2 Properties of single fluorescent molecules
The signal to noise ratio is the most important factor in SMS since it sets the funda-
mental detection limit. Therefore, appropriate fluorescent probes have to be used.
They have to exhibit a high extinction coefficient at the excitation wavelength, a
high fluorescent quantum yield and a high photostability. Additionally, the ideal
fluorophore should have a fairly short fluorescence lifetime so that it can go through
the excitation and emission cycles at high frequency and should not show fluores-
cence intermittencies as a result of, for example, triplet transitions (dark state). The
fluorescent molecule should also emit in the spectral range where the sensitivity of
the detector is high [156]. In cell imaging, red fluorescent reporters are preferred
since the fluorescence background of living cells in this spectral region is low.
An intrinsic property of all conventional organic fluorophores is that they
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undergo irreversible photobleaching, which limits the number of photons that can
be detected from a single fluorophore. Common dye molecules can emit up to 106
photons before photobleaching occurs. This single-step photobleaching is one of the
signature of a single fluorescent molecule and is actually the criterion used in SMS
cell imaging (figure 3.1) due to its direct access. Anti-bunching [179], defined dipole
moments [180] and shape or size and intensity of the spot are the other criteria
characterizing a single fluorescent molecule. Whereas the first three criteria are
very strong, the latter two are very weak because the shape and intensity of the
signal depends on the chemical structure of the fluorophore, its orientation relative
to a support and its molecular environment.
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Figure 3.1: Single fluorescent molecule imaging. (a) Fluorescence image
of single 5-HT3Rs labelled with Atto 647-NTA-Ni in HEK-293 cells. Scale bar
represents 5 µm. (b) Irreversible single step photobleaching of an Atto 647-NTA-
Ni bound to 5-HT3R. The integrated light intensity inside the white circle in (a)
was plotted versus a series of frames. The single-step photobleaching event is a
proof that the encircled bright spot resulted from the emission of only one single
fluorescent molecule.
3.3 Materials and methods
3.3.1 Fluorescent probes
Atto 647-NTA-Ni — The succinimidyl ester of Atto 647 (Fluka, Buchs, Switzer-
land) dissolved in DMF was mixed to five equivalent Ni-NTA-lysine in 50 mM
NaHCO3 pH 8.0 (Atto 647 is less stable pH 9.0). The reaction was incubated
overnight in the dark at 22◦C. The product Atto 647-NTA-Ni was purified by thin
layer chromatography on silica gel 60 plates 200 x 200 x 0.25 mm3 (Merck, Darm-
stadt, Germany) eluted with CHCl3/CH3OH/H20 64:33:4 (Rf = 0.14). The yield of
the reaction was ∼17% after extraction of the product with H2O. The structure of
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Atto 647 was not revealed by the provider.
GR-Cy5 — GR-H (1,2,3,9 tetrahydro-3-[(5-methyl-1H-imidazol-4-yl)methyl]-9-(3-
amino-propyl)-4H-carbazol-4-one) (Glaxo Wellcome, Geneva, Switzerland) was la-
belled with the succinimidyl ester of Cy5 (Amersham Biosciences, NJ, USA) as
described in [145].
3.3.2 Molecular and cellular biology
wt5-HT3R — The sequence corresponds to the long splice variant of the murine
5-HT3R, corresponding to the SwissProt entry p23979 containing two conflict re-
gions, Glu8→Ala-Arg and Thr279→Thr-Ala (mature sequence numbering). The
sequence was inserted into pcDNA 3.1(-) between Xho I and Not I restriction sites
that are located before and after the coding region, respectively. The nucleotide
sequence was verified by restriction analysis and sequencing (the first and last 400
nucleotides of the receptor sequence).
5-HT3R-C-His10 — The sequence corresponds to the short splice variant of the
murine 5-HT3R, corresponding to the SwissProt entry p23979 containing two conflict
regions (Glu8→Ala-Arg and Thr279→Thr-Ala) and lacking the residues 360-365
(mature sequence numbering). A His10 sequence was inserted at the C-terminal of
the protein after Ser464. The construct was inserted in pEAK8 vector between Hind
III and Not I restriction sites that are located just in front and behind the protein
sequence respectively. The nucleotide sequence was verified by restriction analysis
and sequencing of the whole coding region (see appendix A.2).
Cell culturing and transfection — HEK-293 cells were cultured with a density
of 150’000 cells/ml on 0.18 mm thick glass coverslips in 6-well plates in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 2.2% of fetal calf serum under
humidified 5% CO2 atmosphere at 37◦C. Cells were transfected 14 to 18 hours after
splitting using EffecteneTM (Qiagen, Hilden, Germany) according to the supplied
protocol with 0.16 µg receptor plasmid DNA, 0.04 µg EGFP (enhanced green flu-
orescent protein) plasmid DNA (Clontech, Palo Alto, CA, USA), 1.6 µl enhancer,
2 µl effectene and 100 µl EC buffer per well (corresponding to 2 ml medium). Cell
DMEM medium was replaced by DMEM supplemented with 10% of fetal calf serum,
6 to 12 hours after transfection.
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3.3.3 Fluorescence imaging set-up
The setup is based on wide field laser illumination and detection using an intensified
CCD camera sensitive enough to detect light emitted by single fluorescent mole-
cules. A schematic view of the setup is shown in figure 3.2. Circularly polarized
light from a HeNe laser (632.8 nm, 0.5 kW/cm2) or a tunable single mode Ar+ laser
(457.9, 488, 514.5 nm) (both from Coherent, Auburn, CA, USA) was directed by a
dichroic mirror into a microscope objective (C-Apochromat 63x W Korr, 1.2 NA,
Zeiss, Jena, Germany) to illuminate a 22 µm diameter region of the sample. Flu-
orescence was collected by the same objective, passed through adequate filter and
mirror (table 3.1) and imaged on an intensified CCD camera (I-Pentamax 512 EFT,
Roper Scientific, USA). To minimize fluorescence bleaching of the sample, a shutter
(LS3T2, Vincent Association, Rochester, USA) was used with tunable sampling fre-
quencies and illumination times. Illuminated cells were continuously perfused with
a VC-77SP fast step perfusion system (Warner Instruments Corp, Hamden, CT,
USA).
Table 3.1: Excitation wavelength, dichroic mirrors and emission filters
used for SMI.
Dye Excitation (nm) 1Dichroic mirror 1Emission filter
Atto 647 / Cy5 632.8 Q645LP HQ710/120
GFP 488 Q495LP HQ525/50
1 Filters and dichroic mirrors were from Chroma (Rockingham, VT, USA).
3.3.4 Experimental methods
Single-molecule imaging in living cells — The coverslips were transferred to
a sample holder 48 hours after transfection and the cells were covered with 400 µl
Dulbecco’s phosphate-buffered saline (D-PBS) (Gibco Invitrogen, CA, USA) con-
taining 0.9 mM CaCl2, 0.5 mM MgCl2, 2.7 mM KCl, 1.5 mM KH2PO4, 138.0 mM
NaCl and 8.1 mM Na2HPO4 at pH 7.4. All ligands were dissolved in the D-PBS
buffer and cells were continuously perfused during experiments. Single-molecule
fluorescence images were recording at a frequency of 4 Hz with an exposition time
of 50 ms for 100 frames (figure 3.2). Measurements were performed on the up-
per plasma membrane of cells preselected using the cotransfected cytosolic EGFP
marker. Cells expressing the 5-HT3R were incubated for 25-35 seconds with either
100 pM GR-Cy5, 500 pM Atto 647-NTA-Ni or 500 pM Atto 647-NTA-Ni with 2
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Figure 3.2: Schematic view of the single-molecule fluorescence imaging
set-up. HeNe laser generates light of 632.8 nm and the Ar+ laser generates either
457.9, 488 or 514.5 nm wavelengths. Emission filters and dichroic mirrors are
presented in table 3.1. The variable neutral density filer (OD) was used to tune
the excitation laser intensity.
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µM serotonin (5-HT) (Fluka, Buchs, Switzerland) before washing with the buffer.
Series of fluorescent images were recorded with a delay of 6-7 seconds after the start
of washing to ensure that no free fluorescent ligand remained in solution. Before the
first recording, the sample was continuously exposed to excitation light for 1 minute
to decrease the autofluorescence of the cells. No significant unspecific binding of
GR-Cy5 and Atto 647-NTA-Ni was observed on native HEK-293 cells or HEK-293
cells expressing the wt5-HT3R.
Dissociation rate constant of Atto 647-NTA-Ni — Cells transiently express-
ing the 5-HT3R-C-His10 were prepared as for single-molecule imaging (see above)
in D-PBS buffer. Sequences of fluorescence images were performed at different fre-
quencies (1, 2, 4, 6 , 8, 10 and 12 Hz) with an exposition time of 50 ms for 150 frames
(figure 3.2). Cells were incubated for 40 seconds with 2.0-0.5 nM Atto 647-NTA-
Ni and then continuously washed with D-PBS buffer. Series of fluorescent images
were recorded with a delay of 6-7 seconds after start of washing to ensure that no
free fluorescent ligand remained in solution. Recordings at the different sampling
frequencies were all performed on the same cell and the experiment was repeated
twice.
3.3.5 Data treatment
Dissociation rate constant — The dissociation rate constant of Atto 647-NTA-
Ni from 5-HT3-C-His10 was evaluated from the fluorescence intensity decay during
washing. The decrease of fluorescence intensity is a superposition of the dissociation
of the ligand and photobleaching of the fluorophore as described by equations 3.1
and 3.2.
dF
dt
= −koff · F − kbl · ν · tex · F (3.1)
F = F 0 · exp (− (koff + kbl · ν · tex) · t) = F 0 · exp (−kobs · t) (3.2)
F and F 0 are the fluorescent intensity at time t and t = 0 respectively, koff
the dissociation rate (s−1), kbl the photobleaching rate (s−1), tex the exposition time
per frame (s), ν the sampling frequency (Hz) and t the time (s). The dissociation
rate constant is obtained from the intercept of a linear fit of the plot of the effective
fluorescent decay rate constant kobs versus the frequency using equation 3.3.
kobs = koff + kbl · tex · ν (3.3)
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Single molecule tracking — Single-molecule tracking was performed using a
homemade computer program written in the Igor Pro software (WaveMetrics, Lake
Oswego, OR, USA), which first localized single molecules and then tracked them in
order to collect information about the mobility or diffusion constants. Image series
of single fluorescent molecules were processed in six steps. (i) A Gaussian filter
was applied to each image to remove background noise and then (ii) to localize all
the local maxima of intensity. (iii) All the assigned maxima were then marked in
the original image sequence and each of them was fitted (iv) according to a two-
dimensional Gaussian fit. This step allowed us to discriminate single-molecules by
assigning shape constraints on the peaks (e.g. width of the peaks in two dimensions
and intensity). Signal caused by cosmic rays (too narrow), from vesicles or from
the autofluorescence of the cell (too large) and from several fluorescent molecules
within a single spot (elongated peak) were this way discriminated. A successful
fit gave the position of the particle with an accuracy much higher that the actual
size of the pixel (225 x 225 nm2) mainly determined by the surrounding noise. (v)
Trajectories of each selected single molecules were then determined by calculating
for all images of the series the distance separating all fitted molecules in image i
to all fitted molecules in image i+1. Closest molecules in image i and i+1 were
considered to be the same as long as distance remained within a certain threshold
fixed at 4 pixels (1 µm). The trajectories were occasionally interrupted by blinking,
crossing of two molecules and unsuccessful fits. (vi) All trajectories were visually
checked to both link interrupted traces and observe one-step photobleaching. Only
traces fulfilling these seven criteria were used for further analysis.
Classification and characterization of trajectories — Square displacements
r2 were calculated between all points of a tracked trace and averaged for each corre-
sponding time interval between two images (t lag) yielding mean square displacements
MSD(t lag). For each trajectory, the dependency of MSD versus t lag is the signature
of the diffusion properties of the receptor. For a free brownian diffusion in a plane,
the MSD is linearly dependent on t lag and can be fitted by equation 3.4 where D is
the diffusion constant (in µm2s−1).
MSD(tlag) = 4·D · tlag (3.4)
If the particle is confined within a certain domain, the diffusion inside the
compartment will be free yielding a linear dependence for short t lag corresponding
to MSDs much smaller than the compartment dimension. At large t lag, the MSD
reach a constant value which is related to the dimensions L (µm) of the confinement
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area. Such behavior can be fitted with equation 3.5. This relation can also be applied
for Brownian diffusing particles with the difference that the value of L obtained is
large, inconsistent with the observed phenomena.
MSD(tlag) =
L2
3
·
(
1− exp
(
−12 ·D · tlag
L2
))
+ noise (3.5)
The traces of individual molecules were usually too short for the determination
of MSD(t lag) with sufficient accuracy. Therefore, individual molecules were classi-
fied and grouped into two main different categories, immobile particles and mobile
particles according to specific criteria determined from measurements of immobile
molecules on a glass surface (figure 3.3); a distinction was made between mobile
molecules that were confined and non-confined. The r2 within the same category
were combined and MSD(t lag) versus t lag plots were fitted using equation 3.5 yield-
ing diffusion coefficients D and size of the confined domain L. All errors indicated
were calculated according to Gauss propagation method and are 95% confidence
intervals.
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Figure 3.3: Schematic description of the algorithm used for particle
classification. Criteria presented in the boxes yield two classes of particles: the
immobile and the mobile (confined and non-confined) particles.
Classification of trajectories within two main categories, mobile and immobile
particles, was performed using three criteria as presented in figure 3.3. The first
criterium is the microscopic diffusion coefficient Dmicro that corresponds to the dif-
fusion coefficient obtained from a linear fit (equation 3.4) of the first four points
of the MSD(t lag), as described by Kusumi et al. [158]. The second is the maximal
mean r2 and the third one is based on the results of a confined fit (equation 3.5). For
a molecule to be considered as confined, the size of the domain L should be smaller
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than 1 µm and its error ∆L should not exceed the dimensions of the confinement.
Moreover, the trace of the particle should be long enough to ”feel” the confinement:
The final MSD of the particle, according to its Dmicro, should be at least twice the
MSD corresponding to L (4·Dmicro·t lag,max > 2·L2/3). The choice of the threshold
value of 0.005 µm2s−1 for Dmicro,threshold and 0.034 µm2 for <r2>max,threshold are
discussed in details in section 3.4.2, as well as the classification procedure. Particle
classification according to this procedure was in agreement with visual inspection.
3.4 Results and discussion
3.4.1 Reversible labelling for single-molecule spectroscopy
Reversible labelling of proteins with a fluorescent NTA probe for single-molecule
spectroscopy (SMS) was performed on living cells. The serotonin type 3A recep-
tor containing an extracellular C-terminal decahistidine sequence (5-HT3R-C-His10)
(figure 3.4.a) expressed in HEK-293 cells was labelled by incubating for 25 to 35
seconds with 500 pM Atto 647-NTA-Ni, a small organic fluorescent reporter. Under
continuous washing with buffer, single 5-HT3R-C-His10 were imaged in the upper
plasma membrane of living cells (figure 3.4.b) for several frames before the bound
Atto 647-NTA-Ni irreversibly photobleached (figure 3.1.b) or dissociated from the
receptor as a result of the non-covalent interaction. Particle tracking yielded traces
that exceeded 15 frames for at least 50% of the particles (figure 3.4.c). In compari-
son with fluorescent proteins like YFP, for which not more than ten frames can be
recorded before photobleaching occurs [181] in a wide field set-up, the NTA probes
are much more stable and slower events can therefore be directly visualized. Fur-
thermore, full freedom in the choice of the dye is provided, allowing to work in
spectral region where the autofluorescence is low and to tune the properties of the
fluorophore in applications like single-molecule FRET. Diffusion of the labelled re-
ceptor could be imaged up to 20 seconds, which corresponds to 80 frames recorded
at a frequency of 4 Hz (figure 3.4.c).
Specificity of the labelling methodology was verified by incubating native
HEK-293 cells and HEK-293 cells expressing wt5-HT3R (containing no polyhisti-
dine sequence) with 500 pM Atto 647-NTA-Ni for 30 seconds. After washing, no
single fluorescent particles were observed on HEK-293 cell membrane, while few
particles were detected on HEK-293 cells over expressing the wt5-HT3R. All un-
specifically bound probes moved very fast compared to specifically bound ones and
were rapidly washed out during the first 10-15 frames of recording. Unspecific bound
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Figure 3.4: Single-molecule spectroscopy of the 5-HT3R in a living cell.
(a) Topology of a subunit of the homopentameric 5-HT3R showing the N-terminal
ligand-binding region, the four predicted transmembrane segments, the large in-
tracellular loop and the extracellular C-terminus where a His10 sequence was ge-
netically fused. The insert shows a cylindrical model of the 5-HT3 receptor. (b)
HEK-293 cells expressing the 5-HT3R-C-His10 were incubated for 30 seconds with
500 pM Atto 647-NTA-Ni and then continuously washed, labelling only a frac-
tion of the receptor as revealed by single-molecule spectroscopy using 632.8 nm
laser excitation (500 W/cm2). Each bright spot corresponds to a single Atto 647-
NTA-Ni bound to 5-HT3R-C-His10; all of them showed characteristic single-step
photobleaching. Scale bar is 5 µm. (c) Distribution of the trace lengths obtained
from particle tracking (see section 3.3.5) on a population of 222 traces of Atto
647-NTA-Ni bound to 5-HT3R-C-His10. The histogram revealed that 10% of the
traces were longer than 50 frames.
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probes were assessed to be less than 5%. Interestingly, the molecular structure of the
fluorophore played a role in the specificity of the probe. For instance, Cy5-NTA-Ni
(figure 2.3) was not suited for single-particle labelling: Controls revealed significant
unspecific labelling on the membrane of HEK-293 cells (Cy5 is known to be a mem-
brane probe). Therefore, the Atto 647 dye is much more suited for this application
compared to Cy5; it is not a membrane probe and is much more photostable.
Since the attachment of NTA-probes to polyhistidine sequences is reversible
(figure 2.1), the probe can dissociate during washing and labelling can then be re-
peated many times as long as the illuminated cell remains alive. Photobleached
fluorescent labels can thus be removed and replaced by new ones. Successive cycles
of incubation, washing and recording were performed on the same cell (figure 3.5.a)
and the relative fluorescence intensity reached after each association step was found
to vary by less than 7% (figure 3.5.a left row). Each cycles lasted about one minute
(25-35 seconds incubation, 6-7 seconds delay before recording and 100 frames at 4Hz
recording) yielding up to 20 traces longer than 15 frames per recording. Therefore,
acquisition of data could be performed very rapidly as 5 cycles (∼5 minutes) could be
easily performed on the same cell yielding around 100 traces per cell. Experiments on
10-20 cells yielded sufficient traces for good statistics of diffusion modes. Reversible
site-specific labelling presents therefore several advantages for single-molecule spec-
troscopy compared to conventional labelling methods. From an experimental point
of view, this labelling procedure is very convenient since the set-up can be adjusted
and the focus can easily be set because probes bleached during adjustments can be
replaced.
The dissociation rate constant of Atto 647-NTA-Ni was determined on a sin-
gle cell with single-molecule sensitivity from the decay of the fluorescence intensity
in an image series under continuous washing. To distinguish between fluorescence
decrease due to the probe dissociation from the one resulting from fluorescence
bleaching, measurements were repetitively recorded at different frequencies, as de-
scribed in section 3.3.5 (figure 3.5.a). While photobleaching depended only on the
exposure time, which remained constant for all the recordings since the number of
frames recorded was identical, the dissociation of the probe increased with decreas-
ing frequencies corresponding to longer total measurement times (figure 3.5.b). The
resulting dissociation constant koff = 0.026 ± 0.012 s−1 was similar to the values
obtained on the purified GFP-His10 (table 2.3). According to the corresponding
halftime t1/2 = -1/koff · ln(1/2), half of the probes dissociated from the tagged re-
ceptor within 27 seconds under continuous washing. The dissociation kinetics was
therefore slow enough to record 100 frames at 4 Hz and fast enough for repeated
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labelling on the same cell.
The association rate constant of the probe to the histidine tagged receptor
could not be determined due to the relatively high value of the dissociation rate
constant. The procedure to determine this factor is to incubate with the probe
a single cell expressing the 5-HT3R-C-His10 for different time periods and then to
record the fluorescence after a rapid wash allowing to remove all the unbound probes.
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Figure 3.5: In vivo reversible labelling for single-molecule spectroscopy.
(a) Fluorescent images of a cell incubated for 30 seconds incubation with 2 nM
Atto 647-NTA-Ni. After dissociation, Atto 647-NTA-Ni is replaced on the same
cell and cycles are repeated (second and third line). Image sequences were acquired
at different frequencies as indicated and images correspond to frame 0 (left), 50
(middle) and 100 (right). Scale bar is 5 µm. (b) The observed dissociation rate con-
stant (kobs) of Atto 647-NTA-Ni is linearly dependent on the sampling frequency.
Quantitative evaluation using equation 3.3 yields koff = 0.026 ± 0.012 s−1 and kbl
= 1.1 ± 0.1 ms−1. Errors are within the points.
3.4.2 Diffusion of the 5-HT3R in living cells
The lateral mobility of the 5-HT3R-C-His10 was monitored in HEK-293 cells using
repetitive labelling with Atto 647-NTA-Ni and quasi irreversible labelling with GR-
Cy5 (koff = 0.28· 10−3 s−1 corresponding to t1/2 ≈ 40 minutes [150]), a fluorescent
antagonist of the receptor. Typical traces were 20 frames long, some being longer
than 90 frames, yielding reliable trajectories of single receptors in the upper plasma
membrane of living cells (figure 3.6). Trajectories were very heterogeneous and
complex. Most particles were found either immobile (figure 3.6.a), mobile within
a confined region (figure 3.6.b) or freely mobile (figure 3.6.c) as revealed by the
dependency of the mean square displacement (MSD) versus the time lag (t lag) (fig-
ure 3.7). Transitions between these diffusion modes could be observed in some
trajectories: Some mobile molecules became immobile or confined (figure 3.6.d), or
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inversely (figure 3.6.e). In addition to the three main modes, particles exhibiting
hopping, directed or very slow diffusion were also observed (figure 3.6.f, g and h).
This high diversity of diffusing particles impeded a clear classification of particles
into distinct classes. For instance, the method proposed by Schu¨tz and Schmidt [182]
based on the cumulative distribution function did not yield meaningful results. It
is also remarkable that it was not possible to make an homogeneous population of
mobile molecules. This means that the diffusion is heterogeneous in nature with the
5-HT3R being constantly hindered in his diffusion in a way depending on its local
environment. Therefore, another procedure was implemented (see section 3.3.5).
a b c d
e f g h
Figure 3.6: Heterogeneous diffusion of 5-HT3Rs in HEK-293 cells. The
positions of single Atto 647-NTA-Ni probes bound to 5-HT3R-C-His10 were evalu-
ated from 2D Gaussian fits on a series of frame recorded at 4 Hz, yielding trajec-
tories (red line) of the receptor in the upper plasma membrane. Receptors exhibit
three distinctive diffusing modes: (a) immobile, (b) mobile confined and (c) mobile
non-confined. Their corresponding MSDs versus tlag is presented in figure 3.7. Nev-
ertheless, some trajectories present combined diffusion modes. The receptor can
be mobile and then confined (d) or immobile and then mobile (e), hopping from
one confined domain to another (f), or diffusing linearly (g), or slowly moving with
short interruptions (h). The pixel size corresponds to 225 x 225 nm2.
Diffusing particles were classified into two main categories, immobile and mo-
bile particles, according to the microscopic diffusion constant and the maximal
recorded mean square displacement <MSD>max (section 3.3.5). Immobile receptors
were defined as those whose Dmicro is below 0.005 µm2/s. This value corresponds to
the resolution limit of our set-up as determined from measurements on fluorescent
molecules immobilized on a glass surface. It should be noticed that this criterium
does not necessarily mean that the molecules are effectively immobile since they
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Figure 3.7: Diffusion of single receptors in the membrane of living cells.
Mean square displacement MSD versus time lag for an immobile (a), a mobile
confined (b) and a mobile non-confined (c) 5-HT3 receptor in HEK-293 cells labelled
with Atto 647-NTA-Ni. (a) MSD of an immobile particle is constant versus time
meaning that the particle does not move. The average <MSD> = 0.0038 ± 0.0005
µm2 corresponds to the noise and sets the localization accuracy to 44 nm. (b) In the
case of a confined particle, its MSD increases to reach a limiting value corresponding
to the boundary of the confinement. Fitting with equation 3.5 yielded D = 0.010
± 0.006 µm2s−1 and L = 0.347 ± 0.012 µm. (c) In the case of a particle diffusing
freely in the plasma membrane, MSD is linearly dependent on tlag. Fitting with
equation 3.4 yielded D = 0.033 ± 0.006 µm2s−1. Deviation of MSDs from the fit
for large tlag is due to a weak statistics. The MSD of (a), (b) and (c) corresponds
to the trajectories presented in figure 3.6.a, b and c, respectively.
could move very slowly. Indeed, for very long traces, a very small displacement
could be detected for several molecules.
This criterium was however not sufficient for receptor classification. Several
immobile receptors were wrongly classified because they were in noisy regions of the
cell so that the measurements on the glass surface were not representative. The
surrounding noise had a direct effect on the localization precision whose error had
repercussions on the microscopic diffusion coefficient value. To account for this, we
required that receptors moved at least over a certain distance corresponding to an
MSDmax > 0.034 µm2 to consider them truly mobile. Some receptors seemed to
diffuse within confinement region as shown in figure 3.6. We therefore investigated
whether these receptors would diffuse within regions of precise dimensions. The
regions were however found to widely vary. Thus, we considered this apparent
confinement to be a manifestation of the heterogeneous diffusion and did not set a
separate class for them. The classification of receptors according to the procedure
described above was verified for each tracked molecule. Moreover the procedure was
found to allow correct classification of other types of diffusing membrane proteins
like nAChR or MHC (major histocompatibility complex) proteins.
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The heterogeneous behavior of the receptor suggests that it interacts somehow
with the cytoskeleton, probably in a reversible manner. Disruption of the cytoskele-
ton with latrunculin A, an actin-binding toxin, which inhibits actin polymerization,
did not allow measurements. The plasma membranes of such treated cells were not
flat anymore and moreover, cells did not tightly bind to the glass coverslips and
dissociated under washing.
3.4.3 Mobility of the 5-HT3R with and without bound ligand
The diffusion of the 5-HT3R was then investigated in living HEK-293 cells depending
on its state of activation. We used Atto 647-NTA-Ni with or without incubation
with serotonin to determine the mobility of the receptor in its desensitized and in
its basal state, respectively. We then compared and related the results with the
mobility of the receptor revealed with the fluorescent antagonist GR-Cy5, which
most probably stabilized the receptor in the basal state. GR-Cy5 site-specifically
binds to the binding pocket of the 5-HT3R in a quasi irreversible manner; only one
GR-Cy5 binds per receptor [145].
Mobility of receptors obtained from GR-Cy5 and Atto 647-NTA-Ni in the
presence and in the absence of serotonin were first compared via the distributions
of the microscopic diffusion constants of the individual receptors. A comparison
of the medians of the histograms (figure 3.8) revealed that the distribution of the
microscopic diffusion coefficients of the receptors incubated with serotonin (median
= 0.0022 µm2/s) was significantly different from the ones labelled with GR-Cy5
(median = 0.0041 µm2/s) or with the NTA-probe in the absence of serotonin (median
= 0.0038 µm2/s) with 99.9% confidence (Mann-Whitney U -test, P < 0.001). In
contrast, the populations of receptors measured via GR-Cy5 and Atto 647-NTA-Ni
without incubation with serotonin were undistinguishable (Mann-Whitney U -test,
P ≈ 0.4). This analysis therefore shows that the receptor in its desensitized state
was less mobile or that its mobility was slowed down compared to the basal state.
The difference of mobility of the receptor depending on the functional state
was even clearer when considering the mobile and immobile fractions classified as
mentioned above (figure 3.9, table 3.2). The desensitized receptor was significantly
less mobile with 99% confidence compared to both receptors labelled with GR-Cy5
and or with the NTA-probe without serotonin. In contrast, no distinction could be
made between the mobility of receptors reported by GR-Cy5 and Atto 647-NTA-Ni
(χ2 test, P > 0.9). This similarity is a strong indication that both the NTA-probes
and the GR-Cy5 report on receptors in the basal or non-activated state.
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Figure 3.8: Lateral mobility of 5-HT3R in live cells depends on the
functional state of the receptor. Histograms of microscopic diffusion constant
of receptors labelled with the fluorescent antagonist GR-Cy5 (a), Atto 647-NTA-Ni
without 5-HT (b) and Atto 647-NTA-Ni with 5-HT (c). Median values and number
of reconstituted traces are indicated. Bin size corresponds to 0.005 µm2/s. The
histogram in the presence of serotonin is significantly different from the two other
conditions demonstrating that the diffusion of the receptor diminished with 99.9%
confidence (Mann-Whitney U-test, P < 0.001).
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Figure 3.9: Fraction of immobile and mobile 5-HT3 receptors. The frac-
tions of immobile (grey) and mobile (black) receptors as revealed by the antagonist
GR-Cy5 and by Atto 647-NTA-Ni in absence of the serotonin were identical (χ2
test, P > 0.9). The presence of serotonin significantly decreased the mobile frac-
tion from 33% to 21% (χ2 test, P < 0.01). The number of traces constituting the
fractions are indicated in the bars and percentage values reported are indicated in
table 3.2.
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While serotonin modulates the fraction of mobile and immobile receptors,
it does not change the diffusion rate of the mobile receptors as judged from the
calculated MSDs by combining all the mobile trajectories versus t lag (figure 3.10
and table 3.2). The plots show a deviation at large MSDs from a straight line
characteristic for Brownian diffusion. The origin of this deviation is unclear and
might be due to the finite dimension of the membrane region that is flat and where
diffusion can be monitored. In addition, the fraction of confined molecules and
molecules changing their mode of diffusion, will also lower the observed MSD at
high t lag. The macroscopic diffusion constant obtained with the model describing a
confined movement (equation 3.5) yielded diffusion constants that are identical for
the three populations (figure 3.10). The values for D correspond within error to the
diffusion constant obtained by fluorescence correlation spectroscopy (FCS) for the
receptor labelled with GR-Cy5 in live cells (DFCS = 0.027 ± 0.013 µm2/s) [183], as
well as the lateral mobility of the glycine receptor, an other ligand-gated ion channel,
revealed by SMS in the perisynaptic region of neurons [159]. Furthermore from the
fits, we obtain the information that the receptors diffuse in confined region of about
1 µm.
We then further investigated whether the respective proportions of free and
confined receptors vary depending on the functional receptor state. No significant
differences were observed showing that the main influence of the serotonin was to
shift a part of the mobile receptors to the immobile or slow moving particles.
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Figure 3.10: Diffusion coefficients of mobile 5-HT3 receptors in living
cells. Mean square displacement (MSD) versus time lag (tlag) of the mobile re-
ceptors revealed using (a) GR-Cy5, (b) Atto 647-NTA-Ni without and (c) with
serotonin. Fit with equation 3.5 yields (a) D = 0.026 ± 0.012 µm2/s and L = 1.2
± 1.3 µm, (b) D = 0.028 ± 0.004 µm2/s and L = 0.9 ± 0.6 µm, (c) D = 0.033 ±
0.006 µm2/s and L = 1.1 ± 0.2 µm.
What could be the reason for the mobility modulation observed upon addi-
tion of the agonist? Binding of the agonist might induce conformational changes
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of the receptor, which in turn might tighten its interaction with the cytoskeleton
or with other receptors or clusters. The fact that we observed an heterogeneous
behavior points towards a modulated interaction with other cellular components.
The decrease of the fraction of mobile receptors due to receptor internalization [184]
appears rather improbable since the overall receptor number remained constant.
It is likely that this modulation of the mobility will have a profound biological
importance. The decrease in mobility at certain locations when and where the
serotonin is present will result in an increase of the effective concentration of 5-
HT3Rs, which might participate in the development of the synapse. More generally,
such modulation of the mobility as shown for other receptors, like glycine, AMPA
and NMDA receptors [159,168], to be the core mechanisms during synaptic plasticity
as mentioned in the introduction of this chapter.
Table 3.2: Experimental information of the different conditions and their
respective immobile and mobile fractions.
GR-Cy5 Atto 647-NTA-Ni Atto 647-NTA-Ni + 5-HT
Number of cells 10 9 9
Number of traces 143 222 242
Immobile fraction (%) 67.1 ± 7.8 (96) 66.7 ± 6.4 (148) 78.9 ± 5.2 (191)
Mobile fraction (%) 32.9 ± 7.8 (47) 33.3 ± 6.4 (74) 21.1 ± 5.2 (51)
D (µm2/s) 0.026 ± 0.012 0.028 ± 0.004 0.033 ± 0.006
Number of trajectories constituting the fraction are indicated in brackets.
3.5 Conclusion
The present approach of reversible and repetitive labelling with Atto 647-NTA-Ni
has been established here for single particle tracking of membrane receptors. It
overcomes several limitations of existing labelling methods by allowing fast (few
seconds incubation), reversible, site-specific, successive in vivo labelling of proteins
by small, non-perturbing molecular probes. Polyhistidine tags are very versatile
as small recognition sequence peptide and are already genetically fused to many
proteins of interest as the tag is widely used for protein purification. This generic
labelling method can be applied at the single particle level to elucidate the organi-
zation and lateral diffusion of membrane proteins that control signaling pathways in
live cells. This new method allowed us to reveal the heterogeneous diffusion of the
5-HT3R, which was found to be modulated by the presence of the agonist, leading
to the increase immobilization of receptors. We infer that this phenomenon is in-
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strumental in synapse development by increasing the local amount of receptor where
serotonin is liberated by a neighbor cell. The fluorescent NTA-probes report the lat-
eral mobility of the receptor yielding the same diffusing behavior as the fluorescent
antagonist, showing the reliability of the methodology.
Chapter 4
Conformational dynamics of the
5-HT3A receptor
Abstract — Neurotransmitter-gated ion channels, such as the 5-HT3 serotonin
receptor, are important for synaptic transmission between neurons. Using site-
specific fluorescent labelling in living cells, agonist-mediated molecular rearrange-
ments within the extracellular domain of the TM2 were investigated. For this to
be feasible, single cysteine receptor mutants were engineered from position 13’ to
30’, each of them characterized for ligand binding, gating and accessibility of the
cysteine side chain with thiol reactive fluorophores in living cells. Screening over the
functional mutants under different functional states revealed that cysteines localized
at position 17’, 20’ and 24’ could be fluorescently labelled with rhodamine and Cy5
as revealed by the staining of the receptors in the cellular membrane. A rhodamine
fluorophore tethered to the cysteine residue at the 20’ position detected productive
binding of agonist. During serotonin application, fluorescence decreased by ∼18%,
indicating a change of the environment for the fluorophore. In contrast, mCBPGme-
diated an increase of fluorescence intensity revealing a potential different activation
mechanism. These preliminary results demonstrate the potential of single-cysteine
receptor mutants as a tool for probing conformational transition since multiple re-
porter probes can be site-specifically inserted to all accessible regions within the
receptor.
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4.1 Introduction
The activation of ion channels that are gated by neurotransmitters is initiated by the
interaction of agonist and receptor. The signal generated under ligand binding at the
agonist binding-site, which is located in the extracellular N-terminal domain, must
be then propagated to the pore at a distant location. Although radioactive ligands
and electrophysiological studies have provided valuable information about receptor
structure and function, little is known about the structural dynamics underlying
receptor activation and antagonism.
The first developed model of Cys-loop ligand-gated ion channel receptor ac-
tivation is the one proposed by Unwin and coworkers. It is based on the atomic
model of the acetylcholine receptor obtained by cryoelectron microscopy, the res-
olution of which has been extended to 4 A˚ by computational methods [108]. The
model proposes an explanation of how the pore opens when acetylcholine binds to
the receptor. The AChR receptor is viewed as build of two rings; an inner ring of
five α-helices shaping the pore, which curve radially to create a tapering path for
the ions, and an outer ring of fifteen α-helices, which coil around and each other and
shield the inner ring from lipids. The gate is depicted as a constricted hydrophobic
girdle at the middle of the lipid bilayer, formed by weak interactions between neigh-
boring inner helices. When the acetylcholine enters the ligand-binding domain, it
triggers rotations of the protein chains on opposite sides of the entrance to the pore.
These rotations are communicated through the inner helices, and open the pore by
breaking the girdle apart.
This view is not entirely supported by Taly et al. [185]. From normal mode
analysis of the homopentameric α7 nAChR, they proposed that the opening of the
channel is caused by a concerted symmetrical twist of the protein with opposing
rotation of the extracellular and intracellular domains. This model does not involve
any dramatic reorganization of the transmembrane domain compared to the original
model of Unwin. Nevertheless, the question of how binding of an agonist leads to
the channel opening and, which conformational rearrangements are involved remains
unresolved because of the absence of high resolution structure of the open and closed
channel state. In addition to the transmembrane segment TM2, which contains the
receptor gate, also other receptor domains including the transmembrane segment
TM4 move as a consequence of conformational changes induced by agonist-mediated
receptor activation [186], which contradicts the model proposed by Unwin. Most
evidence for this is provided by studies on the nicotinic acetylcholine receptor [187].
There are many experimental techniques to study changes in protein con-
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formation during gating, but no global structural change is implicated by these
observation. Thus, single-channel electrophysiology detects transition of the chan-
nel between open and closed states and allows perturbation analysis using rate-
equilibrium free energy relationship [186]. Fluorescence resonance energy transfer
provides distances between and sometimes rotations of chromophores. Selective ac-
cessibility to covalent modification, such as SCAM [188], disulfide trapping [189] and
electrophysiology-coordinated mass spectrometry [190], indicates which side chains
are accessible in functionally defined states. Conventional mutagenesis [191] and
unnatural amino acid mutagenesis [129] allow to correlate functional measurements
with the chemistry of side chains. Backbone mutagenesis can probe interactions,
and conformational changes, of the backbone. Combining site-specific fluorescent
labelling and simultaneous electrophysiological analysis identified conformational
changes associated with the activation of receptors. Fluorescence allows sensitive
and time-resolved observation of conformational changes due to the inherent sensi-
tivity of fluorophores toward their local environment, i.e. polarity, pH and proxim-
ity of quenchers. If the environment of the fluorophore changes upon activation, a
change in the intensity of fluorescence might be observed. This approach has been
used successfully to identify conformational changes in the voltage sensor of Shaker
potassium channels [192, 193] and to identify an intermediate state of the GABA
transporter [194,195].
Distinct structural changes have been revealed within the Cys-loop ligand-
gated ion channel family. Fluorescent tags attached to cysteine residues in the
region of the binding site of GABA receptor revealed significant fluorescence inten-
sity changes induced by ligand binding and different conformational changes were
detected [196]. Similarly, Lester and colleagues studied conformational transition
of the muscle nicotinic acetylcholine receptor by tethering a rhodamine fluorophore
to a cysteine side chain introduced at the β19’ position in the TM2 region of the
receptor [197]. During agonist activation, they detected a fluorescence increase in-
terpreted as a movement of the fluorophore to a more hydrophobic environment.
The conformational transitions observed were described as not tightly coupled to
channel activation, suggesting that sequential rather than fully concerted transitions
occur during receptor gating. Agonist-induced dynamic rearrangements within the
intracellular side of the 5-HT3A receptor have also been reported [198]. An en-
hanced green fluorescent protein was inserted into each cytoplasmic TM3-TM4 loop
of all five subunits allowing the formation of ionotropic receptor with intrinsic fluo-
rophores in a homopentameric organization and conformational changes induced by
prolonged ligand incubation were sensed by homo-FRET for detergent solubilized
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receptor proteins.
The model proposed by Unwin emphasizes the role of the TM2-TM3 linker
region as a mechanical receiver for binding site conformational changes. Presum-
ably, the force received by this linker region would then pull, push or torque the
gate containing the TM2 helix. Functional changes have been observed as a result
of the TM2-TM3 linker region mutations in the glycine receptor [199], nicotinic re-
ceptors [200], 5-HT3 receptors [201] and GABAA receptors [202,203]. Some of these
involved surface accessibility during agonist exposure [204]. An elegant study com-
bines charge reversal, charge exchange and cysteine crosslinking approaches [202].
Other observations concern the effects of naturally occurring pathological mutations
in the TM2-TM3 linker in the glycine receptor α1 [205] and the nACh receptor α1
subunit [206]. Assuming that TM2-TM3 linker region is the mechanical receiver
of the binding event, two loops close to each other in the extracellular binding site
(L2 and L7 in the structure of the AChBP [52]) are thought to be the mechanical
actuator that engages the TM2-TM3 linker region. According to an experimentally
based model, L2 and L7 bracket the TM2-TM3 loop, mechanically actuating both
the opening and closing events [202].
Detailed SCAM analysis of TM2 residues exposed to water was performed by
Karlin and coworkers [102]. Each residue in the TM2, both in the α- and β- subunits
of the muscular nAChR was mutated to cysteine and the mutants were tested for re-
activity towards small, charged sulphydryl-specific methanethiosulphonate reagents,
such as methanethiosulphonate ethylammonium (MTSEA). Residues reacted with
MTSEA over the entire length of the TM2 but with very different kinetics indi-
cating helical nature of TM2 [207, 208]. At many positions in the TM2 segment,
reactivity of substituted cysteines were different in the resting, desensitized and
open states [207–209], due to accessibility changes, which is correlated to structural
changes. Within the TM2 of the α-subunit of nAChR, the 9’, 13’ and 20’ residues
were reported to be in different environment in the resting, open and desensitized
state [209]. SCAM was also used on the 5-HT3R to identified the amino-acid residues
in the TM2 domain lining the ion conduction pathway [210]. Cysteine was substi-
tuted for each residues, one at a time, from position -4’ to the 20’.
In this chapter, residues within the upper part of the TM2 domain and the
TM2-TM3 linker, corresponding to position 13’ to 30’, were substituted one at a
time in the cysteine-less 5-HT3R. Before 2003, the TM2 was thought to be up to
22’, but since the Unwin’s TM2 structure, its goes up to 28’ where the channel is
wider. Functionality of the mutants expressed in HEK-293 cells was verified and
accessibility of the substituted cysteine residues was then determined by examin-
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ing the ability of fluorescent MTSEA derivatives to couple to them under differ-
ent functional states. Three single-cysteine mutants were site-specifically labelled.
Conformational transitions at the 5-HT3R was observed by tethering a rhodamine
fluorophore to a substituted cysteine at the 20’ position of TM2. Under agonist
application, fluorescence changes were observed indicating a change of environment
of the fluorophore.
4.2 Experimental techniques
As mentioned in the general introduction (chapter 1), ion channels are integrated
in the cell membrane and mediate the ion flux across the membrane. Two experi-
mental techniques applied in this chapter are widely used for their investigation and
characterization. The most direct method to investigate ion channel activity is the
observation of the electrical current caused by the ion flux through the open pores of
channels in the cell plasma membrane, which is performed by whole cell patch-clamp.
The indirect method is the observation of the depolarization or hyperpolarization,
depending of the channel ion selectivity, of the plasma membrane resulting from the
ion flux through the channels. Such variation of the cell membrane potential are re-
ported by fluorescent molecules. While patch-clamp experiments are more sensitive
and provide quantitative information of channel functions, fluorescent based assays
can be performed faster and can easily be automated.
4.2.1 Whole cell patch-clamp
The patch-clamp technique was originally invented by Sakmann and Neher [211]
in 1976 and since then it has been further developed as a standard tool for direct
measurements of ion flux through ion channels embedded in cell membranes. In brief,
a glass pipette with a micrometer-sized hole containing an Ag/AgCl wire connected
to an amplifier headstage serves as measuring electrode, while a ground electrode
is inserted into the surrounding electrolyte buffer. Both electrodes are connected
to a feedback amplifier that maintains a constant voltage, usually around -60 mV,
corresponding to the natural cellular transmembrane potential. Variation in the ion
current from one electrode to the other caused by the opening of ion channels, are
compensated by the feedback voltage, which is monitored and recorded over time.
In the whole cell patch clamp configuration, the pipette tip is first brought in
contact with the cell surface to form first a tight electrical seal by suction (figure 4.1.a
left) and then the membrane is perforated by successive suction. The electrode
within the pipette is in electrical contact with the cytosol of the cell and therefore
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macroscopic current over all ion channels in the cell membrane can be recorded. For
more details, see [212].
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Figure 4.1: Whole cell patch-clamp and fluorescent based membrane po-
tential assay: configuration and principle. (a) A glass pipette containing an
Ag/AgCl electrode is brought into contact with the cell membrane to form a tight
electrical seal. The membrane inside the pipette is disrupted to measure the en-
semble of ion channels embedded in the plasma membrane in the whole cell patch-
clamp configuration. (b) Response mechanisms of membrane potential-sensitive
probes. Lipophilic ion fluorescent probes are translocated across the membrane
by an electrophoretic mechanism. Fluorescent changes associated with transmem-
brane redistribution results from the quenching of extracellular probes by mem-
brane impermeable quenchers.
4.2.2 Fluorescent based membrane potential assay
Potentiometric optical probes were developed in 1970s and were first used to de-
termine the cell membrane potential [213]. These probes enable us to perform
membrane potential measurements in organelles and in cells that are in general too
small for microelectrodes. Moreover, in conjunction with imaging techniques, these
probes can be employed to map variations in membrane potential across excitable
cells, with spatial resolution [214].
Several types of probes with different response mechanisms exist. The mem-
brane potential assay used here is based on probes that exhibit potential-dependent
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changes in their transmembrane distribution. This relative distribution is accom-
panied by a fluorescence change that can be recorded in time as the fluorescence of
the extracellular probes is quenched by non-permeable cell membrane quenchers.
4.3 Materials and methods
4.3.1 Fluorescent probes
MTS-probes — Cyanine 5 aminoethyl methanethiosulfonate (MTSEA) and sulfo-
rhodamine aminoethyl methanethiosulfonate were purchased from TRC (Toronto
Research Chemicals, Toronto, Canada). Throughout this chapter, these probes are
named as MTS-Cy5 and MTS-Rho respectively. Stock solutions of 2-5 mM MTS-
probes in dry DMF were conserved at -80◦C. Reactivity of the probes was checked
by mixing the MTS probes to 5 equivalent L-cysteine (Fluka, Buchs, Switzerland)
in water and incubating 12 hours in the dark. The products were analyzed by
HPLC on a C18 reversed phase column (4.6 mm diameter, 25 cm length) (Vydac,
Hesperia, CA, USA) eluted with 1 ml/min water/acetonitrile (linear gradient of
1%/min acetonitriline) in the presence of 0.1% trifluoroacetic acid. Chromatograms
were compared to the corresponding hydrolyzed MTS probes as control. Elution
times were of 46 min and 53.5 min for Rho-L-cysteine and hydrolyzed MTS-Rho
and 37.2 min and 37.6 min for Cy5-L-cystein and hydrolysed MTS-Cy5 respectively.
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Figure 4.2: Methanethiosulfonate probes. Chemical structure of (a) MTS-
Rho and (b) MTS-Cy5.
GR-flu — GR-H (1,2,3,9 tetrahydro-3-[(5-methyl-1H-imidazol-4-yl) methyl]-9-(3-
amino-propyl)-4H-carbazol-4-one) (Glaxo Wellcome, Geneva, Switzerland) was la-
belled with fluorescein-5-isothiocynate (Molecular Probes Invitrogen, CA, USA) as
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described in [105].
4.3.2 Molecular and cellular biology
5-HT3R-∆Cys-His10 — The sequence of the cysteine-less mutant is based on
the short splice variant of the murine 5-HT3R, corresponding to the SwissProt en-
try p23979 containing two conflict regions, Glu31→Ala-Arg and Thr302→Thr-Ala
(numbering corresponds to the precursor). All the cysteines were substituted with
serine resulting in the following mutations, C269S, C315S, C359S, C381S and C394S
at the exception of Cys161 and Cys175 because they form the disulphide bridge of
the cys-loop (DNA was a kind gift from Nina Dixit). A His10 polyhistidine se-
quence was added at the C-terminus of the protein behind Ser487 by site-directed
mutagenesis (QuickChangeTM mutagenesis kit, Stratagene, CA, USA) under the
conditions required by the provider in the presence of 4% DMSO. Oligonucleotides
5HT3a-∆cysfor and 5HT3a-∆cysrev were used (appendix A.1). The protein coding
sequence was inserted in pcDNA3 vector (Invitrogen, CA, USA) between Hind III
and Not I restriction sites that are located in front and behind the protein sequence
respectively. The nucleotide sequence was verified by restriction analysis and se-
quencing of the whole coding region. The sequence of the construct is detailed in
appendix A.3 and schematized in figure 4.3.a.
Single cysteine 5-HT3R mutants — The sequences of the single substituted
cysteine 5-HT3R mutants were based on the cysteine-less 5-HT3R-∆Cys-His10 se-
quence (see above and appendix A.3). TM2 containing coding sequence comprised
between EcoR V and BamH I restriction sites (figure 4.3.a) was subcloned into
pBluescript II SK (+) (Stratagene) and the resulting plasmid was used as template
for all the site-directed mutagenesis (figure 4.3.c). Corresponding amino acids were
mutated to cysteine using the QuickChangeTM site-directed mutagenesis kit (Strat-
agene) with the conditions required by the provider in the presence of 4% DMSO
for the reaction. All oligonucleotides used are presented in appendix A1 (numbering
corresponds to the amino acid mutated to cysteine of the unprocess precurssor of
5-HT3R-∆Cys-His10). The mutated nucleotide sequence was verified by restriction
analysis and sequencing of the whole insert in pBluescript II SK (+) using the T7
primer; the sequencing was performed in one step. The mutated insert was then
restricted, purified and ligated into the restricted EcoRV/BamH I pcDNA3 vector
yielding 5-HT3R constructs containing a single cysteine and a His10 C-terminal se-
quence (figure 4.3.d and e). Nucleotide sequences of all the single cysteine constructs
were verified and confirmed by restriction analysis and sequencing.
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Figure 4.3: Cloning and mutagenesis procedure of the 5-HT3R mutants
containing a single cysteine. (a) Schematic representation of the sequence of the
5-HT3R-∆Cys-His10 (between the start and the stop codon) made of the 5-HT3R-
∆Cys (black arrow) and comprising a His10 at the C-terminal (black box). The
constuct was cloned in pcDNA3. The sequence contains four unique restriction
sites, Hind III, EcoR V, BamH I and Not I, whose sequence are in italics. For
details, see appendix A.3.1. (b) 5-HT3R-∆Cys-His10 is restricted with EcoR V and
BamH I and the fragment is ligated (c) into pBluescript II SK (+), which serves as
template for the mutagenesis. Site-directed mutagenesis using the corresponding
designed primers yielded mutated fragments of the receptor that were isolated with
EcoR V and Hind III, purified and ligated in the EcoRV/BamH I cut pcDNA3
construct.
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Cell culturing and transfection — HEK-293 cells were cultured with a density
of 150’000 cells/ml on 0.18 mm thick glass coverslips in 6-well plates (2 ml/well, for
cell imaging), or 35 mm cell culture dishes (2 ml/dish, for eletrophysiology exper-
iments), in Greiner 96-wells plates black clear bottom (0.2 ml/well, for membrane
potential assays) or in 8-well chambered coverglass (0.4 ml/well, for cell imaging) in
Dulbecco’s modified Eagle medium (DMEM) supplemented with 2.2% of fetal calf
serum under humidified 5% CO2 atmosphere at 37◦C. Cells were transfected 14 to
18 hours after splitting using EffecteneTM (Qiagen, Hilden, Germany) according to
the supplied protocol with 0.2 µg DNA, 1.6 µl enhancer, 2 µl effectene and 100 µl
EC buffer for 2 ml culture medium. DNA was either 100% receptor plasmid DNA or
80% receptor and 20% EGFP plasmid DNA (Clontech, Palo Alto, CA, USA). Cell
DMEM medium was replaced by DMEM supplemented with 10% fetal calf serum, 6
to 12 hours after transfection for the labelling of the receptor with the MTS probes.
4.3.3 Experimental methods
Electrophysiology — Standard whole-cell patch-clamp experiments were per-
formed on an inverted fluorescent microscope (Axiovert100, Zeiss, Jena, Germany)
with an EPC-9 patch-clamp amplifier (HEKA Elektronik Dr. Schulze GmbH, Lam-
brecht, Germany). Acquisition and storage of data used the A/D converter of the
EPC-9 and the PULSE 8.3 (HEKA) software. Borosilicate glass tubes GB150TF-8P
1.05 x 1.50 x 80 mm3 (Science Products GmbH, Hofheim, Germany) were pulled
with a pipette puller (P87, Sutter Instrument Comp, Novato, CA, USA) yielding
pipettes of 5-10 MΩ resistance. Glass pipettes were filled with 140 mM NaCl, 10
mM EGTA, 10 mM HEPES, pH 7.4 buffer and the ground electrode was connected
to the bath via a 1 M KCl agar bridge. 36-48 hours after transfection, DMEM cul-
ture medium was removed from HEK-293 cells expressing the receptor (in 35 mm
cell culture dishes) and replaced by 2 ml buffer 2 mM CaCl2, 147 mM NaCl, 12
mM glucose, 10 mM HEPES, 2 mM KCl, 1 mM MgCl2, pH 7.4. The experiments
were performed at room temperature with membrane potential kept at -60 mV.
Serotonin (Fluka, Buchs, Switzerland) solutions and buffer were applied with a fast
step RSC-200 perfusion system (Bio-Logic Science Instruments, Claix, France). For
patching, cells were selected using the cotransfected EGFP fluorescent marker. All
perfused solutions were made with the buffer used in the bath.
Membrane potential assays and imaging — Membrane potential fluorescent-
based assay was performed using the FLIPR R© membrane potential assay kit (Mole-
cular Devices Corporation, Sunnyvale, CA, USA). Red loading buffer was dissolved
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in 10 ml ready to use buffer component B according to the supplied protocol. HEK-
293 cells expressing the receptor (in black clear bottom 96 well-plate, Greiner) were
loaded with 50 µl/well loading buffer added to the 200 µl/well DMEM culture
medium for 30-40 minutes at 37◦C, 48 hours after transfection. Experiments were
performed using a Flex Station (Molecular Devices Corporation) with 530 nm exci-
tation and 565 nm emission wavelength with a 550 nm cut-off. Per well, 70 µl sero-
tonin solutions in Dulbecco’s phosphate-buffered saline (D-PBS: 0.901 mM CaCl2,
0.493 mM MgCl2, 2.67 mM KCl, 1.47 mM KH2PO4, 137.93 mM NaCl and 8.06 mM
Na2HPO4 ) (Gibco Invitrogen, CA, USA) was added 20 seconds after the beginning
of the recording with a relative velocity of 2. Recording was performed over 150
seconds with 1.5 seconds interval.
Membrane potential imaging was performed with a LSM 510 confocal micro-
scope (Zeiss) equipped with appropriate excitation and emission filters. Coverslips
were transferred to a sample holder and the cells covered with 200 µl D-PBS and 100
µl loading buffer. After 30-40 minutes incubation, fluorescent image sequences were
then recorded and ligands serotonin was added by hand to a final concentration of
50 µM.
Protein labelling — HEK-293 cells expressing a single cysteine mutant of the
5-HT3R in 8-well chambered coverglass or on glass coverslips in 6-well plates with
10% fetal calf serum supplemented DMEM medium were washed with standard PBS
48 hours after transfection. Cells were labelled with 5 µM MTS-probes in presence
or absence of 100 µM serotonin in standard PBS for 45-60 seconds. Cells were then
washed twice with D-PBS (Gibco Invitrogen, CA, USA) and then incubated for 20
minutes with 15-20 nM either GR-flu or GR-Cy5 in D-PBS before imaging.
Cell imaging — Cell imaging was performed using different set-ups: a LSM 510
confocal microscope (Zeiss) as described previously or a wide field fluorescence imag-
ing microscope. Fluorescence changes were performed using either the set-up pre-
sented in chapter 3 (figure 3.2) or a wide-field imaging system described in the
following. An inverted microscope (Axiovert 200M, Zeiss) was equipped with a
wide-field 40x 1.3NA PlanNeoFluar oil immersion objective (Zeiss), a XBO 75 flu-
orescent lamp (Zeiss) whose light was directed to the sample by adequate filters
and dichroic mirrors (Chroma, Rockingham, VT, USA)(table 4.1). Detection was
performed by a sensitive iXon DV887 FI camera (Andor, Belfast, UK). To minimize
fluorescence bleaching of the sample, a shutter was used with tunable illumination
frequency and illumination times.
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Table 4.1: Filter and dichroic mirrors used for wide field cell imaging.
Dye Excitation filter (nm) 1Dichroic mirror 1Emission filter
GFP S484/15 106361 54461
Cy5 S647/26 106361 54461
Rho S555/25 106361 54461
1 Filters and dichroic mirrors were from Chroma (Rockingham, VT, USA).
4.3.4 Data treatment
Dose response curves and EC 50 values — Fluorescence dose response curves
were recorded using membrane potential sensitive fluorescence dyes. The curves
were analyzed using the software SOFTmax Pro 4.3 (Molecular Devices). The local
maximal slopes S obtained within the 20 seconds after addition of the agonist were
plotted versus the concentration of agonist c. The resulting dose response curve was
fitted with the Hill equation (equation 4.1) where S and Smax are the slope and
the maximal slope, respectively, EC 50 the molar concentration of agonist, which
produces 50% of the maximal response for that agonist and h the Hill coefficient.
Current intensities obtained from whole-cell patch-clamp were reported versus the
concentration of the agonist to be fitted with the Hill equation 4.2. I and Imax
corresponds to the current and maximal current respectively. EC 50 obtained form
equations 4.1 and 4.2 are not identical (see section 4.4.2). All errors were calculated
according to Gauss propagation method and corresponds to 95% confidence interval.
S
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1
1 +
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EC50
c
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4.4 Results and discussion
4.4.1 Cloning and site-directed mutagenesis
Mutation of particular amino-acids to cysteine within the sequence of the 5-HT3A
receptor was performed by site-directed mutagenesis according to the principle of
cassettes. The receptor coding sequence cloned into the pcDNA3 mammalian plas-
mid vector has four distinctive restrictions sites, one to each end of the gene and
two within the gene, yielding three fragments of similar size. Each fragment can be
subcloned into an appropriated cloning vector for mutagenesis. The advantage of
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this strategy is that the probability of introducing undesirable mutations is strongly
reduced due to the small size of the insert and that the mutated fragment can be se-
quenced within one step, which is a substantial gain of time. Moreover, this cloning
approach allows to mix different mutated fragments yielding rapidly many different
mutants of the receptor.
4.4.2 Functionality and characterization of 5-HT3A mutants
Functionality of all the different 5-HT3 receptor mutants was investigated by fluo-
rescent ligand binding experiments, and whole cell patch-clamp measurements and
membrane potential assays in order to test which receptors would be candidates
for MTS-labelling. HEK-293 cells expressing the 5-HT3R mutants were selectively
stained with GR-flu to localize, using fluorescence confocal microscopy, the receptor
within the cellular membrane and estimate their expression level (figure 4.5.a). In
order to image clearly a GR-flu stained cellular membrane, 100’000 receptors per cell
were required. All the single cysteine mutants expressed in HEK-293 cells bound the
fluorescent antagonist as revealed by cell imaging, at the exception of the receptor
containing the V292C mutation (table 4.2). While the expression level was high
enough to be detected, transfection efficiency (1-10%) was very low for nearly all
the mutants. Nevertheless, binding of GR-flu to the receptors does not give infor-
mation about the gating of the channel but rather demonstrated the presence of the
5-HT3R embedded in the cellular membrane and the ability to bind ligands.
Activation of the 5-HT3R mutants by its agonist serotonin was investigated
by measuring variations of the cell membrane potential using a fluorescent-based
assay and by recording the current going through the gated channel using whole
cell patch-clamp measurements. Membrane potential responses were performed by
fluorescence confocal imaging of HEK-293 cells transiently expressing the different
mutant receptors (figure 4.5.b). It allowed a direct visualization of the fluores-
cence response of single cells with high sensitivity compared to fluorescence imaging
plate readers where the response was recorded over an ensemble of cells. However,
fluorescence imaging is not suited for quantitative evaluation of the response and
effective concentration of serotonin (EC 50) were determined with the Flex Station
plate reader. Maximal slope fluorescence responses after addition of serotonin (fig-
ure 4.5.c) were plotted versus the concentration of the agonist and fitted with a Hill
equation (equation 4.1, figure 4.5.d) yielding EC 50 values and Hill coefficients. EC 50
values are reported for mutants whose expression level and transfection efficiency
were high enough to detect a fluorescence response (table 4.2); Hill coefficients are
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Table 4.2: Functional characterization of 5-HT3AR mutants.
Membrane potential Patch-clamp
Receptor GR-flu binding
EC 50 (µM) EC 50 (µM) h
15-HT3A-C-His10 Yes 0.24 ± 0.07 2.2 ± 0.2 2.0 ± 0.4
5-HT3A∆Cys Yes Yes 1.2 ± 0.4 1.5 ± 0.6
13’ V291C Yes 0.04 ± 0.50 Yes
14’ F292C No No No
15’ L293C Yes 0.05 ± 0.16 Yes
16’ I294C Yes 0.02 ± 0.20 Yes
17’ I295C Yes 0.19 ± 0.44 Yes
18’ V296C Yes 0.05 ± 2 Yes
19’ S297C Yes No Yes
20’ D298C Yes Yes 3.7 ± 0.7 1.2 ± 0.3
21’ T299C Yes Yes Yes
22’ L300C Yes No Yes
23’ P301C Yes No Yes
24’ A302C Yes 0.1 ± 9 Yes
25’ T303C Yes 0.42 ± 0.07 Yes
26’ A304C Yes No No
27’ I305C Yes No Yes
28’ G306C Yes 0.50 ± 0.16 4.4 ± 0.8 1.6 ± 0.2
29’ T307C Yes Yes Yes
30’ P308C Yes 0.24 ± 40 Yes
1wt5-HT3A receptor containing a His10 sequence at the C-terminus, see section 3.3.2.
Receptors indicated in bold were labelled with MTS-Rho and MTS-Cy5, see section 4.4.3.
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Figure 4.4: TM2 helix of the 5-HT3A receptor. Schematic representation of
the TM2 segment in α-helix conformation. The channel lumen is to the right of
the helix; TM1 and TM3 (not shown) are to the left. Relative position of amino
acids (©) is based on SCAM data reported in [102, 210] and the structure from
Unwin [108]. The grey lines indicate the boundary of the plasma membrane. The
substituted cysteine residues are indicated in grey and the lethal mutations in
green. Fluorescently labelled substituted cysteine side chains are in red.
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not indicated because they are no significance. Membrane potential fluorescence
assays allowed a fast screening of receptor mutants functionality but required a
transfection efficiency of at least 30%; Complete dose response curves were obtained
for only nine of the receptor mutants.
Screening receptor activity by whole cell patch-clamp screening is more rel-
evant than by membrane potential assays. Only cells expressing the receptors, as
revealed by the coexpression with the fluorescent protein EGFP, were patched and
current responses at 100 µM serotonin were recorded. Under these conditions, whole
cell currents were obtained for all the receptor mutants with the exception of those
containing a substituted cysteine at position F292C and A304C (table 4.2). For
some, dose response curves were performed and fitted with a Hill equation (equa-
tion 4.2) yielding EC 50 values and Hill coefficients (table 4.2).
Dose response curves obtained by membrane potential assays and electrophysi-
ology were not identical; EC 50 values obtained from membrane potential assays were
shifted to smaller values (figure 4.5.d). This difference comes from the fact that the
physical parameter observed upon the opening of the channel are fundamentally
different. In whole cell patch-clamp experiments, EC 50 values correspond to the
concentration of agonist required to open 50% of the channels in a receptor popula-
tion within the cellular membrane, whereas EC 50 values from membrane potential
assays represent the concentration of agonist depolarizing the cellular membrane
half of its maximal value. Since maximal depolarization of the membrane requires
less open channels and therefore less amount of agonist, compared to maximal whole
cell current, EC 50 values are different by about one order of magnitude (table 4.2).
Membrane potential assays are physiologically and pharmacologically more relevant
since they report the depolarization of the membrane, which is indeed the signalling
principle of ion channels within neurons and nerves for instance.
The characterization of the different receptor mutants is by far not complete
but is sufficient to determine those receptors which are functional. The cysteine-less
receptor mutant as well as single cysteine receptor mutants ranging from V291C to
P308C are activated by serotonin at the exception of the F292C and A304C mutants.
Mutation F292C has already been reported to be lethal [210].
4.4.3 Fluorescence labelling of 5-HT3A receptor
The accessibility of the different cysteine residues inserted within the TM2 helix and
TM2-TM3 loop of the cysteine-less 5-HT3 receptor was investigated in living cells.
HEK-293 cells expressing the functional receptor mutants (table 4.6) were exposed
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Figure 4.5: Functional characterization of 5-HT3R mutants in living
cells. (a) HEK-293 cells transiently expressing 5-HT3R were incubated for 15
min with 15 nM GR-flu, resulting in a selective staining of 5-HT3R in the cellu-
lar membrane as revealed by the fluorescence confocal microscopy (scale bar is 15
µm). (b) Fluorescence intensity changes of membrane-potential sensitive probes
after addition of 50 µM serotonin as observed by fluorescence confocal microscopy.
Insert: 5-HT3R expressing HEK-293 cells loaded with membrane potential sensitive
fluorescent probes at the indicated time points of the response. (c) Fluorescence
intensity changes of membrane potential sensitive probes in HEK-293 cells express-
ing the 5-HT3-C-His10 as observed in the Flex Station. Addition of serotonin at
t = 22 s resulted in a transient increase of fluorescence intensity response. (d)
5-HT3-C-His10 normalized dose response curve obtained from membrane potential
assays (◦) and whole cell patch-clamp measurements (+). Fits using the Hill equa-
tion (Eq. 4.1 and Eq 4.2) yielded EC50 = 0.24 ±0.07 µM and 2.2 ± 0.2 µM, and
h = 3.2 ± 1.6 and 2.0 ± 0.4, respectively.
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to thiol-reactive fluorophores, MTS-Rho and MTS-Cy5, in the presence or absence
of serotonin. Accessible cysteine residues within the different functional states of
the receptors were labelled resulting in a selective staining of the receptors in the
cellular membrane (figure 4.6.a). Specificity of the labelling was confirmed by the
colocalization with GR-flu, a highly specific fluorescent antagonist of the 5-HT3R
(figure 4.6.b). No labelling was observed on non-transfected cells (figure 4.6.c), as
well as cells expressing the 5-HT3A∆Cys receptor. An important factor for the
labelling was the composition of cell culture medium. Strong specific labelling was
observed with DMEM medium supplemented with 10% fetal calf serum, whereas
with 2.2% fetal calf serum hardly any fluorescence was observed.
Figure 4.6: Labelling of a single cysteine mutant of the 5-HT3R with
fluorescent MTS in live cells. Confocal images of HEK-293 cells transiently
expressing the 5-HT3R-D298C mutant. Cells were exposed to 5 µM MTS-Rho and
100 µM serotonin for 45 s, then washed and incubated 15 min with 15 nM GR-flu.
Staining of the membrane was observed for both (a) MTS-Rho and (b) GR-flu. (c)
Superposition of (a) and (b) showed the perfect colocalization of the GR-flu and
MTS-Rho labelling. Transfected cells showed a 10-15 fold higher fluorescence than
untransfected cells.
Screening all the functional single cysteine 5-HT3R mutants revealed that only
three could be site-specifically labelled: The 5-HT3R-I295C, D298C and A302C with
their accessible cysteines at the 17’, 20’ and 24’ position, respectively (figures 4.6
and 4.7). The labelling efficiency of these receptors was different and decreased in
the order 5-HT3R-D298C > A302C > I295C, as revealed by the comparison between
GR-flu and MTS-probes fluorescent intensities (figure 4.7). However, no significant
changes of the labelling efficiencies were observed when the reaction was performed
in the resting (labelling without serotonin or after preincubation with a fluorescent
antagonist) or desensitized state (labelling in the presence of serotonin), at the
exception of the 5-HT3R-D298C, where the presence of serotonin slightly increased
the labelling efficiency, indicating a structural change within the upper region of
TM2. No kinetic experiments were performed and reaction efficiencies were based
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on observations at a single time point.
Blocking of endogenous surface sulfhydryl groups with small methanethiosul-
fonate to site-specifically label substituted cysteines with fluorescent MTS-probes
as performed on the nAChR [197] would not have been possible or specific on the
5-HT3R since their accessibility was not influenced by the state of the receptor,
requiring therefore the cysteine-less receptor.
Figure 4.7: Labelling of a single cysteine mutants of the 5-HT3R with
fluorescent MTS probes in living cells. Confocal images of HEK-293 cells
transiently expressing the (a) 5-HT3-I295C, (b) 5-HT3R-D298C and (c) 5-HT3R-
A302C mutants. Cells were exposed to 5 µM MTS-Rho (red) or MTS-Cy5 (blue)
and 100 µM serotonin for 45 s, then washed and incubated 15 min with 15 nM
GR-flu (green) resulting in a colocalized staining of the receptors in the cellular
membrane. Scale bars are 20 µm.
The accessibility of the cysteine residues of the 5-HT3R at positions 17’ and 20’
by fluorescent MTS probes shown here is consistent with SCAM data obtained using
small methanethiosulfonate reagents like MTSEA, MTSET and MTSES on the TM2
segment of the 5-HT3R [210,215] and α subunit of the muscle type nAChR [209]; no
SCAM data have been reported for the 24’ position. Here, labelling was restricted to
the residues positioned towards the channel in the upper part of the TM2 whereas
small MTS can probe down to 2’ in the closed state and -5’ in the open state.
The accessibility of the fluorescent MTS probes was limited by their dimension and
length of the linker. A longer linker would certainly have allowed to probe residues
deeper in the channel.
The number of bound MTS-fluorophores per receptor was not investigated.
Since the 5-HT3R is homopentameric, single cysteine receptor mutants involved
five cysteine residues and each of them can react, thus yielding up to five bound
fluorophores per receptor. According the low resolution structure of the nAChR
(figure 1.5), two relative positions can be assumed for these probes. First, the flu-
orophore moiety of the probes points inside the pore of the receptor directly into
the extracellular funnel. Secondly, the fluorophore is inserted between the subunits
just above the membrane or between the transmembrane helices pointing therefore
outwards. The former position will allow the presence of only one fluorescent mole-
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cule for sterical reasons whereas the latter will allow up to five MTS-fluorophores
to react and bind to the substituted cysteines.
4.4.4 Conformational changes of 5-HT3A receptor
Rhodamine covalently bound to the extracellular end of the TM2 of the 5-HT3 re-
ceptor was used as a fluorescent reporter of conformational changes occuring during
receptor activation and desensitization. The 5-HT3R-D298C mutant expressed in
HEK-293 cells was labelled with MTS-Rho as described in section 4.4.3. This single-
cysteine receptor mutant was selected over the other potential candidates due to the
high accessibility and reactivity of the substituted cysteine at position 20’. Addi-
tion of serotonin resulted in a ∼18% decrease of fluorescence intensity (figure 4.8),
indicating a change of the fluorophore’s environment due to conformational changes
upon receptor activation. The decrease of fluorescence induced by the binding of
serotonin as well as its recovery seems to be biphasic as already reported by similar
measurements on the nAChR [197]. No fluorescence dose response was measured.
On control cells devoid of 5-HT3 receptor, a 2-4% decrease of the fluorescence in-
tensity was observed as result of serotonin application.
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Figure 4.8: Conformational changes in 5-HT3R induced by the binding
of serotonin and observed by fluorescent probes. Normalized fluorescence
intensity of rhodamine bound to the 20’ cysteine residue of the 5-HT3R-D298C is
depicted versus time. Application of the agonist serotonin to HEK-293 cells ex-
pressing the receptor resulted in a fluorescence intensity decrease of ∼18%, which
was reversed upon washing. Insert: Fluorescence image of a HEK-293 cell express-
ing the 5-HT3R-D298C labelled with MTS-Rho. Scale bar is 5 µm.
Application of 10 µM mCPBG, another agonist of the 5-HT3R, to the rho-
damine labelled receptor induced an increase of ∼5% fluorescence intensity (data
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not shown). After washing, fluorescence intensity reached again its initial value.
No intensity changes were observed on control cells. Fluorescence intensity increase
reported conformational changes within the surrounding region of the extracellu-
lar end of TM2. However, activation mechanism of the channel by mCPBG was
different compared to serotonin since the fluorescence intensity changes were oppo-
site. These phenomena were observed on different cells and on different days with
high reproducibility. Nevertheless, these results are preliminary but might present
interesting insights within the activation mechanism and conformational changes
initiated by the interaction of agonist and receptor.
4.5 Conclusion
The cysteine-less receptor mutant of the 5-HT3R has been revealed to be fully func-
tional in terms of gating and ligand binding. It allowed therefore to substitute
cysteine within its sequence whose accessibility can be then probe by multiple thiol-
reactive compounds in order to yield structural features, opening therefore the door
to decipher the gating mechanism. Cysteine residues within the outer half TM2
have been stained selectively with fluorescent thiol-reactive compounds. Prelimi-
nary results indicate that the fluorescence intensity is modulated by the interaction
of the agonist with the binding site of the receptor, and that these changes depend
on the nature of the agonist suggesting a potentially different gating mechanism.
Simultaneous measurements of electrical current and fluorescence intensity would
give insights to the dynamics of gating as well as comparison between fluorescent
and current dose-response. In conjunction with structural studies, such knowledge
will enhance our understanding of the structural transitions occurring during al-
losterically controlled channel gating.
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Chapter 5
Effect of ligand binding on
single 5-HT3A receptor ion
current
Abstract — Current through single 5-HT3A mutant receptor-gated ion channels
was recorded. Replacement of three arginine residues in the cytoplasmic loop of
the cysteine-less 5-HT3 receptor increased its conductance 70-fold compared to the
wild-type receptor. Five conductance levels were determined ranging from 11 to 52
pS and their probability of occurrence was modulated by the amount of serotonin.
These different current amplitudes were assumed to represent distinctive molecular
entities probably modulated by the phosphorylation of the subunits. Amplitudes
of open-channel ionic currents were increased in the presence of serotonin, which
might result from structural fluctuations within the receptor. Noise analysis of cur-
rent fluctuations revealed a 1/f α dependence with α < 1. Moreover, this protein
dynamics was related to a fractional Gaussian noise. A model based on continuous
current changes proposed that charged amino-acids play a role in the structural fluc-
tuations. This high conductive 5-HT3 receptor mutant will be a building block for
the investigation of the dynamics of the receptor in combination with fluorescently
labelled single-cysteine receptors.
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5.1 Introduction
Single-channel patch-clamp is a well suited and a widely used technique for the in-
vestigation and characterization of ion channels. It resolves in time ion flux through
single channel yielding information on the kinetics and thermodynamics of channel
gating. Nevertheless, only few experimental data of single-channel electrophysiology
were reported on the 5-HT3 receptor mainly due to its low conductance compared
to other members of the ligand-gated ion channel family.
The first recording of current through single heteromeric 5-HT3 receptors was
reported in the late eighties by Derkach and colleagues [216]. They observed unitary
currents of 15 pS and 9 pS in excised membrane patches from neurons of the guinea
pig; the probability of occurrence of the high conductance channel decreased in time.
Later, in N1E-115 neuroblastoma cells, discrete 5-HT3 receptor-gated channels with
a conductance of 6 pS were resolved in excised membrane patches when the driving
force for Na+ was enhanced [217]. Using the same cells but in cell-attached patches,
distinctive conductive levels of 27, 18, 11 and 6 pS were observed [218]. Inhibition
of protein kinase activity or patch excision increased the probability of occurrence
of the 6 pS level and decrease that of the 27 pS level. Conversely, patch cramming
and stimulation of protein kinase activity enhanced the probability of occurrence
of the 27 pS level and decreased that of low conductance levels. These findings
indicated for the first time that phosphorylation controls the conductance of the
5-HT3 receptor. Other experiments reported the potential role of phosphorylation
on the current mediated by the 5-HT3 receptor. Substance P, an agonist of the NK1
tachykinin receptor has been reported to potentiate the 5-HT3 receptor-mediated
current in ganglion neurons through the activation of the protein kinase C [219].
Although single-channel currents of native 5-HT3 receptors have been resolved
since more than fifteen years, current through single cloned homopentameric 5-HT3A
receptors have been reported only few years ago [220]. The low conductance value of
the 5-HT3A receptor of less than 1 pS did not allow single-channel recording; instead
fluctuation analysis on macroscopic currents was used [221]. However, in Ca2+- and
Mg2+- free solutions, single channel current events were resolved yielding a unique
conductance of 48 pS. These divalent cations were reported to decrease the channel
conductance [94,222]
The single-channel conductance of the 5-HT3 receptor assembled as homomers
of 5-HT3A subunits, or heteromers of 5-HT3A and 5-HT3B subunits, are markedly
different, being <1 pS and 16 pS [75], respectively. Where does this difference come
from? Paradoxically, the channel-lining of TM2 domain of the 5-HT3A subunit would
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be predicted to promote cation conductance, whereas that of the 5-HT3B would
not [75]. A large cytosolic loop was reported to be responsible for the observed
single-channel conductance values [223]. Replacement of three arginine residues,
only present in this region of the 5-HT3A subunit, by the corresponding sequences of
the 5-HT3B subunit increased single-channel conductance of the homopentameric 5-
HT3AR mutant 28-fold. According to the refined structure of the nAChR [109], these
arginine residues are localized in the narrowest region of the membrane pore, forming
lateral windows in the intracellular vestibule and thus determine the conductance
of the channel.
Here, these three arginine residues unique to the 5-HT3A were replaced by
the corresponding 5-HT3B sequences in the cysteine-less 5-HT3A receptor. Single-
channel current were recorded and multiple conductance levels were observed whose
probability of occurrence was modulated by the amount of serotonin present. Unex-
pectedly, high current fluctuations were observed in the open state when the receptor
was activated with serotonin. Noise analysis of the current in the open-state was
performed for the first time on the 5-HT3 receptor suggesting that charged residues
are involved in the fluctuating domains.
5.2 Experimental techniques
As introduced in section 4.2, electrophysiology is well suited and extremely sensitive
for investigating the function of ion channels embedded in membranes. Usually, two
major methods are used to record ion currents passing a single channel in real time:
the black lipid membrane (BLM) and the single-channel patch clamp techniques.
In BLM experiments [224], channel proteins have to be reconstituted in an artificial
planar lipid bilayer, which covers a hole in a teflon septum. In contrast, the patch-
clamp technique allows to measure directly on living cells or on native membrane
fragments and therefore to investigate channels in their native environment. In these
two techniques, two electrodes are placed on the opposite sides of the membrane and
connected to a feedback amplifier to record electrical currents.
5.2.1 Single-channel patch-clamp
The principle of a single-channel patch-clamp experiment is similar to that of a
whole cell patch-clamp experiment; the differences concern the sensitivity and the
patch configurations. Several configurations exist to resolve single channel currents,
but only two of them are described. In the so-called cell-attached configuration, the
pipette tip is brought into contact with the cell surface yielding a tight electrical seal
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by gentle suction (figure 5.1.a). Channels within the pipette tip are activated by
ligand dissolved in the pipette buffer. In this configuration, the potential difference
across the channel within the pipette tip corresponds to the applied potential plus
the cellular membrane potential.
V
V
V
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a b c
Figure 5.1: Single-channel patch-clamp configurations. (a) Cell-attached,
(b) whole-cell and (c) outside-out configurations.
From the cell-attached configuration, the membrane in the patch pipette can
be broken (whole-cell configuration) and then, by gently pulling the pipette away
from the cell, a part of the membrane can be extracted. This manipulation yields
the so-called outside-out configuration where the extracellular side of the membrane
faces the bath. Here, the potential difference across the membrane corresponds to
the applied potential.
5.3 Materials and methods
5.3.1 Molecular and cellular biology
5-HT3R-QDA — The sequence is based on the 5-HT3R-∆Cys-His10 (see sec-
tion 4.3.2 and appendix A.3) with three mutations: R441Q, R445D and R449A
(numbering corresponds to the unprocessed precursor). Coding sequence comprised
between BamH I and Not I (figure 4.3.a) was subcloned into pBluescript II SK
(+) (Stratagene, California, USA), and the resulting plasmid was used as tem-
plate for site-directed mutagenesis. Arg441, Arg445 and Arg449 were mutated using
the QuickChangeTM site-directed mutagenesis kit (Stratagene) and oligonucleotides
5HT3aQDAfor and 5HT3aQDArev (appendix A.1) with the conditions required by
the provider in the presence of 4% DMSO. The mutated nucleotide sequence was
verified by restriction analysis and sequencing of the whole insert in pBluescript
II SK (+) using the T7 primer; the sequencing was performed in one step. The
mutated insert was then restricted, purified and ligated into the original pcDNA3
vector yielding 5-HT3R-QDA construct.
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Cell culturing and transfection — HEK-293 cells were cultured with a density
of 150’000 cells/ml in 35 mm culture dishes (2 ml/dish) in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 2.2% of fetal calf serum under humidified 5%
CO2 atmosphere at 37◦C. Cells were transfected 14 to 18 hours after splitting using
EffecteneTM (Qiagen, Hilden, Germany) according to the supplied protocol with
0.16 µg receptor DNA, 0.04 µg EGFP plasmid DNA (Clontech, Palo Alto, CA,
USA), 1.6 µl enhancer, 2 µl effectene and 100 µl EC buffer for 2 ml culture medium.
5.3.2 Experimental methods
Electrophysiology — Standard whole cell patch-clamp experiments were per-
formed as described in section 4.3.3. For single channel patch-clamp, borosilicate
glass tubes GB150F-8P 1.05 x 1.50 x 80 mm3 (Science Products GmbH, Hofheim,
Germany) and an Ag/AgCl ground electrode were used. Data were recorded at 10
kHz and filtered at 2.9 kHz.
5.3.3 Data treatment
Dose response curves and EC 50 values — Current intensities obtained from
whole cell patch-clamp were treated as already described in section 4.3.4 and fitted
with equation 4.2 yielding EC 50 and Hill coefficient h. All errors were calculated
according to Gauss propagation method and are 95% confidence intervals.
Determination of the conductance — Single-step amplitude of ionic current
were measured using the Igor Pro software (WaveMetrics, Lake Oswego, OR, USA)
and reported versus the holding potential. Fit using the modified Ohm’s law (equa-
tion 5.1) yielded the single-channel conductance g and cellular membrane potential
φ. V is the holding potential and I the current. All errors were calculated according
to Gauss propagation method and are 95% confidence intervals.
I = g · (V + φ) (5.1)
Intrinsic Johnson and shot noise — Johnson current noise σth is an equilibrium
thermal noise and is defined by equation 5.2 where kB is the Boltzmann’s constant, T
the absolute temperature, g the single-channel conductance and f B the bandwidth
[225].
σth =
√
4kB · T · g · fB (5.2)
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The shot noise σsh arises from the discrete nature of ionic flow through the
channel and is defined by equation 5.3 where ∆i is the average single-channel current
and e the elementary charge [226].
σsh =
√
2 ·∆i · e · fB (5.3)
Power spectral density — Power spectral densities were computed using the
Igor Pro software (WaveMetrics). The analysis were performed on segments of 51.2
ms sampled at 10 kHz with a bandwidth of 2.9 kHz.
5.4 Results and discussion
In order to resolve single channel events underlying the 5-HT3R ion current, three
arginine residues within the cytosolic loop of each subunit were substituted by glu-
tamine, aspartic acid and alanine increasing the conductance of the ion channel as
reported by Kelley et al. [223]. The sequence of the receptor investigated here is
based on the cysteine-less receptor presented and characterized in chapter 4 with the
three corresponding mutations yielding the 5-HT3R-QDA. The cloning strategy as
described in section 5.3.1 allows to insert the mutated region coding for the intracel-
lular domain of the receptor, within the eighteen single cysteine receptor constructs
presented in table 4.2. This would provide mutants for simultaneously recording
single channel currents and conformational changes reported by a site-specifically
bound fluorescent MTS-probe. The 5-HT3AR mutant is functional in terms of gating
(see below) and fluorescent antagonist binding (data not shown).
5.4.1 Whole cell patch-clamp characterization
Whole cell patch-clamp recorded inward currents of HEK-293 cells expressing the
5-HT3R-QDA. The channels opened within tens of milliseconds after binding of the
agonist reaching up to nanoampere currents, and then desensitized extremely slowly
compared to the wt-5HT3A receptor (figure 5.2.a). Dose response curves were fitted
with a Hill equation yielded EC 50 = 0.2 ± 0.1 µM and h = 0.9 ± 0.3 (figure 5.2.b),
which are significantly different compared to the wt5-HT3R (table 4.2); the affinity
of the 5-HT3R-QDA for serotonin was increased 10-fold. The unity value of the Hill
coefficient supposes that only one ligand was required for the opening of the receptor
mutant. These differences of behavior seem to be mainly due to the three mutations
within the intracellular loop as the cysteine-less mutant featured similar EC 50 and
h values compared to the wild type receptor (table 4.2). No direct comparison can
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be made with the mutant reported by Kelley et al. [223] since only its conductance
was reported. Amplitude of the recording currents were in the same range as for the
wild-type receptor expressed in HEK-293 cells, showing that indeed the expression
level of the mutant receptor is significantly lower as its conductance was enhanced
by about 70-fold (see section 5.4.2).
Figure 5.2: Whole-cell current characterization of the 5-HT3R-QDA
mutant. (a) Whole-cell inward current response of HEK-293 cells expressing
wt5-HT3R and 5-HT3R-QDA under continuous flow of serotonin. (b) Normalized
dose response curve of the 5-HT3R-QDA for serotonin. Fit using a Hill equation
(Eq. 4.2) yielded EC50 = 0.2 ± 0.1 µM and h = 0.9 ± 0.3.
5.4.2 Single channel current events
Ionic currents of single 5-HT3R-QDA were recorded using two patch-clamp configu-
rations, the cell-attached and the outside-out configuration. The signal to noise ratio
of the former was higher compared to the later allowing the resolution of the open-
ing of small conductances, and moreover the recording of events for several minutes
since the stability of the seal is high. Nevertheless, determination of the conduc-
tance in this configuration required to record events at different holding potentials
to account for the cell membrane potential, which is not required in the outside-out
configuration. However, data obtained in both configurations are compared for a
better reliability of the determined conductances of the channel.
Opening events were easily resolved and multiple conductances were observed
in every recorded trace (figure 5.3.a). Five different conductances were determined
from the slope of the current-potential plots, ranging from 11 pS to 52 pS (fig-
ure 5.3.b), which corresponds to a 70-fold increase of the conductance compared to
the wild-type receptor [94, 223]. The activity of the unliganded receptor was rel-
atively high since all the different conductance levels were observed (figure 5.3.a).
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At 10 µM serotonin, the channel activity increased, but also the distribution of the
different conductances (figure 5.4). Unliganded receptors showed two main conduc-
tances of 52 pS and 19 pS, whereas the presence of agonist increased the probability
of occurrence of the higher conductance states at the expense of the lower.
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Figure 5.3: Multiple conductances of the 5-HT3-QDA mutant receptor.
(a) Single channel events of the unliganded 5-HT3R-QDA expressed in HEK-293
cells recorded at 10 kHz and filtered at 2.9 kHz with a holding potential of -100 mV
in the cell-attached configuration. The membrane potential φ was estimated to be
-32 mV. Five different amplitudes of single step events were observed, each of them
corresponds to a different conductance. All the events reported originated from
the same patch. (b) Current-potential plots of the five different open amplitudes
shown in (a). Mean slope of the linear fits yielded conductances of 11 ± 2, 19 ±
3, 34 ± 4, 42 ± 5 and 52 ± 2 pS from the left to the right, respectively.
We did not control whether antagonists blocked or decreased the activity of
the receptor. Since the activity of the unliganded receptor is relatively important,
antagonist binding should result in a decrease of the whole-cell current in a whole-cell
patch.
All the current transitions opened and closed within one step (figure 5.3.a)
at the exception of a few of them (0.5-1%) where intermediate levels corresponding
to one of the conductances of the mutant receptor appeared either in the opening
or closing of the channel (figure 5.5). We cannot conclude that the different con-
ductances observed correspond to intermediate gating states since they were rarely
observed. It rather seems that the different conductive channels are independent
and that they correspond to distinctive molecular properties like phosphorylated or
non-phosphorylated subunits [218]. These modifications are relatively slow and take
place mostly in the closed state.
Within a burst, almost no flickering between closed and open states were
observed in both the presence and absence of serotonin. This corresponds to a
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Figure 5.4: Distribution of conductances of the 5-HT3R-QDA in living
cells. Histograms of all the conductances of the receptor recorded in the outside-
out configuration at -100 mV for (a) the unliganded receptor and (b) in the presence
of 10 µM of serotonin. Bin size is 4 pS. Experiments shown in (a) and (b) were
performed on two different cells and number of events measured are indicated.
Figure 5.5: Intermediate open states of the 5-HT3R-QDA. Single-channel
current of the unliganded receptor in the cell-attached configuration with an hold-
ing potential of -100 mV. The channel opened within two steps and closed within
one step. The opening amplitudes corresponded to conductances of 19 ± 2 pS and
11 ± 2 pS, and the closing amplitude to a conductance of 34 ± 4 pS, respectively.
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gating equilibrium constant Θ estimated to be ∼300. The large value of Θ and the
long open times explain the very slow desensitization of the receptor observed in
whole-cell experiments (figure 5.2.a).
The multiple conductances of the 5-HT3-QDA receptor mutant stem most
probably from the substituted cysteines residues, since only one conductance was
reported for the high conductive human 5-HT3A receptor mutant [223]. However,
multiple conductances were already measured for the heteropentameric 5-HT3R in
N1E-115 neuroblastoma cells [216, 218]. It has been reported that phosphorylation
modulated the probability of occurrence of particular conductances [218].
5.4.3 Noise analysis of single activated 5-HT3R
The amplitude of the ionic current in the open-channel state was larger when the 5-
HT3 receptor mutant was activated by 0.2 µM serotonin compared to the unliganded
receptor indicating that the serotonin binding site is at the origin of a structural
fluctuation somewhere within the channel lumen or any regions lining the ion flow
(figure 5.6). The excess noise of an open-channel σex was determined by subtracting
the standard deviation of the current of the closed state from that of the open
states. The contribution of the Johnson thermal noise and the shot noise originating
from the ionic flow through the channel were determined according to equations 5.2
and 5.3, respectively. These two contributions were normalized by the current ∆i in
order to take into account all the opening transitions ranging from 11 pS to 52 pS.
It resulted in a theoretical excess standard deviation defined as (σth2 + σsh2)/∆i
equal to 1.3·10−3 pA at an holding potential of -100 mV and bandwidth of 2.9
kHz in the case where the Johnson and shot noise are the only contribution of the
excess of noise. In comparison, experimental normalized standard deviation of the
open channel ionic current σex2/∆i determined over thirty events were of 1.4 ±
1.2·10−3 pA for the unliganded receptor mutant and of 7.7 ± 2.0·10−2 pA for the
activated receptor mutant. These values showed that the modest excess noise of the
unliganded receptor mutant arose mainly from the intrinsic thermal and shot noise
whereas the large current fluctuations of the activated receptor have another origin.
The ionic current fluctuations were analyzed using the power spectral density
(defined as the Fourrier transform of the autocorrelation function <i(t) i(t ’)>),
which represents the frequency distribution of signal energy. The true spectrum
of the channel current fluctuations S i(f ) corresponding to the open-channel noise
excess, was obtained by subtracting the averaged spectrum of the background (i.e.
closed state) from the opened channel spectrum. To minimize the influence of any
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Figure 5.6: Amplitude of open-channel ion currents. Typical current traces
of 5-HT3R in (a) the absence and (b) presence of 0.2 µM serotonin. Recording were
obtained at 2.9 kHz bandwidth and -100 mV applied voltage in the cell-attached
configuration.
changes in the fluctuations of the baseline, background spectra were accumulated
from segments adjacent to the single channel events [227].
The power spectral density, which characterizes the open channel state, was
clearly different from the background and could be fitted by a power law function S i
∝ 1/f α yielding α = 0.43 ± 0.02 (figure 5.7). The value of α suggests that memory
effects are involved in the protein dynamics and that the open-channel spectrum is
related to a fractional Gaussian noise. To our knowledge, this is the first time that
such a behavior is observed for a single ion channel.
However, 1/f noise (α = 1) was observed on different bacterial channels recon-
stituted into planar lipid bilayer [228–230]. The mechanism involved in the creation
of 1/f noise is not very clear. For instance, in the case of the maltoporin channel
it was observed that in single channel open states, switches between substates of
slightly different conductances occurred [230] indicating that the 1/f dependence
of the noise might originate from slow opening and closing events of the channel
related to conformational flexibility of structural constituents. This hypothesis was
confirmed on nanofabricated synthetic pores where this noise was related to the
underlying motions of channel wall constituents [231].
Interestingly, the histogram of current fluctuation amplitudes of open acti-
vated 5-HT3 receptors was perfectly fitted using a single Gaussian distribution,
which was two times broader compared to the unliganded receptor mutant (fig-
ure 5.8.a). This excess of Gaussian noise is likely to arise from continuous current
changes and not from discrete current transitions between conductance states [227].
The most probable origin of this continuous current changes is to consider that
spontaneous thermal fluctuations arise within structural protein domains modulat-
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Figure 5.7: Spectral density analysis of ionic current fluctuations of
the 5-HT3 mutant receptor. Averaged power spectral densities of current
fluctuations in the closed state (grey) and open state after background substraction
(black) of single 5-HT3R channels activated by 0.2 µM serotonin. Dotted line is a
fit using Si(f) ∝ 1/f α yielding α = 0.43 ± 0.02.
ing the size of the ion conductive pathway and therefore its conductance [232,233].
The regions of the receptor that control channel conductance are the transmem-
brane pore as well as the proposed filter located in the intracellular loop [109,223].
According to the homopentameric symmetry of the receptor, we can consider that
conformational oscillations of elastic protein domains occur in a concerted normal
mode and that the radius x of the pore is a normal coordinate. In this model,
the current fluctuations δi were related to the variation of the radius δx = x - x eq
around the equilibrium radius x eq, the conductance g and the potential V resulting
in equation 5.4.
δi = V ·
(
δg
δx
)
xeq
δx (5.4)
The potential of the mean force was calculated using U(δx) = −kBT ·ln(P (δx)),
where P(δx ) is the probability density distribution of the radial motions derived from
P(δi) (figure 5.8.b). For a Gaussian distribution, U (δx ) corresponds to a harmonic
potential described by equation 5.5 where <x 2> is the mean square displacement
and was used to fit U (δx ) (figure 5.8.b).
U(δx) =
kBTδx
2
2 < x2 >
(5.5)
The potential U (δx ) determined from the probability density function P(δi)
assuming (δg/δx)xeq= 10 pS/nm was not relevant. It assumed a variation of the pore
radius inconsistent with the structure of the receptor; the minimum radial distance
from the central axis of the nAChR was reported to be 3 A˚ [108]. Thus, values for
5.5. Conclusion 107
0.10
0.08
0.06
0.04
0.02
0.00
-4 -2 0 2 4
7
6
5
4
3
2
1
0
-4 -2 0 2 4
Current δi(t), (pA) δx (nm)
P
o
rb
ab
il
it
y
 d
en
si
ty
 d
is
tr
ib
u
ti
o
n
U
(δ
x
)/
k
B
T
a b
Figure 5.8: Gaussian current fluctuations and harmonic potential. (a)
Probability density distribution of the current fluctuations in the background
(black) and in the open state (grey), both in the presence of 0.2 µM serotonin.
The dashed line is the fit according to a Gaussian distribution. (b) Mean force
potential represented in the domain coordinates using (δg/δx) = 10 pS/nm (¤),
30 pS/nm (4) and 100 pS/nm (©), and V = -100 mV. Fits using equation 5.5
yielded values of the root mean square displacements
√
< x2 > of 1.12 nm, 0.37
nm and 0.11 nm, respectively.
(δg/δx)xeq in the range of 30-100 pS/nm have to be assumed suggesting that the
oscillating domains in the 5-HT3 receptor mutant contain charged amino acids. In
comparison, (δg/δx)xeq≈ 5-10 pS/nm were reported for the nAChR [232]. The pro-
posed model can be further developed using the Langevin equation to characterize
the dynamics of the oscillations as it was already reported for the nAChR [232].
The mathematical development (not presented here) suggests that the current fluc-
tuations correspond to a fractional Gaussian noise.
Thermodynamic investigations revealed that agonist binding is entropy-driven
for the 5-HT3 receptor [234] which corroborate the proposed model of oscillating
domain in the activated state. Note that in the case of the nAChR, agonist binding
is enthalpy and entropy driven [235].
5.5 Conclusion
The three mutated amino acids within the intracellular domain of the 5-HT3 receptor
subunits greatly enhanced its conductance and drastically decreased its desensiti-
zation rate. Single-channel openings and closings were resolved and five different
conductance levels ranging from 11 to 52 pS were determined. We infer that the
different conductances correspond to distinctive molecular states rather than inter-
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mediate open states of the receptor; experimental evidence of multiple step opening
and closing were rare. The origin of the excess noise in the open state of the liganded
receptor is unclear. This might be caused by different mechanisms of the gating for
5-HT3 activated and spontaneous openings, or by a cytosolic factor like phosphory-
lation [218]. According to our proposed model, current fluctuations observed in the
open-states are related to an oscillating domain composed of charged amino-acids.
Noise analysis show that the fluctuations were not random and non-correlated, and
are assimilated to a fraction Gaussian noise.
Insertion of these cytoplasmic mutations within the 5-HT3-D298C receptor
mutant (table 4.2) will allow to simultaneous record conformational changes reported
by a tethered cysteine reactive fluorophore and single-channel electrophysiology.
Chapter 6
General conclusions and outlook
The dynamics of both the 5-HT3A receptor and 5-HT3A receptor within cells was
studied using fluorescence techniques and patch-clamp electrophysiology. This work
provided new tools, a labelling method and receptor mutants, for the investiga-
tion of the distribution of receptors, receptor-ligand interactions, lateral mobility,
conformational changes and gating of the receptor in living cells.
The method for protein labelling, based on small nickel-chelating nitrilotri-
acetic probes, represents an attractive alternative over current labelling approaches
for studying molecular interactions and structural properties of proteins. These
NTA-probes bind within seconds specifically and reversibly to short recognition pep-
tides of six to ten histidines that can be genetically encoded to the C- or N-terminus
or inserted within accessible loops of the target protein. Moreover, they are read-
ily and economically produced from commercially available compounds. Applied
to the 5-HT3 receptor in live cells, we succeeded in determining plasma membrane
distribution, receptor-ligand interactions and structural information on a ensemble
of receptors. This new labelling method was further used to detect single receptors
in the cell membrane and yielded information on their lateral mobility in different
functional states. These NTA-probes represent a significant advantage over conven-
tional methods (i.e. covalent labelling) for single molecule microscopy. They allow
the successive labelling of receptors and therefore to record several movies on the
same cell reducing significantly the time needed to obtain sufficient trajectories for
a statistical evaluation. Moreover, this new method overcomes the irreversible pho-
tobleaching of organic fluorophores as well as the large size of e.g. quantum dots
or antibodies. These small reporters should allow to access confined regions, like
synapses, and to report on the organization and dynamics of their constituents.
Single-molecule microscopy revealed a surprising modulation of the receptor’s
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lateral mobility by the agonist serotonin. Desensitized 5-HT3 receptors were signif-
icantly less mobile then receptors in the resting state. Receptors might accumulate
where and when serotonin is released by a neighbor neuron resulting in the for-
mation a synapse. Thus serotonin might be instrumental in serotonergic synapse
development. Nevertheless, the mechanism involved in this decrease of lateral mo-
bility is unclear. This could arise from an increased interaction of the receptor with
the cellular membrane or the cytoskeletal network due to structural changes within
the transmembrane domain or the intracellular domain, respectively. The mobility
of the receptor in its open state was not investigated. Nevertheless this would be
accessed using a slow desensitizing mutant receptor like the one presented in chapter
5 for instance.
The receptor mutants developed are powerful tools. The receptor containing
no cysteine has shown to be fully functional. Therefore, cysteine residues can be in-
serted within the whole receptor sequence where they do not interfere with the func-
tionality of the receptor allowing thus the insertion of multiple reporter probes. We
demonstrated that a rhodamine fluorophore tethered to a cysteine residue could re-
port conformational transitions of the receptor upon activation. However, other fluo-
rescent reporters would have been even more sensitive towards environment changes
like electrostatic sensitive [236] or environment sensitive dyes [237].
The high conductive receptor mutant, where three arginine residues in the
cytosolic loop where replaced, allowed to resolve multiple conductive levels. In
single-channel patch-clamp experiments, the activity of the unliganded receptor was
relatively high indicating that the receptor mutants in the resting state might be
opened or partially opened. In a whole-cell patch-clamp experiment, channel block-
ers or antagonists should result in a decrease of the current according to the hy-
pothesis. This would give an explanation to the low currents observed in whole-cell
patches.
This work is not at its end but valuable tools were developed to decipher the
dynamics of the 5-HT3A receptor. More insights of the gating mechanism of the 5-
HT3 receptor will be obtained using a high conductance receptor mutant containing
a single cysteine that can be fluorescently labelled. Using single molecule microscopy
and single-channel patch-clamp, conformational changes and electrical current will
be simultaneously measured. The ionic current could be even more resolved using
adequate buffers.
Abbreviations
5-HT serotonin, 5-hydroxytryptamine
5-HT3R serotonin type 3 receptor
AChBP acetylcholine binding protein
ACP acyl carrier protein
Ala alanine
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
ATP adenosine triphosphate
BirA biotin ligase
BLM black lipid membrane
BS binding site
cAMP cyclic adenosine diphosphate
CHO Chinese hamster ovary
Cys cysteine
D diffusion coefficient
DA dopamine
DHFR dihydrofolate reductase
DMEM Dubelcco’s modified Eagle medium
DMF dimethylformamide
DMSO dimethylsulfoxide
DNA deoxyribonucleic acid
D-PBS Dulbecco’s phosphate-buffered saline
EC50 half maximal effective concentration
EDT ethanedithiol
EDTA ethylenediaminetetraacetic acid
EGFP enhanced green fluorescent protein
EGTA ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid
ER endoplasmic reticulum
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FCS fluorescence correlation spectroscopy
FKBP FK506 binding protein
FlAsH fluorescein arsenical helix binder
FRAP fluorescence recovery after photobleaching
FRET fluorescence resonance energy transfer
GABA γ-aminobutyric acid
GFP green fluorescent protein
Gln glutamine
GluR glutamate receptor
Gly glycine
GPCR G protein-coupled receptor
GR 1,2,3,9 tetrahydro-3-[(5-methyl-1H-imidazol-4-yl)methyl]-9-
(3-amino-propyl)-4H-carbazol-4-one
GR-flu 1,2,3,9 tetrahydro-3-[(5-methyl-1H-imidazol-4-yl)methyl]-9-
(3-amino-(N-fluorescein-thiocarbamoyl)-propyl)-4H-carbazol-4-one
hAGT O6-alkylguanine-DNA-alkyltransferase
HEPES 4-(2-hydroxyethyl)-1-piperazine-1-ethanesulfonic acid
HEK-293 human embryonic kidney cell
His histidine
HPLC high pressure liquid chromatography
IC50 half maximal inhibitory concentration
IP3 inositol trisphosphate
IPTG isopropyl thiogalactoside
IUPHAR international union of pharmacology
kon association rate constant
koff dissociation rate constant
K a association constant
K d dissociation constant
l liter
LGIC ligand-gated ion channel
M molar (mol/l)
mCPBG m-chlorophenylbiguanide
MHC major histocompatibility complex
mol mole
MSD mean square displacement
MTS methanethiosulfonate
MTSEA 2-aminoethyl-methanethiosulfonate or methanethiosulphonate
ethylammonium
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MTSES 2-sulfonatoethyl-methanthiosulfonate
MTSET 2-trimethylammonioethyl-methanethiosulfonate
MW molecular weight
NCBI national center for biotechnology information
http://www.ncbi.nlm.nih.gov
NMDA N-methyl-D-aspartic acid
NTA nitrilotriacetic acid
NTA-lysine N-(5-amino-1-carboxypentyl)iminodiacetic acid
OD optical density
P2x purinergic receptor
PBS phosphate-buffered saline
PLP pyridoxal-5’-phosphate
PPTase phosphopantetheine transferase
Pro proline
SCAM substituted-cysteine accessibility method
Ser serine
SDS-PAGE sodium dodecylsulfate polyacrylamide gel electrophoresis
SMI single molecule imaging
SMS single molecule spectroscopy
Thr threonine
TLC thin layer chromatography
TM transmembrane domain
tRNA transfer ribonucleic acid
wt wild-type
YFP yellow fluorescent protein
ZAC zinc activated channel
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Appendices
A.1 Oligonucleotides for site-directed mutagenesis
Oligonucleotide sequences used for site-directed mutagenesis. Mutated or inserted
nucleic acids are underlined. The numbering in the primer names (from 291 to 308)
corresponds to the target sequence of 5-HT3R-∆Cys-His10 whose sequence is pre-
sented in appendix A.3.
p10xHis-wtGFPfor 5’-G GAG GAA TAA ACC ATG GGG GGA TCC CAT CAC CAT
CAC CAT CAT CAT CAT CAT CAT GG-3’
p10xHis-wtGFPrev 5’-CC ATG ATG ATG ATG ATG ATG GTG ATG GTG ATG GGA
TCC CCC CAT GGT TTA TTC CTC C-3’
5HT3a-∆cysfor 5’-C ACA TCT GGG AAG CTT GCC ATG CGG-3’
5HT3a-∆cysrev 5’-A TAG TTT AGC GGC CGC TCA ATG GTG ATG GTG ATG
GTG ATG GTG ATG GTG AGA ATA ATG CCA AAT GGA CCA
G-3’
5HT3aV291Cfor 5’-CTT CTG GGA TAC TCA TGC TTC CTG ATC ATC GTG TCA
GA-3’
5HT3aV291Crev 5’-TCT GAC ACG ATG ATC AGG AAG CAT GAG TAT CCC AGA
AG-3’
5HT3aF292Cfor 5’-GGG ATA CTC AGT CTG CCT CAT CAT CGT GTC AG-3’
5HT3aF292Crev 5’-CTG ACA CGA TGA TGA GGC AGA CTG AGT ATC CC-3’
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5HT3aL293Cfor 5’-GAT ACT CAG TCT TCT GCA TCA TCG TGT CAG ACA-3’
5HT3aL293Crev 5’-TGT CTG ACA CGA TGA TGC AGA AGA CTG AGT ATC-3’
5HT3aI294Cfor 5’-GGG ATA CTC AGT CTT CCT CTG CAT CGT GTC AGA C-3’
5HT3aI294Crev 5’-GTC TGA CAC GAT GCA GAG GAA GAC TGA GTA TCC C-3’
5HT3aI295Cfor 5’-CAG TCT TCC TCA TCT GCG TGT CAG ACA CAC TGC C-3’
5HT3aI295Crev 5’-GGC AGT GTG TCT GAC ACG CAG ATG AGG AAG ACT G-3’
5HT3aV296Cfor 5’-GTC TTC CTA ATC ATC TGC TCA GAC ACA CTG CCG-3’
5HT3aV296Crev 5’-CGG CAG TGT GTC TGA GCA GAT GAT GAG GAA GAC-3’
5HT3aS297Cfor 5’-CTT CCT CAT CAT CGT GTG TGA CAC ACT GCC GGC-3’
5HT3aS297Crev 5’-GCC GGC AGT GTG TCA CAC ACG ATG ATG AGG AAG-3’
5HT3aD298Cfor 5’-CCT CAT CAT CGT GTC ATG CAC ACT GCC GGC-3’
5HT3aD298Crev 5’-GCC GGC AGT GTG CAT GAC ACG ATG ATG AGG-3’
5HT3aT299Cfor 5’-CAT CAT CGT GTC AGA CTG TCT GCC GGC AAC GG-3’
5HT3aT299Crev 5’-CCG TTG CCG GCA GAC AGT CTG ACA CGA TGA TG-3’
5HT3aL300Cfor 5’-CAT CGT GTC AGA CAC ATG TCC GGC AAC GGC CAT CG-3’
5HT3aL300Crev 5’-CGA TGG CCG TTG CCG GAC ATG TGT CTG ACA CGA TG-3’
5HT3aP301Cfor 5’-CGT GTC AGA CAC ACT GTG CGC AAC GGC CAT CG-3’
5HT3aP301Crev 5’-CGA TGG CCG TTG CGC ACA GTG TGT CTG ACA CG-3’
5HT3aA302Cfor 5’-CGT GTC AGA CAC ACT GCC GTG TAC GGC CAT CGG TAC
C-3’
5HT3aA302Crev 5’-GGT ACC GAT GGC CGT ACA CGG CAG TGT GTC TGA CAC
G-3’
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5HT3aT303Cfor 5’-GAC ACA CTG CCG GCA TGT GCC ATC GGT ACC C-3’
5HT3aT303Crev 5’-GGG TAC CGA TGG CAC ATG CCG GCA GTG TGT C-3’
5HT3aA304Cfor 5’-CAC ACT GCC GGC AAC GTG CAT CGG TAC CCC-3’
5HT3aA304Crev 5’-GGG GTA CCG ATG CAC GTT GCC GGC AGT GTG-3’
5HT3aI305Cfor 5’-GGC AAC GGC CTG CGG TAC CCC C-3’
5HT3aI305Crev 5’-GGG GGT ACC GCA GGC CGT TGC C-3’
5HT3aG306Cfor 5’-GCA ACG GCC ATC TGT ACC CCC CTC-3’
5HT3aG306Crev 5’-GAG GGG GGT ACA GAT GGC CGT TGC-3’
5HT3aT307Cfor 5’-GCA ACG GCC ATC GGT TGC CCC CTC ATT GGT GTC-3’
5HT3aT307Crev 5’-GAC ACC AAT GAG GGG GCA ACC GAT GGC CGT TGC-3’
5HT3aP308Cfor 5’-CGG CCA TCG GTA CCT GCC TCA TTG GTG TCT AC-3’
5HT3aP308Cfor 5’-GTA GAC ACC AAT GAG GCA GGT ACC GAT GGC CG-3’
5HT3aQDAfor 5’-C CAC TTC CTG GAG AAG CAG GAT GAG ATG GAT GAG GTG
GCA GCG GAC TGG CTG CGG GTG G-3’
5HT3aQDArev 5’-C CAC CCG CAG CCA GTC CGC TGC CAC CTC ATC CAT CTC
ATC CTG CTT CTC CAG GAA GTG G-3’
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A.2 Sequence of the 5-HT3R-C-His10
A.2.1 Nucleotide sequence
1 AAA GCT TAC TCC ACC atg CGG CTC TGC ATC CCG CAG GTG CTG TTG
11 GCC TTG TTC CTT TCC ATG CTG ACA GCG CCG GGA GAA GGC AGC CGG
26 AGG AGG GCC ACC CAG GCC CGA GAT ACC ACC CAG CCT GCT CTA CTA
41 AGG CTG TCA GAC CAC CTC CTG GCT AAC TAC AAG AAG GGG GTG CGG
56 CCT GTG CGG GAC TGG AGG AAG CCT ACT ACT GTC TCC ATT GAT GTC
71 ATC ATG TAT GCC ATC CTC AAC GTG GAT GAG AAG AAC CAG GTT CTG
86 ACC ACC TAC ATA TGG TAC CGG CAG TAC TGG ACT GAT GAG TTT CTG
101 CAG TGG ACT CCT GAG GAC TTC GAC AAT GTC ACC AAA TTG TCC ATC
116 CCC ACA GAC AGC ATC TGG GTC CCT GAC ATT CTC ATC AAT GAG TTT
131 GTG GAC GTG GGG AAG TCT CCG AAC ATT CCT TAT GTG TAC GTG CAT
146 CAT CGA GGT GAA GTT CAG AAC TAC AAG CCC TTG CAA TTG GTG ACC
161 GCC TGT AGC CTT GAC ATC TAC AAC TTC CCC TTT GAT GTG CAG AAC
176 TGT TCT CTG ACT TTC ACC AGC TGG CTG CAC ACC ATC CAG GAC ATC
191 AAC ATT ACT CTG TGG CGA TCA CCG GAA GAA GTG AGG TCT GAC AAG
206 AGC ATC TTC ATA AAT CAG GGC GAG TGG GAG CTG CTG GAG GTG TTC
221 CCC CAG TTC AAG GAG TTC AGC ATA GAT ATC AGT AAC AGC TAT GCA
236 GAA ATG AAG TTC TAC GTG ATC ATC CGC CGG AGG CCT TTA TTC TAT
251 GCA GTC AGC CTC TTG CTG CCC AGT ATC TTC CTC ATG GTC GTG GAC
266 ATT GTG GGC TTT TGC CTG CCC CCG GAC AGT GGT GAG AGA GTC TCT
281 TTT AAG ATC ACA CTC CTT CTG GGA TAC TCA GTC TTC CTC ATC ATC
296 GTG TCA GAC ACA CTG CCG GCA ACG GCC ATC GGT ACC CCC CTC ATT
311 GGT GTC TAC TTT GTG GTG TGC ATG GCT CTG CTA GTG ATA AGC CTC
326 GCT GAG ACC ATC TTC ATT GTG CGG CTG GTG CAT AAG CAG GAC CTA
341 CAG CGG CCA GTA CCT GAC TGG CTG AGG CAC CTG GTC CTA GAC AGA
356 ATA GCC TGG ATA CTC TGC CTA GGG GAG CAG CCT ATG GCC CAT AGA
371 CCC CCA GCC ACC TTC CAA GCC AAC AAG ACT GAT GAC TGC TCA GCC
386 ATG GGA AAC CAC TGC AGC CAT GTT GGA GGA CCT CAG GAC TTG GAG
401 AAG ACC CCA AGG GGC AGA GGT AGC CCT CTT CCA CCA CCA AGG GAG
416 GCC TCA CTG GCT GTG CGT GGT CTC TTG CAA GAG CTA TCC TCC ATC
431 CGC CAC TTC CTG GAG AAG CGG GAT GAG ATG CGG GAG GTG GCA AGG
446 GAC TGG CTG CGG GTG GGA TAC GTG CTG GAC AGG CTG CTG TTC CGC
461 ATC TAC CTG CTG GCT GTG CTC GCT TAC AGC ATC ACC CTG GTC ACT
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476 CTC TGG TCC ATT TGG CAT TAT TCT CAC CAC CAT CAT CAC CAC CAT
491 CAT CAC CAC tga GCG GCC GCA
5’ to 3’ nucleotide sequence of the 5-HT3R-C-His10. The numbers correspond to
the codons starting from the ATG start codon until the TGA stop codon indicated
in lower cases. The membrane targeting signal sequence is indicated in italics. The
underlined nucleotides correspond to the restriction sites of Hind III and Not I, re-
spectively. For more details, see section 3.3.2.
A.2.2 Amino acid sequence
1 MRLCI PQVLL ALFLS MLTAP GEG SR RRATQ ARDTT QPALL RLSDH LLANY
51 KKGVR PVRDW RKPTT VSIDV IMYAI LNVDE KNQVL TTYIW YRQYW TDEFL
101 QWTPE DFDNV TKLSI PTDSI WVPDI LINEF VDVGK SPNIP YVYVH HRGEV
151 QNYKP LQLVT ACSLD IYNFP FDVQN CSLTF TSWLH TIQDI NITLW RSPEE
201 VRSDK SIFIN QGEWE LLEVF PQFKE FSIDI SNSYA EMKFY VIIRR RPLFY
251 AVSLL LPSIF LMVVD IVGFC LPPDS GERVS FKITL LLGYS VFLII VSDTL
301 PATAI GTPLI GVYFV VCMAL LVISL AETIF IVRLV HKQDL QRPVP DWLRH
351 LVLDR IAWIL CLGEQ PMAHR PPATF QANKT DDCSA MGNHC SHVGG PQDLE
401 KTPRG RGSPL PPPRE ASLAV RGLLQ ELSSI RHFLE KRDEM REVAR DWLRV
451 GYVLD RLLFR IYLLA VLAYS ITLVT LWSIW HYSHH HHHHH HHH
Amino acid sequence of the 5-HT3R-C-His10. The numbering does not correspond
to the SwissPort entry p23979 due to conflict regions (see section 3.3.2). The 23
amino acids in italics correspond to the membrane targeting signal sequence.
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A.3 Sequence of the 5-HT3R-∆Cys-His10
A.3.1 Nucleotide sequence
1 AAG CTT GCC atg CGG CTC TGC ATC CCG CAG GTG CTG TTG GCC TTG
13 TTC CTT TCC ATG CTG ACA GCC CCG GGA GAA GGC AGC CGG AGG AGG
28 GCC ACC CAG GCC CGA GAT ACC ACC CAG CCT GCT CTA CTA AGG CTG
43 TCA GAC CAC CTC CTG GCT AAC TAC AAG AAG GGG GTG CGG CCT GTG
58 CGG GAC TGG AGG AAG CCT ACT ACT GTC TCC ATT GAT GTC ATC ATG
73 TAT GCC ATC CTC AAC GTG GAT GAG AAG AAC CAG GTT CTG ACC ACC
88 TAC ATA TGG TAC CGG CAG TAC TGG ACT GAT GAG TTT CTG CAG TGG
103 ACT CCT GAG GAC TTC GAC AAT GTC ACC AAA TTG TCC ATC CCC ACA
118 GAC AGC ATC TGG GTC CCT GAC ATT CTC ATC AAT GAG TTT GTG GAC
133 GTG GGG AAG TCT CCG AAC ATT CCT TAT GTG TAC GTG CAT CAT CGA
148 GGT GAA GTT CAG AAC TAC AAG CCC TTG CAA TTG GTG ACC GCC TGT
163 AGC CTT GAC ATC TAC AAC TTC CCC TTT GAT GTG CAG AAC TGT TCT
178 CTG ACT TTC ACC AGC TGG CTG CAC ACC ATC CAG GAC ATC AAC ATT
193 ACT CTG TGG CGA TCA CCG GAA GAA GTG AGG TCT GAC AAG AGC ATC
208 TTC ATA AAT CAG GGC GAG TGG GAG CTG CTG GAG GTG TTC CCC CAG
223 TTC AAG GAG TTC AGC ATA GAT ATC AGT AAC AGC TAT GCA GAA ATG
238 AAG TTC TAC GTG ATC ATC CGC CGG AGG CCT TTA TTC TAT GCA GTC
253 AGC CTC TTG CTG CCC AGT ATC TTC CTC ATG GTC GTC GAC ATT GTG
268 GGC TTT TCC CTG CCC CCG GAC AGT GGT GAG AGA GTC TCT TTC AAG
283 ATC ACA CTC CTT CTG GGA TAC TCA GTC TTC CTC ATC ATC GTG TCA
298 GAC ACA CTG CCG GCA ACG GCC ATC GGT ACC CCC CTC ATT GGT GTC
313 TAC TTT GTG GTG TCC ATG GCT CTA CTA GTG ATA AGC CTC GCT GAG
328 ACC ATC TTC ATT GTG CGG CTG GTG CAT AAG CAG GAC CTA CAG CGG
343 CCA GTA CCT GAC TGG CTG AGG CAC CTG GTC CTA GAC AGA ATA GCC
358 TGG ATC CTC TCC CTA GGG GAG CAG CCT ATG GCC CAT AGA CCC CCA
373 GCC ACC TTC CAA GCC AAC AAG ACT GAT GAC TCC TCA GGT TCT GAT
388 CTC CTC CCA GCC ATG GGA AAC CAC TCC AGC CAT GTT GGA GGG CCC
403 CAG GAC TTG GAG AAG ACC CCA AGG GGC AGA GGT AGC CCT CTT CCA
418 CCA CCA AGG GAG GCC TCA CTG GCT GTG CGT GGT CTC TTG CAA GAG
433 CTA TCC TCC ATC CGC CAC TTC CTG GAG AAG CGG GAT GAG ATG CGG
448 GAG GTG GCA AGG GAC TGG CTG CGG GTG GGA TAC GTG CTG GAC AGG
463 CTG CTG TTC CGC ATC TAC CTG CTG GCT GTG CTC GCT TAC AGC ATC
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478 ACC CTG GTC ACT CTC TGG TCC ATT TGG CAT TAT TCT CAC CAT CAC
493 CAT CAC CAT CAC CAT CAC CAT tga GCG GCC GC
5’ to 3’ nucleotide sequence of the 5-HT3R-∆Cys-His10 where all cysteines were
replaced by serine except the two that form the disulfide bridge. The numbers cor-
respond to the codons starting from the ATG start codon until the TGA stop codon
indicated in lower cases. The membrane targeting signal sequence is indicated in
italics. The underlined nucleotides correspond to the restriction sites of Hind III,
EcoR V, BamH I and Not I, respectively. For more details, see section 4.3.2 and
figure 4.3.a.
A.3.2 Amino acid sequence
1 MRLCI PQVLL ALFLS MLTAP GEG SR RRATQ ARDTT QPALL RLSDH LLANY
51 KKGVR PVRDW RKPTT VSIDV IMYAI LNVDE KNQVL TTYIW YRQYW TDEFL
101 QWTPE DFDNV TKLSI PTDSI WVPDI LINEF VDVGK SPNIP YVYVH HRGEV
151 QNYKP LQLVT ACSLD IYNFP FDVQN CSLTF TSWLH TIQDI NITLW RSPEE
201 VRSDK SIFIN QGEWE LLEVF PQFKE FSIDI SNSYA EMKFY VIIRR RPLFY
251 AVSLL LPSIF LMVVD IVGFS LPPDS GERVS FKITL LLGYS VFLII VSDTL
301 PATAI GTPLI GVYFV VSMAL LVISL AETIF IVRLV HKQDL QRPVP DWLRH
351 LVLDR IAWIL SLGEQ PMAHR PPATF QANKT DDSSG SDLLP AMGNH SSHVG
401 GPQDL EKTPR GRGSP LPPPR EASLA VRGLL QELSS IRHFL EKRDE MREVA
451 RDWLR VGYVL DRLLF RIYLL AVLAY SITLV TLWSI WHYSH HHHHH HHHH
Amino acid sequence of the 5-HT3R-∆Cys-His10. Cys162 and Cys176 form a disul-
fide bridge (this numbering do not correspond to the SwissPort entry p23979 due to
conflict regions, see section 4.3.2). All other Cysteines were replaced by Serine. The
23 amino acids in italics correspond to the membrane targeting signal sequence.
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